id	sid	tid	token	lemma	pos
ajbspi-34500	1	1	volume	volume	NOUN
ajbspi-34500	1	2	04	04	NUM
ajbspi-34500	1	3	issue	issue	NOUN
ajbspi-34500	1	4	03	03	NUM
ajbspi-34500	1	5	-	-	SYM
ajbspi-34500	1	6	2024	2024	NUM
ajbspi-34500	1	7	36	36	NUM
ajbspi-34500	1	8	american	american	ADJ
ajbspi-34500	1	9	journal	journal	PROPN
ajbspi-34500	1	10	of	of	ADP
ajbspi-34500	1	11	biomedical	biomedical	PROPN
ajbspi-34500	1	12	science	science	PROPN
ajbspi-34500	1	13	&	&	CCONJ
ajbspi-34500	1	14	pharmaceutical	pharmaceutical	PROPN
ajbspi-34500	1	15	innovation	innovation	NOUN
ajbspi-34500	1	16	(	(	PUNCT
ajbspi-34500	1	17	issn	issn	PROPN
ajbspi-34500	1	18	–	–	PUNCT
ajbspi-34500	1	19	2771	2771	NUM
ajbspi-34500	1	20	-	-	SYM
ajbspi-34500	1	21	2753	2753	NUM
ajbspi-34500	1	22	)	)	PUNCT
ajbspi-34500	1	23	volume	volume	NOUN
ajbspi-34500	1	24	04	04	NUM
ajbspi-34500	1	25	issue	issue	NOUN
ajbspi-34500	1	26	03	03	NUM
ajbspi-34500	1	27	pages	page	NOUN
ajbspi-34500	1	28	:	:	PUNCT
ajbspi-34500	1	29	36	36	NUM
ajbspi-34500	1	30	-	-	SYM
ajbspi-34500	1	31	43	43	NUM
ajbspi-34500	1	32	sjif	sjif	NOUN
ajbspi-34500	1	33	impact	impact	NOUN
ajbspi-34500	1	34	factor	factor	NOUN
ajbspi-34500	1	35	(	(	PUNCT
ajbspi-34500	1	36	2022	2022	NUM
ajbspi-34500	1	37	:	:	PUNCT
ajbspi-34500	1	38	5	5	NUM
ajbspi-34500	1	39	.	.	NOUN
ajbspi-34500	1	40	705	705	NUM
ajbspi-34500	1	41	)	)	PUNCT
ajbspi-34500	1	42	(	(	PUNCT
ajbspi-34500	1	43	2023	2023	NUM
ajbspi-34500	1	44	:	:	PUNCT
ajbspi-34500	1	45	6.534	6.534	NUM
ajbspi-34500	1	46	)	)	PUNCT
ajbspi-34500	1	47	(	(	PUNCT
ajbspi-34500	1	48	2024	2024	NUM
ajbspi-34500	1	49	:	:	PUNCT
ajbspi-34500	1	50	7.7	7.7	NUM
ajbspi-34500	1	51	)	)	PUNCT
ajbspi-34500	1	52	oclc	oclc	PROPN
ajbspi-34500	1	53	–	–	PUNCT
ajbspi-34500	1	54	1121105677	1121105677	NUM
ajbspi-34500	1	55	publisher	publisher	NOUN
ajbspi-34500	1	56	:	:	PUNCT
ajbspi-34500	1	57	oscar	oscar	NOUN
ajbspi-34500	1	58	publishing	publishing	NOUN
ajbspi-34500	1	59	services	service	NOUN
ajbspi-34500	1	60	servi	servi	ADJ
ajbspi-34500	1	61	abstract	abstract	ADJ
ajbspi-34500	1	62	glomerular	glomerular	ADJ
ajbspi-34500	1	63	kidney	kidney	NOUN
ajbspi-34500	1	64	damage	damage	NOUN
ajbspi-34500	1	65	glomerulonephritis	glomerulonephritis	NOUN
ajbspi-34500	1	66	(	(	PUNCT
ajbspi-34500	1	67	gn	gn	PROPN
ajbspi-34500	1	68	)	)	PUNCT
ajbspi-34500	1	69	is	be	AUX
ajbspi-34500	1	70	one	one	NUM
ajbspi-34500	1	71	of	of	ADP
ajbspi-34500	1	72	the	the	DET
ajbspi-34500	1	73	serious	serious	ADJ
ajbspi-34500	1	74	medical	medical	ADJ
ajbspi-34500	1	75	and	and	CCONJ
ajbspi-34500	1	76	economic	economic	ADJ
ajbspi-34500	1	77	problems	problem	NOUN
ajbspi-34500	1	78	.	.	PUNCT
ajbspi-34500	2	1	often	often	ADV
ajbspi-34500	2	2	,	,	PUNCT
ajbspi-34500	2	3	gn	gn	PROPN
ajbspi-34500	2	4	is	be	AUX
ajbspi-34500	2	5	the	the	DET
ajbspi-34500	2	6	main	main	ADJ
ajbspi-34500	2	7	cause	cause	NOUN
ajbspi-34500	2	8	of	of	ADP
ajbspi-34500	2	9	end	end	NOUN
ajbspi-34500	2	10	-	-	PUNCT
ajbspi-34500	2	11	stage	stage	NOUN
ajbspi-34500	2	12	chronic	chronic	ADJ
ajbspi-34500	2	13	renal	renal	ADJ
ajbspi-34500	2	14	failure	failure	NOUN
ajbspi-34500	2	15	,	,	PUNCT
ajbspi-34500	2	16	which	which	PRON
ajbspi-34500	2	17	is	be	AUX
ajbspi-34500	2	18	incompatible	incompatible	ADJ
ajbspi-34500	2	19	with	with	ADP
ajbspi-34500	2	20	life	life	NOUN
ajbspi-34500	2	21	and	and	CCONJ
ajbspi-34500	2	22	requires	require	VERB
ajbspi-34500	2	23	renal	renal	ADJ
ajbspi-34500	2	24	replacement	replacement	NOUN
ajbspi-34500	2	25	therapy	therapy	NOUN
ajbspi-34500	2	26	(	(	PUNCT
ajbspi-34500	2	27	dialysis	dialysis	NOUN
ajbspi-34500	2	28	,	,	PUNCT
ajbspi-34500	2	29	donor	donor	NOUN
ajbspi-34500	2	30	kidney	kidney	NOUN
ajbspi-34500	2	31	transplantation	transplantation	NOUN
ajbspi-34500	2	32	)	)	PUNCT
ajbspi-34500	3	1	[	[	X
ajbspi-34500	3	2	2	2	NUM
ajbspi-34500	3	3	]	]	PUNCT
ajbspi-34500	3	4	.	.	PUNCT
ajbspi-34500	4	1	according	accord	VERB
ajbspi-34500	4	2	to	to	ADP
ajbspi-34500	4	3	the	the	DET
ajbspi-34500	4	4	course	course	NOUN
ajbspi-34500	4	5	of	of	ADP
ajbspi-34500	4	6	the	the	DET
ajbspi-34500	4	7	disease	disease	NOUN
ajbspi-34500	4	8	,	,	PUNCT
ajbspi-34500	4	9	there	there	PRON
ajbspi-34500	4	10	is	be	VERB
ajbspi-34500	4	11	an	an	DET
ajbspi-34500	4	12	acute	acute	ADJ
ajbspi-34500	4	13	form	form	NOUN
ajbspi-34500	4	14	of	of	ADP
ajbspi-34500	4	15	gn	gn	PROPN
ajbspi-34500	4	16	(	(	PUNCT
ajbspi-34500	4	17	the	the	DET
ajbspi-34500	4	18	duration	duration	NOUN
ajbspi-34500	4	19	of	of	ADP
ajbspi-34500	4	20	the	the	DET
ajbspi-34500	4	21	disease	disease	NOUN
ajbspi-34500	4	22	is	be	AUX
ajbspi-34500	4	23	less	less	ADJ
ajbspi-34500	4	24	than	than	ADP
ajbspi-34500	4	25	one	one	NUM
ajbspi-34500	4	26	year	year	NOUN
ajbspi-34500	4	27	)	)	PUNCT
ajbspi-34500	4	28	and	and	CCONJ
ajbspi-34500	4	29	chronic	chronic	ADJ
ajbspi-34500	4	30	(	(	PUNCT
ajbspi-34500	4	31	the	the	DET
ajbspi-34500	4	32	duration	duration	NOUN
ajbspi-34500	4	33	of	of	ADP
ajbspi-34500	4	34	the	the	DET
ajbspi-34500	4	35	disease	disease	NOUN
ajbspi-34500	4	36	is	be	AUX
ajbspi-34500	4	37	more	more	ADJ
ajbspi-34500	4	38	than	than	ADP
ajbspi-34500	4	39	one	one	NUM
ajbspi-34500	4	40	year	year	NOUN
ajbspi-34500	4	41	)	)	PUNCT
ajbspi-34500	4	42	.	.	PUNCT
ajbspi-34500	5	1	in	in	ADP
ajbspi-34500	5	2	clinical	clinical	ADJ
ajbspi-34500	5	3	practice	practice	NOUN
ajbspi-34500	5	4	,	,	PUNCT
ajbspi-34500	5	5	there	there	PRON
ajbspi-34500	5	6	are	be	VERB
ajbspi-34500	5	7	often	often	ADV
ajbspi-34500	5	8	difficulties	difficulty	NOUN
ajbspi-34500	5	9	in	in	ADP
ajbspi-34500	5	10	timely	timely	ADJ
ajbspi-34500	5	11	differentiation	differentiation	NOUN
ajbspi-34500	5	12	of	of	ADP
ajbspi-34500	5	13	chronic	chronic	ADJ
ajbspi-34500	5	14	gn	gn	PROPN
ajbspi-34500	5	15	and	and	CCONJ
ajbspi-34500	5	16	acute	acute	ADJ
ajbspi-34500	5	17	gn	gn	PROPN
ajbspi-34500	5	18	exacerbation	exacerbation	NOUN
ajbspi-34500	5	19	,	,	PUNCT
ajbspi-34500	5	20	in	in	ADP
ajbspi-34500	5	21	particular	particular	ADJ
ajbspi-34500	5	22	,	,	PUNCT
ajbspi-34500	5	23	in	in	ADP
ajbspi-34500	5	24	the	the	DET
ajbspi-34500	5	25	urinary	urinary	ADJ
ajbspi-34500	5	26	(	(	PUNCT
ajbspi-34500	5	27	hidden	hidden	ADJ
ajbspi-34500	5	28	)	)	PUNCT
ajbspi-34500	5	29	form	form	NOUN
ajbspi-34500	5	30	of	of	ADP
ajbspi-34500	5	31	the	the	DET
ajbspi-34500	5	32	disease	disease	NOUN
ajbspi-34500	5	33	,	,	PUNCT
ajbspi-34500	5	34	due	due	ADP
ajbspi-34500	5	35	to	to	ADP
ajbspi-34500	5	36	the	the	DET
ajbspi-34500	5	37	lack	lack	NOUN
ajbspi-34500	5	38	of	of	ADP
ajbspi-34500	5	39	clear	clear	ADJ
ajbspi-34500	5	40	criteria	criterion	NOUN
ajbspi-34500	5	41	for	for	ADP
ajbspi-34500	5	42	their	their	PRON
ajbspi-34500	5	43	diagnosis	diagnosis	NOUN
ajbspi-34500	5	44	.	.	PUNCT
ajbspi-34500	6	1	keywords	keyword	NOUN
ajbspi-34500	6	2	chronic	chronic	ADJ
ajbspi-34500	6	3	glomerulonephritis	glomerulonephritis	NOUN
ajbspi-34500	6	4	,	,	PUNCT
ajbspi-34500	6	5	cytokine	cytokine	ADJ
ajbspi-34500	6	6	balance	balance	NOUN
ajbspi-34500	6	7	,	,	PUNCT
ajbspi-34500	6	8	children	child	NOUN
ajbspi-34500	6	9	.	.	PUNCT
ajbspi-34500	7	1	introduction	introduction	NOUN
ajbspi-34500	7	2	glomerular	glomerular	ADJ
ajbspi-34500	7	3	kidney	kidney	NOUN
ajbspi-34500	7	4	damage	damage	NOUN
ajbspi-34500	7	5	glomerulonephritis	glomerulonephritis	NOUN
ajbspi-34500	7	6	(	(	PUNCT
ajbspi-34500	7	7	gn	gn	PROPN
ajbspi-34500	7	8	)	)	PUNCT
ajbspi-34500	7	9	is	be	AUX
ajbspi-34500	7	10	one	one	NUM
ajbspi-34500	7	11	of	of	ADP
ajbspi-34500	7	12	the	the	DET
ajbspi-34500	7	13	serious	serious	ADJ
ajbspi-34500	7	14	medical	medical	ADJ
ajbspi-34500	7	15	and	and	CCONJ
ajbspi-34500	7	16	economic	economic	ADJ
ajbspi-34500	7	17	problems	problem	NOUN
ajbspi-34500	7	18	.	.	PUNCT
ajbspi-34500	8	1	often	often	ADV
ajbspi-34500	8	2	,	,	PUNCT
ajbspi-34500	8	3	gn	gn	PROPN
ajbspi-34500	8	4	is	be	AUX
ajbspi-34500	8	5	the	the	DET
ajbspi-34500	8	6	main	main	ADJ
ajbspi-34500	8	7	cause	cause	NOUN
ajbspi-34500	8	8	of	of	ADP
ajbspi-34500	8	9	end	end	NOUN
ajbspi-34500	8	10	-	-	PUNCT
ajbspi-34500	8	11	stage	stage	NOUN
ajbspi-34500	8	12	chronic	chronic	ADJ
ajbspi-34500	8	13	renal	renal	ADJ
ajbspi-34500	8	14	failure	failure	NOUN
ajbspi-34500	8	15	,	,	PUNCT
ajbspi-34500	8	16	which	which	PRON
ajbspi-34500	8	17	is	be	AUX
ajbspi-34500	8	18	incompatible	incompatible	ADJ
ajbspi-34500	8	19	with	with	ADP
ajbspi-34500	8	20	life	life	NOUN
ajbspi-34500	8	21	and	and	CCONJ
ajbspi-34500	8	22	requires	require	VERB
ajbspi-34500	8	23	research	research	NOUN
ajbspi-34500	8	24	article	article	NOUN
ajbspi-34500	8	25	acute	acute	NOUN
ajbspi-34500	8	26	and	and	CCONJ
ajbspi-34500	8	27	disease	disease	NOUN
ajbspi-34500	8	28	with	with	ADP
ajbspi-34500	8	29	glomerulonephritis	glomerulonephritis	NOUN
ajbspi-34500	8	30	cytokine	cytokine	ADJ
ajbspi-34500	8	31	balance	balance	NOUN
ajbspi-34500	8	32	in	in	ADP
ajbspi-34500	8	33	sick	sick	ADJ
ajbspi-34500	8	34	patients	patient	NOUN
ajbspi-34500	8	35	submission	submission	NOUN
ajbspi-34500	8	36	date	date	NOUN
ajbspi-34500	8	37	:	:	PUNCT
ajbspi-34500	8	38	march	march	PROPN
ajbspi-34500	8	39	07	07	NUM
ajbspi-34500	8	40	,	,	PUNCT
ajbspi-34500	8	41	2024	2024	NUM
ajbspi-34500	8	42	,	,	PUNCT
ajbspi-34500	8	43	accepted	accept	VERB
ajbspi-34500	8	44	date	date	NOUN
ajbspi-34500	8	45	:	:	PUNCT
ajbspi-34500	8	46	march	march	NOUN
ajbspi-34500	8	47	12	12	NUM
ajbspi-34500	8	48	,	,	PUNCT
ajbspi-34500	8	49	2024	2024	NUM
ajbspi-34500	8	50	,	,	PUNCT
ajbspi-34500	8	51	published	publish	VERB
ajbspi-34500	8	52	date	date	NOUN
ajbspi-34500	8	53	:	:	PUNCT
ajbspi-34500	8	54	march	march	PROPN
ajbspi-34500	8	55	17	17	NUM
ajbspi-34500	8	56	,	,	PUNCT
ajbspi-34500	8	57	2024	2024	NUM
ajbspi-34500	8	58	crossref	crossref	NOUN
ajbspi-34500	8	59	doi	doi	PROPN
ajbspi-34500	8	60	:	:	PUNCT
ajbspi-34500	8	61	https://doi.org/10.37547/ajbspi/volume04issue03-05	https://doi.org/10.37547/ajbspi/volume04issue03-05	PROPN
ajbspi-34500	8	62	ishkabulova	ishkabulova	PROPN
ajbspi-34500	8	63	gulchexra	gulchexra	PROPN
ajbspi-34500	8	64	djankurazovna	djankurazovna	PROPN
ajbspi-34500	8	65	department	department	PROPN
ajbspi-34500	8	66	of	of	ADP
ajbspi-34500	8	67	pediatrics	pediatric	NOUN
ajbspi-34500	8	68	,	,	PUNCT
ajbspi-34500	8	69	faculty	faculty	NOUN
ajbspi-34500	8	70	of	of	ADP
ajbspi-34500	8	71	medicine	medicine	NOUN
ajbspi-34500	8	72	,	,	PUNCT
ajbspi-34500	8	73	candidate	candidate	NOUN
ajbspi-34500	8	74	of	of	ADP
ajbspi-34500	8	75	medical	medical	ADJ
ajbspi-34500	8	76	sciences	sciences	PROPN
ajbspi-34500	8	77	,	,	PUNCT
ajbspi-34500	8	78	samarkand	samarkand	PROPN
ajbspi-34500	8	79	state	state	PROPN
ajbspi-34500	8	80	medical	medical	PROPN
ajbspi-34500	8	81	university	university	PROPN
ajbspi-34500	8	82	,	,	PUNCT
ajbspi-34500	8	83	samarkand	samarkand	PROPN
ajbspi-34500	8	84	,	,	PUNCT
ajbspi-34500	8	85	uzbekistan	uzbekistan	PROPN
ajbspi-34500	8	86	raxmonkulov	raxmonkulov	PROPN
ajbspi-34500	8	87	shaxzod	shaxzod	PROPN
ajbspi-34500	8	88	islomjon	islomjon	NOUN
ajbspi-34500	8	89	o`g`li	o`g`li	PROPN
ajbspi-34500	8	90	student	student	NOUN
ajbspi-34500	8	91	of	of	ADP
ajbspi-34500	8	92	the	the	DET
ajbspi-34500	8	93	faculty	faculty	NOUN
ajbspi-34500	8	94	of	of	ADP
ajbspi-34500	8	95	pediatrics	pediatric	NOUN
ajbspi-34500	8	96	,	,	PUNCT
ajbspi-34500	8	97	samarkand	samarkand	PROPN
ajbspi-34500	8	98	state	state	PROPN
ajbspi-34500	8	99	medical	medical	PROPN
ajbspi-34500	8	100	university	university	PROPN
ajbspi-34500	8	101	,	,	PUNCT
ajbspi-34500	8	102	samarkand	samarkand	PROPN
ajbspi-34500	8	103	,	,	PUNCT
ajbspi-34500	8	104	uzbekistan	uzbekistan	PROPN
ajbspi-34500	8	105	axtamova	axtamova	PROPN
ajbspi-34500	8	106	shirin	shirin	PROPN
ajbspi-34500	8	107	xayrullaevna	xayrullaevna	PROPN
ajbspi-34500	8	108	student	student	PROPN
ajbspi-34500	8	109	of	of	ADP
ajbspi-34500	8	110	the	the	DET
ajbspi-34500	8	111	faculty	faculty	NOUN
ajbspi-34500	8	112	of	of	ADP
ajbspi-34500	8	113	medicine	medicine	NOUN
ajbspi-34500	8	114	,	,	PUNCT
ajbspi-34500	8	115	samarkand	samarkand	PROPN
ajbspi-34500	8	116	state	state	PROPN
ajbspi-34500	8	117	medical	medical	PROPN
ajbspi-34500	8	118	university	university	PROPN
ajbspi-34500	8	119	,	,	PUNCT
ajbspi-34500	8	120	samarkand	samarkand	PROPN
ajbspi-34500	8	121	,	,	PUNCT
ajbspi-34500	8	122	uzbekistan	uzbekistan	PROPN
ajbspi-34500	8	123	journal	journal	PROPN
ajbspi-34500	8	124	website	website	NOUN
ajbspi-34500	8	125	:	:	PUNCT
ajbspi-34500	8	126	https://theusajournals	https://theusajournals	PROPN
ajbspi-34500	8	127	.	.	PUNCT
ajbspi-34500	8	128	com	com	NOUN
ajbspi-34500	8	129	/	/	SYM
ajbspi-34500	8	130	index.php	index.php	VERB
ajbspi-34500	8	131	/	/	SYM
ajbspi-34500	8	132	ajbspi	ajbspi	NOUN
ajbspi-34500	8	133	copyright	copyright	NOUN
ajbspi-34500	8	134	:	:	PUNCT
ajbspi-34500	8	135	original	original	ADJ
ajbspi-34500	8	136	content	content	NOUN
ajbspi-34500	8	137	from	from	ADP
ajbspi-34500	8	138	this	this	DET
ajbspi-34500	8	139	work	work	NOUN
ajbspi-34500	8	140	may	may	AUX
ajbspi-34500	8	141	be	be	AUX
ajbspi-34500	8	142	used	use	VERB
ajbspi-34500	8	143	under	under	ADP
ajbspi-34500	8	144	the	the	DET
ajbspi-34500	8	145	terms	term	NOUN
ajbspi-34500	8	146	of	of	ADP
ajbspi-34500	8	147	the	the	DET
ajbspi-34500	8	148	creative	creative	ADJ
ajbspi-34500	8	149	commons	common	NOUN
ajbspi-34500	8	150	attributes	attribute	VERB
ajbspi-34500	8	151	4.0	4.0	NUM
ajbspi-34500	8	152	licence	licence	NOUN
ajbspi-34500	8	153	.	.	PUNCT
ajbspi-34500	9	1	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	PROPN
ajbspi-34500	9	2	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	AUX
ajbspi-34500	9	3	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	PROPN
ajbspi-34500	9	4	https://theusajournals.com/	https://theusajournals.com/	PROPN
ajbspi-34500	9	5	https://doi.org/10.37547/ajbspi/volume04issue03-05	https://doi.org/10.37547/ajbspi/volume04issue03-05	PROPN
ajbspi-34500	9	6	https://doi.org/10.37547/ajbspi/volume04issue03-05	https://doi.org/10.37547/ajbspi/volume04issue03-05	NOUN
ajbspi-34500	9	7	https://theusajournals.com/index.php/ajbspi	https://theusajournals.com/index.php/ajbspi	NOUN
ajbspi-34500	9	8	https://theusajournals.com/index.php/ajbspi	https://theusajournals.com/index.php/ajbspi	NOUN
ajbspi-34500	9	9	https://theusajournals.com/index.php/ajbspi	https://theusajournals.com/index.php/ajbspi	NOUN
ajbspi-34500	9	10	https://theusajournals.com/index.php/ajbspi	https://theusajournals.com/index.php/ajbspi	NOUN
ajbspi-34500	9	11	volume	volume	NOUN
ajbspi-34500	9	12	04	04	NUM
ajbspi-34500	9	13	issue	issue	NOUN
ajbspi-34500	9	14	03	03	NUM
ajbspi-34500	9	15	-	-	SYM
ajbspi-34500	9	16	2024	2024	NUM
ajbspi-34500	9	17	37	37	NUM
ajbspi-34500	9	18	american	american	ADJ
ajbspi-34500	9	19	journal	journal	PROPN
ajbspi-34500	9	20	of	of	ADP
ajbspi-34500	9	21	biomedical	biomedical	PROPN
ajbspi-34500	9	22	science	science	PROPN
ajbspi-34500	9	23	&	&	CCONJ
ajbspi-34500	9	24	pharmaceutical	pharmaceutical	PROPN
ajbspi-34500	9	25	innovation	innovation	NOUN
ajbspi-34500	9	26	(	(	PUNCT
ajbspi-34500	9	27	issn	issn	PROPN
ajbspi-34500	9	28	–	–	PUNCT
ajbspi-34500	9	29	2771	2771	NUM
ajbspi-34500	9	30	-	-	SYM
ajbspi-34500	9	31	2753	2753	NUM
ajbspi-34500	9	32	)	)	PUNCT
ajbspi-34500	9	33	volume	volume	NOUN
ajbspi-34500	9	34	04	04	NUM
ajbspi-34500	9	35	issue	issue	NOUN
ajbspi-34500	9	36	03	03	NUM
ajbspi-34500	9	37	pages	page	NOUN
ajbspi-34500	9	38	:	:	PUNCT
ajbspi-34500	9	39	36	36	NUM
ajbspi-34500	9	40	-	-	SYM
ajbspi-34500	9	41	43	43	NUM
ajbspi-34500	9	42	sjif	sjif	NOUN
ajbspi-34500	9	43	impact	impact	NOUN
ajbspi-34500	9	44	factor	factor	NOUN
ajbspi-34500	9	45	(	(	PUNCT
ajbspi-34500	9	46	2022	2022	NUM
ajbspi-34500	9	47	:	:	PUNCT
ajbspi-34500	9	48	5	5	NUM
ajbspi-34500	9	49	.	.	NOUN
ajbspi-34500	9	50	705	705	NUM
ajbspi-34500	9	51	)	)	PUNCT
ajbspi-34500	9	52	(	(	PUNCT
ajbspi-34500	9	53	2023	2023	NUM
ajbspi-34500	9	54	:	:	PUNCT
ajbspi-34500	9	55	6.534	6.534	NUM
ajbspi-34500	9	56	)	)	PUNCT
ajbspi-34500	9	57	(	(	PUNCT
ajbspi-34500	9	58	2024	2024	NUM
ajbspi-34500	9	59	:	:	PUNCT
ajbspi-34500	9	60	7.7	7.7	NUM
ajbspi-34500	9	61	)	)	PUNCT
ajbspi-34500	9	62	oclc	oclc	PROPN
ajbspi-34500	9	63	–	–	PUNCT
ajbspi-34500	9	64	1121105677	1121105677	NUM
ajbspi-34500	9	65	publisher	publisher	NOUN
ajbspi-34500	9	66	:	:	PUNCT
ajbspi-34500	9	67	oscar	oscar	NOUN
ajbspi-34500	9	68	publishing	publishing	NOUN
ajbspi-34500	9	69	services	service	NOUN
ajbspi-34500	9	70	servi	servi	PROPN
ajbspi-34500	9	71	renal	renal	ADJ
ajbspi-34500	9	72	replacement	replacement	NOUN
ajbspi-34500	9	73	therapy	therapy	NOUN
ajbspi-34500	9	74	(	(	PUNCT
ajbspi-34500	9	75	dialysis	dialysis	NOUN
ajbspi-34500	9	76	,	,	PUNCT
ajbspi-34500	9	77	donor	donor	NOUN
ajbspi-34500	9	78	kidney	kidney	NOUN
ajbspi-34500	9	79	transplantation	transplantation	NOUN
ajbspi-34500	9	80	)	)	PUNCT
ajbspi-34500	10	1	[	[	X
ajbspi-34500	10	2	2	2	NUM
ajbspi-34500	10	3	]	]	PUNCT
ajbspi-34500	10	4	.	.	PUNCT
ajbspi-34500	11	1	according	accord	VERB
ajbspi-34500	11	2	to	to	ADP
ajbspi-34500	11	3	the	the	DET
ajbspi-34500	11	4	course	course	NOUN
ajbspi-34500	11	5	of	of	ADP
ajbspi-34500	11	6	the	the	DET
ajbspi-34500	11	7	disease	disease	NOUN
ajbspi-34500	11	8	,	,	PUNCT
ajbspi-34500	11	9	there	there	PRON
ajbspi-34500	11	10	is	be	VERB
ajbspi-34500	11	11	an	an	DET
ajbspi-34500	11	12	acute	acute	ADJ
ajbspi-34500	11	13	form	form	NOUN
ajbspi-34500	11	14	of	of	ADP
ajbspi-34500	11	15	gn	gn	PROPN
ajbspi-34500	11	16	(	(	PUNCT
ajbspi-34500	11	17	the	the	DET
ajbspi-34500	11	18	duration	duration	NOUN
ajbspi-34500	11	19	of	of	ADP
ajbspi-34500	11	20	the	the	DET
ajbspi-34500	11	21	disease	disease	NOUN
ajbspi-34500	11	22	is	be	AUX
ajbspi-34500	11	23	less	less	ADJ
ajbspi-34500	11	24	than	than	ADP
ajbspi-34500	11	25	one	one	NUM
ajbspi-34500	11	26	year	year	NOUN
ajbspi-34500	11	27	)	)	PUNCT
ajbspi-34500	11	28	and	and	CCONJ
ajbspi-34500	11	29	chronic	chronic	ADJ
ajbspi-34500	11	30	(	(	PUNCT
ajbspi-34500	11	31	the	the	DET
ajbspi-34500	11	32	duration	duration	NOUN
ajbspi-34500	11	33	of	of	ADP
ajbspi-34500	11	34	the	the	DET
ajbspi-34500	11	35	disease	disease	NOUN
ajbspi-34500	11	36	is	be	AUX
ajbspi-34500	11	37	more	more	ADJ
ajbspi-34500	11	38	than	than	ADP
ajbspi-34500	11	39	one	one	NUM
ajbspi-34500	11	40	year	year	NOUN
ajbspi-34500	11	41	)	)	PUNCT
ajbspi-34500	11	42	.	.	PUNCT
ajbspi-34500	12	1	in	in	ADP
ajbspi-34500	12	2	clinical	clinical	ADJ
ajbspi-34500	12	3	practice	practice	NOUN
ajbspi-34500	12	4	,	,	PUNCT
ajbspi-34500	12	5	there	there	PRON
ajbspi-34500	12	6	are	be	VERB
ajbspi-34500	12	7	often	often	ADV
ajbspi-34500	12	8	difficulties	difficulty	NOUN
ajbspi-34500	12	9	in	in	ADP
ajbspi-34500	12	10	timely	timely	ADJ
ajbspi-34500	12	11	differentiation	differentiation	NOUN
ajbspi-34500	12	12	of	of	ADP
ajbspi-34500	12	13	chronic	chronic	ADJ
ajbspi-34500	12	14	gn	gn	PROPN
ajbspi-34500	12	15	and	and	CCONJ
ajbspi-34500	12	16	acute	acute	ADJ
ajbspi-34500	12	17	gn	gn	PROPN
ajbspi-34500	12	18	exacerbation	exacerbation	NOUN
ajbspi-34500	12	19	,	,	PUNCT
ajbspi-34500	12	20	in	in	ADP
ajbspi-34500	12	21	particular	particular	ADJ
ajbspi-34500	12	22	,	,	PUNCT
ajbspi-34500	12	23	in	in	ADP
ajbspi-34500	12	24	the	the	DET
ajbspi-34500	12	25	urinary	urinary	ADJ
ajbspi-34500	12	26	(	(	PUNCT
ajbspi-34500	12	27	hidden	hidden	ADJ
ajbspi-34500	12	28	)	)	PUNCT
ajbspi-34500	12	29	form	form	NOUN
ajbspi-34500	12	30	of	of	ADP
ajbspi-34500	12	31	the	the	DET
ajbspi-34500	12	32	disease	disease	NOUN
ajbspi-34500	12	33	,	,	PUNCT
ajbspi-34500	12	34	due	due	ADP
ajbspi-34500	12	35	to	to	ADP
ajbspi-34500	12	36	the	the	DET
ajbspi-34500	12	37	lack	lack	NOUN
ajbspi-34500	12	38	of	of	ADP
ajbspi-34500	12	39	clear	clear	ADJ
ajbspi-34500	12	40	criteria	criterion	NOUN
ajbspi-34500	12	41	for	for	ADP
ajbspi-34500	12	42	their	their	PRON
ajbspi-34500	12	43	diagnosis	diagnosis	NOUN
ajbspi-34500	12	44	.	.	PUNCT
ajbspi-34500	13	1	there	there	PRON
ajbspi-34500	13	2	are	be	VERB
ajbspi-34500	13	3	works	work	NOUN
ajbspi-34500	13	4	dedicated	dedicate	VERB
ajbspi-34500	13	5	to	to	ADP
ajbspi-34500	13	6	the	the	DET
ajbspi-34500	13	7	study	study	NOUN
ajbspi-34500	13	8	of	of	ADP
ajbspi-34500	13	9	biomarkers	biomarker	NOUN
ajbspi-34500	13	10	of	of	ADP
ajbspi-34500	13	11	glomerulonephritis	glomerulonephritis	ADJ
ajbspi-34500	13	12	chronicity	chronicity	NOUN
ajbspi-34500	13	13	[	[	X
ajbspi-34500	13	14	1	1	NUM
ajbspi-34500	13	15	,	,	PUNCT
ajbspi-34500	13	16	3	3	NUM
ajbspi-34500	13	17	,	,	PUNCT
ajbspi-34500	13	18	7	7	NUM
ajbspi-34500	13	19	]	]	PUNCT
ajbspi-34500	13	20	.	.	PUNCT
ajbspi-34500	14	1	at	at	ADP
ajbspi-34500	14	2	the	the	DET
ajbspi-34500	14	3	same	same	ADJ
ajbspi-34500	14	4	time	time	NOUN
ajbspi-34500	14	5	,	,	PUNCT
ajbspi-34500	14	6	the	the	DET
ajbspi-34500	14	7	role	role	NOUN
ajbspi-34500	14	8	of	of	ADP
ajbspi-34500	14	9	proand	proand	NOUN
ajbspi-34500	14	10	anti	anti	ADJ
ajbspi-34500	14	11	-	-	ADJ
ajbspi-34500	14	12	inflammatory	inflammatory	ADJ
ajbspi-34500	14	13	cytokines	cytokine	NOUN
ajbspi-34500	14	14	in	in	ADP
ajbspi-34500	14	15	maintaining	maintain	VERB
ajbspi-34500	14	16	the	the	DET
ajbspi-34500	14	17	inflammatory	inflammatory	ADJ
ajbspi-34500	14	18	process	process	NOUN
ajbspi-34500	14	19	in	in	ADP
ajbspi-34500	14	20	glomerulonephritis	glomerulonephritis	NOUN
ajbspi-34500	14	21	of	of	ADP
ajbspi-34500	14	22	various	various	ADJ
ajbspi-34500	14	23	clinical	clinical	ADJ
ajbspi-34500	14	24	courses	course	NOUN
ajbspi-34500	14	25	has	have	AUX
ajbspi-34500	14	26	not	not	PART
ajbspi-34500	14	27	yet	yet	ADV
ajbspi-34500	14	28	been	be	AUX
ajbspi-34500	14	29	determined	determine	VERB
ajbspi-34500	14	30	.	.	PUNCT
ajbspi-34500	15	1	in	in	ADP
ajbspi-34500	15	2	relation	relation	NOUN
ajbspi-34500	15	3	to	to	ADP
ajbspi-34500	15	4	the	the	DET
ajbspi-34500	15	5	above	above	NOUN
ajbspi-34500	15	6	,	,	PUNCT
ajbspi-34500	15	7	the	the	DET
ajbspi-34500	15	8	aim	aim	NOUN
ajbspi-34500	15	9	of	of	ADP
ajbspi-34500	15	10	this	this	DET
ajbspi-34500	15	11	study	study	NOUN
ajbspi-34500	15	12	was	be	AUX
ajbspi-34500	15	13	to	to	PART
ajbspi-34500	15	14	investigate	investigate	VERB
ajbspi-34500	15	15	the	the	DET
ajbspi-34500	15	16	circulating	circulate	VERB
ajbspi-34500	15	17	levels	level	NOUN
ajbspi-34500	15	18	of	of	ADP
ajbspi-34500	15	19	cytokines	cytokine	NOUN
ajbspi-34500	15	20	in	in	ADP
ajbspi-34500	15	21	patients	patient	NOUN
ajbspi-34500	15	22	with	with	ADP
ajbspi-34500	15	23	acute	acute	ADJ
ajbspi-34500	15	24	and	and	CCONJ
ajbspi-34500	15	25	chronic	chronic	ADJ
ajbspi-34500	15	26	gn	gn	PROPN
ajbspi-34500	15	27	.	.	PROPN
ajbspi-34500	15	28	methods	method	NOUN
ajbspi-34500	15	29	this	this	DET
ajbspi-34500	15	30	study	study	NOUN
ajbspi-34500	15	31	included	include	VERB
ajbspi-34500	15	32	55	55	NUM
ajbspi-34500	15	33	patients	patient	NOUN
ajbspi-34500	15	34	with	with	ADP
ajbspi-34500	15	35	gn	gn	PROPN
ajbspi-34500	15	36	aged	aged	ADJ
ajbspi-34500	15	37	10	10	NUM
ajbspi-34500	15	38	to	to	PART
ajbspi-34500	15	39	18	18	NUM
ajbspi-34500	15	40	years	year	NOUN
ajbspi-34500	15	41	who	who	PRON
ajbspi-34500	15	42	were	be	AUX
ajbspi-34500	15	43	treated	treat	VERB
ajbspi-34500	15	44	in	in	ADP
ajbspi-34500	15	45	the	the	DET
ajbspi-34500	15	46	nephrology	nephrology	NOUN
ajbspi-34500	15	47	department	department	NOUN
ajbspi-34500	15	48	at	at	ADP
ajbspi-34500	15	49	children	child	NOUN
ajbspi-34500	15	50	's	's	PART
ajbspi-34500	15	51	city	city	NOUN
ajbspi-34500	15	52	hospital	hospital	NOUN
ajbspi-34500	15	53	no	no	INTJ
ajbspi-34500	15	54	.	.	NOUN
ajbspi-34500	15	55	1	1	NUM
ajbspi-34500	15	56	in	in	ADP
ajbspi-34500	15	57	samarkand	samarkand	PROPN
ajbspi-34500	15	58	.	.	PUNCT
ajbspi-34500	16	1	at	at	ADP
ajbspi-34500	16	2	the	the	DET
ajbspi-34500	16	3	beginning	beginning	NOUN
ajbspi-34500	16	4	of	of	ADP
ajbspi-34500	16	5	the	the	DET
ajbspi-34500	16	6	disease	disease	NOUN
ajbspi-34500	16	7	,	,	PUNCT
ajbspi-34500	16	8	10	10	NUM
ajbspi-34500	16	9	patients	patient	NOUN
ajbspi-34500	16	10	(	(	PUNCT
ajbspi-34500	16	11	acute	acute	PROPN
ajbspi-34500	16	12	gn	gn	PROPN
ajbspi-34500	16	13	)	)	PUNCT
ajbspi-34500	16	14	,	,	PUNCT
ajbspi-34500	16	15	with	with	ADP
ajbspi-34500	16	16	exacerbation	exacerbation	NOUN
ajbspi-34500	16	17	of	of	ADP
ajbspi-34500	16	18	chronic	chronic	ADJ
ajbspi-34500	16	19	gn	gn	PROPN
ajbspi-34500	16	20	45	45	NUM
ajbspi-34500	16	21	patients	patient	NOUN
ajbspi-34500	16	22	were	be	AUX
ajbspi-34500	16	23	studied	study	VERB
ajbspi-34500	16	24	.	.	PUNCT
ajbspi-34500	17	1	diagnostic	diagnostic	ADJ
ajbspi-34500	17	2	nephrobiopsy	nephrobiopsy	NOUN
ajbspi-34500	17	3	was	be	AUX
ajbspi-34500	17	4	performed	perform	VERB
ajbspi-34500	17	5	in	in	ADP
ajbspi-34500	17	6	34	34	NUM
ajbspi-34500	17	7	patients	patient	NOUN
ajbspi-34500	17	8	,	,	PUNCT
ajbspi-34500	17	9	mesangioproliferative	mesangioproliferative	ADJ
ajbspi-34500	17	10	variant	variant	NOUN
ajbspi-34500	17	11	of	of	ADP
ajbspi-34500	17	12	gn	gn	PROPN
ajbspi-34500	17	13	was	be	AUX
ajbspi-34500	17	14	detected	detect	VERB
ajbspi-34500	17	15	in	in	ADP
ajbspi-34500	17	16	21	21	NUM
ajbspi-34500	17	17	cases	case	NOUN
ajbspi-34500	17	18	,	,	PUNCT
ajbspi-34500	17	19	membranoproliferative	membranoproliferative	ADJ
ajbspi-34500	17	20	variant	variant	NOUN
ajbspi-34500	17	21	in	in	ADP
ajbspi-34500	17	22	6	6	NUM
ajbspi-34500	17	23	cases	case	NOUN
ajbspi-34500	17	24	,	,	PUNCT
ajbspi-34500	17	25	membranous	membranous	ADJ
ajbspi-34500	17	26	in	in	ADP
ajbspi-34500	17	27	6	6	NUM
ajbspi-34500	17	28	cases	case	NOUN
ajbspi-34500	17	29	,	,	PUNCT
ajbspi-34500	17	30	and	and	CCONJ
ajbspi-34500	17	31	gn	gn	PROPN
ajbspi-34500	17	32	with	with	ADP
ajbspi-34500	17	33	minimal	minimal	ADJ
ajbspi-34500	17	34	changes	change	NOUN
ajbspi-34500	17	35	in	in	ADP
ajbspi-34500	17	36	1	1	NUM
ajbspi-34500	17	37	case	case	NOUN
ajbspi-34500	17	38	.	.	PUNCT
ajbspi-34500	18	1	there	there	PRON
ajbspi-34500	18	2	are	be	VERB
ajbspi-34500	18	3	24	24	NUM
ajbspi-34500	18	4	girls	girl	NOUN
ajbspi-34500	18	5	and	and	CCONJ
ajbspi-34500	18	6	31	31	NUM
ajbspi-34500	18	7	boys	boy	NOUN
ajbspi-34500	18	8	among	among	ADP
ajbspi-34500	18	9	those	those	PRON
ajbspi-34500	18	10	who	who	PRON
ajbspi-34500	18	11	passed	pass	VERB
ajbspi-34500	18	12	the	the	DET
ajbspi-34500	18	13	examination	examination	NOUN
ajbspi-34500	18	14	.	.	PUNCT
ajbspi-34500	19	1	groups	group	NOUN
ajbspi-34500	19	2	of	of	ADP
ajbspi-34500	19	3	patients	patient	NOUN
ajbspi-34500	19	4	with	with	ADP
ajbspi-34500	19	5	acute	acute	ADJ
ajbspi-34500	19	6	gn	gn	PROPN
ajbspi-34500	19	7	and	and	CCONJ
ajbspi-34500	19	8	chronic	chronic	ADJ
ajbspi-34500	19	9	gn	gn	PROPN
ajbspi-34500	19	10	were	be	AUX
ajbspi-34500	19	11	representative	representative	ADJ
ajbspi-34500	19	12	of	of	ADP
ajbspi-34500	19	13	patients	patient	NOUN
ajbspi-34500	19	14	with	with	ADP
ajbspi-34500	19	15	different	different	ADJ
ajbspi-34500	19	16	morphological	morphological	ADJ
ajbspi-34500	19	17	variants	variant	NOUN
ajbspi-34500	19	18	of	of	ADP
ajbspi-34500	19	19	the	the	DET
ajbspi-34500	19	20	disease	disease	NOUN
ajbspi-34500	19	21	and	and	CCONJ
ajbspi-34500	19	22	representative	representative	NOUN
ajbspi-34500	19	23	of	of	ADP
ajbspi-34500	19	24	the	the	DET
ajbspi-34500	19	25	functional	functional	ADJ
ajbspi-34500	19	26	status	status	NOUN
ajbspi-34500	19	27	of	of	ADP
ajbspi-34500	19	28	the	the	DET
ajbspi-34500	19	29	patients	patient	NOUN
ajbspi-34500	19	30	'	'	PART
ajbspi-34500	19	31	kidneys	kidney	NOUN
ajbspi-34500	19	32	.	.	PUNCT
ajbspi-34500	20	1	in	in	ADP
ajbspi-34500	20	2	addition	addition	NOUN
ajbspi-34500	20	3	to	to	ADP
ajbspi-34500	20	4	the	the	DET
ajbspi-34500	20	5	generally	generally	ADV
ajbspi-34500	20	6	accepted	accept	VERB
ajbspi-34500	20	7	studies	study	NOUN
ajbspi-34500	20	8	(	(	PUNCT
ajbspi-34500	20	9	general	general	ADJ
ajbspi-34500	20	10	clinical	clinical	ADJ
ajbspi-34500	20	11	blood	blood	NOUN
ajbspi-34500	20	12	and	and	CCONJ
ajbspi-34500	20	13	urine	urine	NOUN
ajbspi-34500	20	14	tests	test	NOUN
ajbspi-34500	20	15	,	,	PUNCT
ajbspi-34500	20	16	biochemical	biochemical	ADJ
ajbspi-34500	20	17	studies	study	NOUN
ajbspi-34500	20	18	creatinine	creatinine	NOUN
ajbspi-34500	20	19	,	,	PUNCT
ajbspi-34500	20	20	urea	urea	NOUN
ajbspi-34500	20	21	,	,	PUNCT
ajbspi-34500	20	22	bilirubin	bilirubin	NOUN
ajbspi-34500	20	23	,	,	PUNCT
ajbspi-34500	20	24	transaminases	transaminase	NOUN
ajbspi-34500	20	25	,	,	PUNCT
ajbspi-34500	20	26	hemostasiogram	hemostasiogram	PROPN
ajbspi-34500	20	27	,	,	PUNCT
ajbspi-34500	20	28	proteinogram	proteinogram	NOUN
ajbspi-34500	20	29	,	,	PUNCT
ajbspi-34500	20	30	creactive	creactive	ADJ
ajbspi-34500	20	31	protein	protein	NOUN
ajbspi-34500	20	32	,	,	PUNCT
ajbspi-34500	20	33	glomerular	glomerular	ADJ
ajbspi-34500	20	34	filtration	filtration	NOUN
ajbspi-34500	20	35	rate	rate	NOUN
ajbspi-34500	20	36	,	,	PUNCT
ajbspi-34500	20	37	tubular	tubular	ADJ
ajbspi-34500	20	38	reabsorption	reabsorption	NOUN
ajbspi-34500	20	39	,	,	PUNCT
ajbspi-34500	20	40	ultrasound	ultrasound	NOUN
ajbspi-34500	20	41	examination	examination	NOUN
ajbspi-34500	20	42	of	of	ADP
ajbspi-34500	20	43	the	the	DET
ajbspi-34500	20	44	kidneys	kidney	NOUN
ajbspi-34500	20	45	)	)	PUNCT
ajbspi-34500	20	46	,	,	PUNCT
ajbspi-34500	20	47	concentration	concentration	NOUN
ajbspi-34500	20	48	.	.	PUNCT
ajbspi-34500	21	1	the	the	DET
ajbspi-34500	21	2	main	main	ADJ
ajbspi-34500	21	3	cytokines	cytokine	NOUN
ajbspi-34500	21	4	circulating	circulate	VERB
ajbspi-34500	21	5	in	in	ADP
ajbspi-34500	21	6	the	the	DET
ajbspi-34500	21	7	blood	blood	NOUN
ajbspi-34500	21	8	were	be	AUX
ajbspi-34500	21	9	identified	identify	VERB
ajbspi-34500	21	10	interleukin-1b	interleukin-1b	NUM
ajbspi-34500	21	11	(	(	PUNCT
ajbspi-34500	21	12	il-1b	il-1b	PROPN
ajbspi-34500	21	13	)	)	PUNCT
ajbspi-34500	21	14	,	,	PUNCT
ajbspi-34500	21	15	interleukin-2	interleukin-2	NOUN
ajbspi-34500	21	16	(	(	PUNCT
ajbspi-34500	21	17	il-2	il-2	NUM
ajbspi-34500	21	18	)	)	PUNCT
ajbspi-34500	21	19	,	,	PUNCT
ajbspi-34500	21	20	interleukin-10	interleukin-10	PROPN
ajbspi-34500	21	21	(	(	PUNCT
ajbspi-34500	21	22	il-10	il-10	NUM
ajbspi-34500	21	23	)	)	PUNCT
ajbspi-34500	21	24	,	,	PUNCT
ajbspi-34500	21	25	interferon	interferon	PROPN
ajbspi-34500	21	26	-	-	PUNCT
ajbspi-34500	21	27	y	y	PROPN
ajbspi-34500	21	28	(	(	PUNCT
ajbspi-34500	21	29	ifn	ifn	PROPN
ajbspi-34500	21	30	-	-	PUNCT
ajbspi-34500	21	31	y	y	NOUN
ajbspi-34500	21	32	)	)	PUNCT
ajbspi-34500	21	33	and	and	CCONJ
ajbspi-34500	21	34	il-1b	il-1b	PROPN
ajbspi-34500	21	35	receptor	receptor	NOUN
ajbspi-34500	21	36	antagonist	antagonist	NOUN
ajbspi-34500	21	37	ra	ra	PROPN
ajbspi-34500	21	38	-il-1b	-il-1b	PROPN
ajbspi-34500	21	39	.	.	PUNCT
ajbspi-34500	22	1	the	the	DET
ajbspi-34500	22	2	object	object	NOUN
ajbspi-34500	22	3	of	of	ADP
ajbspi-34500	22	4	the	the	DET
ajbspi-34500	22	5	study	study	NOUN
ajbspi-34500	22	6	was	be	AUX
ajbspi-34500	22	7	venous	venous	ADJ
ajbspi-34500	22	8	blood	blood	NOUN
ajbspi-34500	22	9	serum	serum	NOUN
ajbspi-34500	22	10	.	.	PUNCT
ajbspi-34500	23	1	blood	blood	NOUN
ajbspi-34500	23	2	tests	test	NOUN
ajbspi-34500	23	3	were	be	AUX
ajbspi-34500	23	4	performed	perform	VERB
ajbspi-34500	23	5	twice	twice	ADV
ajbspi-34500	23	6	at	at	ADP
ajbspi-34500	23	7	admission	admission	NOUN
ajbspi-34500	23	8	to	to	ADP
ajbspi-34500	23	9	inpatient	inpatient	NOUN
ajbspi-34500	23	10	treatment	treatment	NOUN
ajbspi-34500	23	11	(	(	PUNCT
ajbspi-34500	23	12	on	on	ADP
ajbspi-34500	23	13	days	day	NOUN
ajbspi-34500	23	14	2	2	NUM
ajbspi-34500	23	15	-	-	SYM
ajbspi-34500	23	16	3	3	NUM
ajbspi-34500	23	17	)	)	PUNCT
ajbspi-34500	23	18	and	and	CCONJ
ajbspi-34500	23	19	at	at	ADP
ajbspi-34500	23	20	the	the	DET
ajbspi-34500	23	21	end	end	NOUN
ajbspi-34500	23	22	of	of	ADP
ajbspi-34500	23	23	the	the	DET
ajbspi-34500	23	24	period	period	NOUN
ajbspi-34500	23	25	of	of	ADP
ajbspi-34500	23	26	inpatient	inpatient	NOUN
ajbspi-34500	23	27	treatment	treatment	NOUN
ajbspi-34500	23	28	(	(	PUNCT
ajbspi-34500	23	29	on	on	ADP
ajbspi-34500	23	30	days	day	NOUN
ajbspi-34500	23	31	12	12	NUM
ajbspi-34500	23	32	-	-	SYM
ajbspi-34500	23	33	14	14	NUM
ajbspi-34500	23	34	)	)	PUNCT
ajbspi-34500	23	35	.	.	PUNCT
ajbspi-34500	24	1	the	the	DET
ajbspi-34500	24	2	following	follow	VERB
ajbspi-34500	24	3	parameters	parameter	NOUN
ajbspi-34500	24	4	of	of	ADP
ajbspi-34500	24	5	descriptive	descriptive	ADJ
ajbspi-34500	24	6	statistics	statistic	NOUN
ajbspi-34500	24	7	were	be	AUX
ajbspi-34500	24	8	determined	determine	VERB
ajbspi-34500	24	9	:	:	PUNCT
ajbspi-34500	24	10	arithmetic	arithmetic	ADJ
ajbspi-34500	24	11	mean	mean	NOUN
ajbspi-34500	24	12	(	(	PUNCT
ajbspi-34500	24	13	m	m	NOUN
ajbspi-34500	24	14	)	)	PUNCT
ajbspi-34500	24	15	,	,	PUNCT
ajbspi-34500	24	16	standard	standard	ADJ
ajbspi-34500	24	17	deviation	deviation	NOUN
ajbspi-34500	24	18	(	(	PUNCT
ajbspi-34500	24	19	sd	sd	NOUN
ajbspi-34500	24	20	)	)	PUNCT
ajbspi-34500	24	21	.	.	PUNCT
ajbspi-34500	25	1	when	when	SCONJ
ajbspi-34500	25	2	comparing	compare	VERB
ajbspi-34500	25	3	two	two	NUM
ajbspi-34500	25	4	samples	sample	NOUN
ajbspi-34500	25	5	,	,	PUNCT
ajbspi-34500	25	6	student	student	NOUN
ajbspi-34500	25	7	's	's	PART
ajbspi-34500	25	8	t	t	NOUN
ajbspi-34500	25	9	-	-	PUNCT
ajbspi-34500	25	10	test	test	NOUN
ajbspi-34500	25	11	(	(	PUNCT
ajbspi-34500	25	12	p	p	NOUN
ajbspi-34500	25	13	)	)	PUNCT
ajbspi-34500	25	14	was	be	AUX
ajbspi-34500	25	15	used	use	VERB
ajbspi-34500	25	16	to	to	PART
ajbspi-34500	25	17	assess	assess	VERB
ajbspi-34500	25	18	the	the	DET
ajbspi-34500	25	19	significance	significance	NOUN
ajbspi-34500	25	20	of	of	ADP
ajbspi-34500	25	21	differences	difference	NOUN
ajbspi-34500	25	22	.	.	PUNCT
ajbspi-34500	26	1	in	in	ADP
ajbspi-34500	26	2	the	the	DET
ajbspi-34500	26	3	case	case	NOUN
ajbspi-34500	26	4	of	of	ADP
ajbspi-34500	26	5	asymmetric	asymmetric	ADJ
ajbspi-34500	26	6	distribution	distribution	NOUN
ajbspi-34500	26	7	of	of	ADP
ajbspi-34500	26	8	the	the	DET
ajbspi-34500	26	9	set	set	NOUN
ajbspi-34500	26	10	of	of	ADP
ajbspi-34500	26	11	indicator	indicator	NOUN
ajbspi-34500	26	12	values	value	NOUN
ajbspi-34500	26	13	in	in	ADP
ajbspi-34500	26	14	the	the	DET
ajbspi-34500	26	15	groups	group	NOUN
ajbspi-34500	26	16	,	,	PUNCT
ajbspi-34500	26	17	the	the	DET
ajbspi-34500	26	18	median	median	NOUN
ajbspi-34500	26	19	(	(	PUNCT
ajbspi-34500	26	20	me	i	PRON
ajbspi-34500	26	21	)	)	PUNCT
ajbspi-34500	26	22	was	be	AUX
ajbspi-34500	26	23	calculated	calculate	VERB
ajbspi-34500	26	24	,	,	PUNCT
ajbspi-34500	26	25	the	the	DET
ajbspi-34500	26	26	limits	limit	NOUN
ajbspi-34500	26	27	of	of	ADP
ajbspi-34500	26	28	variation	variation	NOUN
ajbspi-34500	26	29	of	of	ADP
ajbspi-34500	26	30	the	the	DET
ajbspi-34500	26	31	study	study	NOUN
ajbspi-34500	26	32	population	population	NOUN
ajbspi-34500	26	33	were	be	AUX
ajbspi-34500	26	34	from	from	ADP
ajbspi-34500	26	35	5	5	NUM
ajbspi-34500	26	36	%	%	NOUN
ajbspi-34500	26	37	to	to	PART
ajbspi-34500	26	38	95	95	NUM
ajbspi-34500	26	39	%	%	NOUN
ajbspi-34500	26	40	(	(	PUNCT
ajbspi-34500	26	41	p5	p5	ADJ
ajbspi-34500	26	42	p95	p95	NOUN
ajbspi-34500	26	43	)	)	PUNCT
ajbspi-34500	26	44	,	,	PUNCT
ajbspi-34500	26	45	and	and	CCONJ
ajbspi-34500	26	46	the	the	DET
ajbspi-34500	26	47	reliability	reliability	NOUN
ajbspi-34500	26	48	of	of	ADP
ajbspi-34500	26	49	the	the	DET
ajbspi-34500	26	50	differences	difference	NOUN
ajbspi-34500	26	51	was	be	AUX
ajbspi-34500	26	52	non	non	ADJ
ajbspi-34500	26	53	-	-	ADJ
ajbspi-34500	26	54	parametric	parametric	ADJ
ajbspi-34500	26	55	mann	mann	PROPN
ajbspi-34500	26	56	-	-	PUNCT
ajbspi-34500	26	57	whitney	whitney	PROPN
ajbspi-34500	26	58	tests	test	VERB
ajbspi-34500	26	59	for	for	ADP
ajbspi-34500	26	60	independent	independent	ADJ
ajbspi-34500	26	61	groups	group	NOUN
ajbspi-34500	26	62	.	.	PUNCT
ajbspi-34500	27	1	(	(	PUNCT
ajbspi-34500	27	2	pm	pm	NOUN
ajbspi-34500	27	3	-	-	PUNCT
ajbspi-34500	27	4	w	w	NOUN
ajbspi-34500	27	5	)	)	PUNCT
ajbspi-34500	28	1	and	and	CCONJ
ajbspi-34500	28	2	was	be	AUX
ajbspi-34500	28	3	evaluated	evaluate	VERB
ajbspi-34500	28	4	using	use	VERB
ajbspi-34500	28	5	wilcoxon	wilcoxon	PROPN
ajbspi-34500	28	6	(	(	PUNCT
ajbspi-34500	28	7	pw	pw	NOUN
ajbspi-34500	28	8	)	)	PUNCT
ajbspi-34500	28	9	for	for	ADP
ajbspi-34500	28	10	conjugated	conjugated	ADJ
ajbspi-34500	28	11	groups	group	NOUN
ajbspi-34500	28	12	[	[	X
ajbspi-34500	28	13	4	4	NUM
ajbspi-34500	28	14	]	]	PUNCT
ajbspi-34500	28	15	.	.	PUNCT
ajbspi-34500	29	1	the	the	DET
ajbspi-34500	29	2	reliability	reliability	NOUN
ajbspi-34500	29	3	of	of	ADP
ajbspi-34500	29	4	the	the	DET
ajbspi-34500	29	5	relationship	relationship	NOUN
ajbspi-34500	29	6	between	between	ADP
ajbspi-34500	29	7	two	two	NUM
ajbspi-34500	29	8	series	series	NOUN
ajbspi-34500	29	9	of	of	ADP
ajbspi-34500	29	10	observations	observation	NOUN
ajbspi-34500	29	11	was	be	AUX
ajbspi-34500	29	12	evaluated	evaluate	VERB
ajbspi-34500	29	13	based	base	VERB
ajbspi-34500	29	14	on	on	ADP
ajbspi-34500	29	15	the	the	DET
ajbspi-34500	29	16	calculation	calculation	NOUN
ajbspi-34500	29	17	of	of	ADP
ajbspi-34500	29	18	the	the	DET
ajbspi-34500	29	19	spearman	spearman	NOUN
ajbspi-34500	29	20	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	PROPN
ajbspi-34500	29	21	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	AUX
ajbspi-34500	29	22	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	ADJ
ajbspi-34500	29	23	volume	volume	NOUN
ajbspi-34500	29	24	04	04	NUM
ajbspi-34500	29	25	issue	issue	NOUN
ajbspi-34500	29	26	03	03	NUM
ajbspi-34500	29	27	-	-	SYM
ajbspi-34500	29	28	2024	2024	NUM
ajbspi-34500	29	29	38	38	NUM
ajbspi-34500	29	30	american	american	ADJ
ajbspi-34500	29	31	journal	journal	NOUN
ajbspi-34500	29	32	of	of	ADP
ajbspi-34500	29	33	biomedical	biomedical	PROPN
ajbspi-34500	29	34	science	science	PROPN
ajbspi-34500	29	35	&	&	CCONJ
ajbspi-34500	29	36	pharmaceutical	pharmaceutical	PROPN
ajbspi-34500	29	37	innovation	innovation	NOUN
ajbspi-34500	29	38	(	(	PUNCT
ajbspi-34500	29	39	issn	issn	PROPN
ajbspi-34500	29	40	–	–	PUNCT
ajbspi-34500	29	41	2771	2771	NUM
ajbspi-34500	29	42	-	-	SYM
ajbspi-34500	29	43	2753	2753	NUM
ajbspi-34500	29	44	)	)	PUNCT
ajbspi-34500	29	45	volume	volume	NOUN
ajbspi-34500	29	46	04	04	NUM
ajbspi-34500	29	47	issue	issue	NOUN
ajbspi-34500	29	48	03	03	NUM
ajbspi-34500	29	49	pages	page	NOUN
ajbspi-34500	29	50	:	:	PUNCT
ajbspi-34500	29	51	36	36	NUM
ajbspi-34500	29	52	-	-	SYM
ajbspi-34500	29	53	43	43	NUM
ajbspi-34500	29	54	sjif	sjif	NOUN
ajbspi-34500	29	55	impact	impact	NOUN
ajbspi-34500	29	56	factor	factor	NOUN
ajbspi-34500	29	57	(	(	PUNCT
ajbspi-34500	29	58	2022	2022	NUM
ajbspi-34500	29	59	:	:	PUNCT
ajbspi-34500	29	60	5	5	NUM
ajbspi-34500	29	61	.	.	NOUN
ajbspi-34500	29	62	705	705	NUM
ajbspi-34500	29	63	)	)	PUNCT
ajbspi-34500	29	64	(	(	PUNCT
ajbspi-34500	29	65	2023	2023	NUM
ajbspi-34500	29	66	:	:	PUNCT
ajbspi-34500	29	67	6.534	6.534	NUM
ajbspi-34500	29	68	)	)	PUNCT
ajbspi-34500	29	69	(	(	PUNCT
ajbspi-34500	29	70	2024	2024	NUM
ajbspi-34500	29	71	:	:	PUNCT
ajbspi-34500	29	72	7.7	7.7	NUM
ajbspi-34500	29	73	)	)	PUNCT
ajbspi-34500	29	74	oclc	oclc	PROPN
ajbspi-34500	29	75	–	–	PUNCT
ajbspi-34500	29	76	1121105677	1121105677	NUM
ajbspi-34500	29	77	publisher	publisher	NOUN
ajbspi-34500	29	78	:	:	PUNCT
ajbspi-34500	29	79	oscar	oscar	NOUN
ajbspi-34500	29	80	publishing	publishing	NOUN
ajbspi-34500	29	81	services	service	NOUN
ajbspi-34500	29	82	servi	servi	PROPN
ajbspi-34500	29	83	rank	rank	PROPN
ajbspi-34500	29	84	correlation	correlation	NOUN
ajbspi-34500	29	85	coefficient	coefficient	NOUN
ajbspi-34500	29	86	(	(	PUNCT
ajbspi-34500	29	87	rs	rs	NOUN
ajbspi-34500	29	88	)	)	PUNCT
ajbspi-34500	29	89	,	,	PUNCT
ajbspi-34500	29	90	the	the	DET
ajbspi-34500	29	91	reliability	reliability	NOUN
ajbspi-34500	29	92	of	of	ADP
ajbspi-34500	29	93	the	the	DET
ajbspi-34500	29	94	coefficients	coefficient	NOUN
ajbspi-34500	29	95	was	be	AUX
ajbspi-34500	29	96	considered	consider	VERB
ajbspi-34500	29	97	acceptable	acceptable	ADJ
ajbspi-34500	29	98	when	when	SCONJ
ajbspi-34500	29	99	prs<0.05	prs<0.05	NOUN
ajbspi-34500	29	100	.	.	PUNCT
ajbspi-34500	30	1	the	the	DET
ajbspi-34500	30	2	values	value	NOUN
ajbspi-34500	30	3	of	of	ADP
ajbspi-34500	30	4	the	the	DET
ajbspi-34500	30	5	laboratory	laboratory	NOUN
ajbspi-34500	30	6	parameters	parameter	NOUN
ajbspi-34500	30	7	obtained	obtain	VERB
ajbspi-34500	30	8	during	during	ADP
ajbspi-34500	30	9	the	the	DET
ajbspi-34500	30	10	study	study	NOUN
ajbspi-34500	30	11	were	be	AUX
ajbspi-34500	30	12	compared	compare	VERB
ajbspi-34500	30	13	with	with	ADP
ajbspi-34500	30	14	the	the	DET
ajbspi-34500	30	15	reference	reference	NOUN
ajbspi-34500	30	16	values	value	NOUN
ajbspi-34500	30	17	,	,	PUNCT
ajbspi-34500	30	18	which	which	PRON
ajbspi-34500	30	19	were	be	AUX
ajbspi-34500	30	20	the	the	DET
ajbspi-34500	30	21	results	result	NOUN
ajbspi-34500	30	22	of	of	ADP
ajbspi-34500	30	23	the	the	DET
ajbspi-34500	30	24	examination	examination	NOUN
ajbspi-34500	30	25	of	of	ADP
ajbspi-34500	30	26	25	25	NUM
ajbspi-34500	30	27	practically	practically	ADV
ajbspi-34500	30	28	healthy	healthy	ADJ
ajbspi-34500	30	29	people	people	NOUN
ajbspi-34500	30	30	.	.	PUNCT
ajbspi-34500	31	1	research	research	NOUN
ajbspi-34500	31	2	results	result	NOUN
ajbspi-34500	31	3	and	and	CCONJ
ajbspi-34500	31	4	discussion	discussion	NOUN
ajbspi-34500	31	5	.	.	PUNCT
ajbspi-34500	32	1	the	the	DET
ajbspi-34500	32	2	results	result	NOUN
ajbspi-34500	32	3	of	of	ADP
ajbspi-34500	32	4	the	the	DET
ajbspi-34500	32	5	study	study	NOUN
ajbspi-34500	32	6	show	show	VERB
ajbspi-34500	32	7	that	that	SCONJ
ajbspi-34500	32	8	patients	patient	NOUN
ajbspi-34500	32	9	with	with	ADP
ajbspi-34500	32	10	gn	gn	PROPN
ajbspi-34500	32	11	,	,	PUNCT
ajbspi-34500	32	12	regardless	regardless	ADV
ajbspi-34500	32	13	of	of	ADP
ajbspi-34500	32	14	the	the	DET
ajbspi-34500	32	15	nature	nature	NOUN
ajbspi-34500	32	16	of	of	ADP
ajbspi-34500	32	17	the	the	DET
ajbspi-34500	32	18	clinical	clinical	ADJ
ajbspi-34500	32	19	course	course	NOUN
ajbspi-34500	32	20	of	of	ADP
ajbspi-34500	32	21	the	the	DET
ajbspi-34500	32	22	disease	disease	NOUN
ajbspi-34500	32	23	acute	acute	NOUN
ajbspi-34500	32	24	or	or	CCONJ
ajbspi-34500	32	25	chronic	chronic	NOUN
ajbspi-34500	32	26	,	,	PUNCT
ajbspi-34500	32	27	produce	produce	VERB
ajbspi-34500	32	28	both	both	DET
ajbspi-34500	32	29	pro	pro	ADJ
ajbspi-34500	32	30	-	-	ADJ
ajbspi-34500	32	31	inflammatory	inflammatory	ADJ
ajbspi-34500	32	32	cytokines	cytokine	NOUN
ajbspi-34500	32	33	(	(	PUNCT
ajbspi-34500	32	34	il-1b	il-1b	PROPN
ajbspi-34500	32	35	,	,	PUNCT
ajbspi-34500	32	36	il-2	il-2	NUM
ajbspi-34500	32	37	)	)	PUNCT
ajbspi-34500	32	38	and	and	CCONJ
ajbspi-34500	32	39	anti	anti	ADJ
ajbspi-34500	32	40	-	-	ADJ
ajbspi-34500	32	41	inflammatory	inflammatory	ADJ
ajbspi-34500	32	42	cytokines	cytokine	NOUN
ajbspi-34500	32	43	.	.	PUNCT
ajbspi-34500	33	1	is	be	AUX
ajbspi-34500	33	2	released	release	VERB
ajbspi-34500	33	3	.	.	PUNCT
ajbspi-34500	34	1	il-10	il-10	X
ajbspi-34500	34	2	and	and	CCONJ
ajbspi-34500	34	3	ra	ra	PROPN
ajbspi-34500	34	4	-	-	PUNCT
ajbspi-34500	34	5	il-1b	il-1b	PROPN
ajbspi-34500	34	6	.	.	PUNCT
ajbspi-34500	35	1	the	the	DET
ajbspi-34500	35	2	object	object	NOUN
ajbspi-34500	35	3	of	of	ADP
ajbspi-34500	35	4	research	research	NOUN
ajbspi-34500	35	5	was	be	AUX
ajbspi-34500	35	6	venous	venous	ADJ
ajbspi-34500	35	7	blood	blood	NOUN
ajbspi-34500	35	8	serum	serum	NOUN
ajbspi-34500	35	9	.	.	PUNCT
ajbspi-34500	36	1	blood	blood	NOUN
ajbspi-34500	36	2	tests	test	NOUN
ajbspi-34500	36	3	were	be	AUX
ajbspi-34500	36	4	performed	perform	VERB
ajbspi-34500	36	5	twice	twice	ADV
ajbspi-34500	36	6	at	at	ADP
ajbspi-34500	36	7	admission	admission	NOUN
ajbspi-34500	36	8	to	to	ADP
ajbspi-34500	36	9	inpatient	inpatient	NOUN
ajbspi-34500	36	10	treatment	treatment	NOUN
ajbspi-34500	36	11	(	(	PUNCT
ajbspi-34500	36	12	on	on	ADP
ajbspi-34500	36	13	2	2	NUM
ajbspi-34500	36	14	-	-	SYM
ajbspi-34500	36	15	3	3	NUM
ajbspi-34500	36	16	days	day	NOUN
ajbspi-34500	36	17	)	)	PUNCT
ajbspi-34500	36	18	and	and	CCONJ
ajbspi-34500	36	19	at	at	ADP
ajbspi-34500	36	20	the	the	DET
ajbspi-34500	36	21	end	end	NOUN
ajbspi-34500	36	22	of	of	ADP
ajbspi-34500	36	23	the	the	DET
ajbspi-34500	36	24	inpatient	inpatient	NOUN
ajbspi-34500	36	25	treatment	treatment	NOUN
ajbspi-34500	36	26	period	period	NOUN
ajbspi-34500	36	27	(	(	PUNCT
ajbspi-34500	36	28	on	on	ADP
ajbspi-34500	36	29	12	12	NUM
ajbspi-34500	36	30	-	-	SYM
ajbspi-34500	36	31	14	14	NUM
ajbspi-34500	36	32	days	day	NOUN
ajbspi-34500	36	33	)	)	PUNCT
ajbspi-34500	36	34	.	.	PUNCT
ajbspi-34500	37	1	the	the	DET
ajbspi-34500	37	2	statistics	statistic	NOUN
ajbspi-34500	37	3	of	of	ADP
ajbspi-34500	37	4	the	the	DET
ajbspi-34500	37	5	obtained	obtain	VERB
ajbspi-34500	37	6	result	result	NOUN
ajbspi-34500	37	7	were	be	AUX
ajbspi-34500	37	8	determined	determine	VERB
ajbspi-34500	37	9	by	by	ADP
ajbspi-34500	37	10	the	the	DET
ajbspi-34500	37	11	following	follow	VERB
ajbspi-34500	37	12	parameters	parameter	NOUN
ajbspi-34500	37	13	:	:	PUNCT
ajbspi-34500	37	14	arithmetic	arithmetic	ADJ
ajbspi-34500	37	15	mean	mean	NOUN
ajbspi-34500	37	16	(	(	PUNCT
ajbspi-34500	37	17	m	m	NOUN
ajbspi-34500	37	18	)	)	PUNCT
ajbspi-34500	37	19	,	,	PUNCT
ajbspi-34500	37	20	standard	standard	ADJ
ajbspi-34500	37	21	deviation	deviation	NOUN
ajbspi-34500	37	22	(	(	PUNCT
ajbspi-34500	37	23	sd	sd	NOUN
ajbspi-34500	37	24	)	)	PUNCT
ajbspi-34500	37	25	.	.	PUNCT
ajbspi-34500	38	1	when	when	SCONJ
ajbspi-34500	38	2	comparing	compare	VERB
ajbspi-34500	38	3	two	two	NUM
ajbspi-34500	38	4	samples	sample	NOUN
ajbspi-34500	38	5	,	,	PUNCT
ajbspi-34500	38	6	student	student	NOUN
ajbspi-34500	38	7	's	's	PART
ajbspi-34500	38	8	t	t	NOUN
ajbspi-34500	38	9	-	-	PUNCT
ajbspi-34500	38	10	test	test	NOUN
ajbspi-34500	38	11	(	(	PUNCT
ajbspi-34500	38	12	p	p	NOUN
ajbspi-34500	38	13	)	)	PUNCT
ajbspi-34500	38	14	was	be	AUX
ajbspi-34500	38	15	used	use	VERB
ajbspi-34500	38	16	to	to	PART
ajbspi-34500	38	17	assess	assess	VERB
ajbspi-34500	38	18	the	the	DET
ajbspi-34500	38	19	significance	significance	NOUN
ajbspi-34500	38	20	of	of	ADP
ajbspi-34500	38	21	differences	difference	NOUN
ajbspi-34500	38	22	.	.	PUNCT
ajbspi-34500	39	1	in	in	ADP
ajbspi-34500	39	2	the	the	DET
ajbspi-34500	39	3	case	case	NOUN
ajbspi-34500	39	4	of	of	ADP
ajbspi-34500	39	5	asymmetric	asymmetric	ADJ
ajbspi-34500	39	6	distribution	distribution	NOUN
ajbspi-34500	39	7	of	of	ADP
ajbspi-34500	39	8	the	the	DET
ajbspi-34500	39	9	set	set	NOUN
ajbspi-34500	39	10	of	of	ADP
ajbspi-34500	39	11	indicator	indicator	NOUN
ajbspi-34500	39	12	values	value	NOUN
ajbspi-34500	39	13	in	in	ADP
ajbspi-34500	39	14	the	the	DET
ajbspi-34500	39	15	groups	group	NOUN
ajbspi-34500	39	16	,	,	PUNCT
ajbspi-34500	39	17	the	the	DET
ajbspi-34500	39	18	median	median	NOUN
ajbspi-34500	39	19	(	(	PUNCT
ajbspi-34500	39	20	me	i	PRON
ajbspi-34500	39	21	)	)	PUNCT
ajbspi-34500	39	22	was	be	AUX
ajbspi-34500	39	23	calculated	calculate	VERB
ajbspi-34500	39	24	,	,	PUNCT
ajbspi-34500	39	25	the	the	DET
ajbspi-34500	39	26	limits	limit	NOUN
ajbspi-34500	39	27	of	of	ADP
ajbspi-34500	39	28	variation	variation	NOUN
ajbspi-34500	39	29	of	of	ADP
ajbspi-34500	39	30	the	the	DET
ajbspi-34500	39	31	study	study	NOUN
ajbspi-34500	39	32	population	population	NOUN
ajbspi-34500	39	33	were	be	AUX
ajbspi-34500	39	34	from	from	ADP
ajbspi-34500	39	35	5	5	NUM
ajbspi-34500	39	36	%	%	NOUN
ajbspi-34500	39	37	to	to	PART
ajbspi-34500	39	38	95	95	NUM
ajbspi-34500	39	39	%	%	NOUN
ajbspi-34500	39	40	(	(	PUNCT
ajbspi-34500	39	41	p5	p5	ADJ
ajbspi-34500	39	42	p95	p95	NOUN
ajbspi-34500	39	43	)	)	PUNCT
ajbspi-34500	39	44	,	,	PUNCT
ajbspi-34500	39	45	and	and	CCONJ
ajbspi-34500	39	46	the	the	DET
ajbspi-34500	39	47	reliability	reliability	NOUN
ajbspi-34500	39	48	of	of	ADP
ajbspi-34500	39	49	the	the	DET
ajbspi-34500	39	50	differences	difference	NOUN
ajbspi-34500	39	51	was	be	AUX
ajbspi-34500	39	52	nonparametric	nonparametric	ADJ
ajbspi-34500	39	53	mann	mann	PROPN
ajbspi-34500	39	54	-	-	PUNCT
ajbspi-34500	39	55	whitney	whitney	PROPN
ajbspi-34500	39	56	tests	test	VERB
ajbspi-34500	39	57	for	for	ADP
ajbspi-34500	39	58	independent	independent	ADJ
ajbspi-34500	39	59	groups	group	NOUN
ajbspi-34500	39	60	.	.	PUNCT
ajbspi-34500	40	1	(	(	PUNCT
ajbspi-34500	40	2	pm	pm	NOUN
ajbspi-34500	40	3	-	-	PUNCT
ajbspi-34500	40	4	w	w	NOUN
ajbspi-34500	40	5	)	)	PUNCT
ajbspi-34500	41	1	and	and	CCONJ
ajbspi-34500	41	2	was	be	AUX
ajbspi-34500	41	3	evaluated	evaluate	VERB
ajbspi-34500	41	4	using	use	VERB
ajbspi-34500	41	5	wilcoxon	wilcoxon	PROPN
ajbspi-34500	41	6	(	(	PUNCT
ajbspi-34500	41	7	pw	pw	NOUN
ajbspi-34500	41	8	)	)	PUNCT
ajbspi-34500	41	9	for	for	ADP
ajbspi-34500	41	10	conjugated	conjugated	ADJ
ajbspi-34500	41	11	groups	group	NOUN
ajbspi-34500	41	12	[	[	X
ajbspi-34500	41	13	4	4	NUM
ajbspi-34500	41	14	]	]	PUNCT
ajbspi-34500	41	15	.	.	PUNCT
ajbspi-34500	42	1	the	the	DET
ajbspi-34500	42	2	reliability	reliability	NOUN
ajbspi-34500	42	3	of	of	ADP
ajbspi-34500	42	4	the	the	DET
ajbspi-34500	42	5	relationship	relationship	NOUN
ajbspi-34500	42	6	between	between	ADP
ajbspi-34500	42	7	two	two	NUM
ajbspi-34500	42	8	series	series	NOUN
ajbspi-34500	42	9	of	of	ADP
ajbspi-34500	42	10	observations	observation	NOUN
ajbspi-34500	42	11	was	be	AUX
ajbspi-34500	42	12	evaluated	evaluate	VERB
ajbspi-34500	42	13	based	base	VERB
ajbspi-34500	42	14	on	on	ADP
ajbspi-34500	42	15	the	the	DET
ajbspi-34500	42	16	calculation	calculation	NOUN
ajbspi-34500	42	17	of	of	ADP
ajbspi-34500	42	18	the	the	DET
ajbspi-34500	42	19	spearman	spearman	NOUN
ajbspi-34500	42	20	rank	rank	NOUN
ajbspi-34500	42	21	correlation	correlation	NOUN
ajbspi-34500	42	22	coefficient	coefficient	NOUN
ajbspi-34500	42	23	(	(	PUNCT
ajbspi-34500	42	24	rs	rs	NOUN
ajbspi-34500	42	25	)	)	PUNCT
ajbspi-34500	42	26	,	,	PUNCT
ajbspi-34500	42	27	the	the	DET
ajbspi-34500	42	28	reliability	reliability	NOUN
ajbspi-34500	42	29	of	of	ADP
ajbspi-34500	42	30	the	the	DET
ajbspi-34500	42	31	coefficients	coefficient	NOUN
ajbspi-34500	42	32	was	be	AUX
ajbspi-34500	42	33	considered	consider	VERB
ajbspi-34500	42	34	acceptable	acceptable	ADJ
ajbspi-34500	42	35	when	when	SCONJ
ajbspi-34500	42	36	prs<0.05	prs<0.05	NOUN
ajbspi-34500	42	37	.	.	PUNCT
ajbspi-34500	43	1	the	the	DET
ajbspi-34500	43	2	values	value	NOUN
ajbspi-34500	43	3	of	of	ADP
ajbspi-34500	43	4	the	the	DET
ajbspi-34500	43	5	laboratory	laboratory	NOUN
ajbspi-34500	43	6	parameters	parameter	NOUN
ajbspi-34500	43	7	obtained	obtain	VERB
ajbspi-34500	43	8	during	during	ADP
ajbspi-34500	43	9	the	the	DET
ajbspi-34500	43	10	study	study	NOUN
ajbspi-34500	43	11	were	be	AUX
ajbspi-34500	43	12	compared	compare	VERB
ajbspi-34500	43	13	with	with	ADP
ajbspi-34500	43	14	the	the	DET
ajbspi-34500	43	15	values	value	NOUN
ajbspi-34500	43	16	of	of	ADP
ajbspi-34500	43	17	the	the	DET
ajbspi-34500	43	18	results	result	NOUN
ajbspi-34500	43	19	of	of	ADP
ajbspi-34500	43	20	the	the	DET
ajbspi-34500	43	21	examination	examination	NOUN
ajbspi-34500	43	22	of	of	ADP
ajbspi-34500	43	23	25	25	NUM
ajbspi-34500	43	24	practically	practically	ADV
ajbspi-34500	43	25	healthy	healthy	ADJ
ajbspi-34500	43	26	people	people	NOUN
ajbspi-34500	43	27	.	.	PUNCT
ajbspi-34500	44	1	results	result	VERB
ajbspi-34500	44	2	the	the	DET
ajbspi-34500	44	3	results	result	NOUN
ajbspi-34500	44	4	of	of	ADP
ajbspi-34500	44	5	the	the	DET
ajbspi-34500	44	6	study	study	NOUN
ajbspi-34500	44	7	show	show	VERB
ajbspi-34500	44	8	that	that	SCONJ
ajbspi-34500	44	9	in	in	ADP
ajbspi-34500	44	10	patients	patient	NOUN
ajbspi-34500	44	11	with	with	ADP
ajbspi-34500	44	12	gn	gn	PROPN
ajbspi-34500	44	13	,	,	PUNCT
ajbspi-34500	44	14	regardless	regardless	ADV
ajbspi-34500	44	15	of	of	ADP
ajbspi-34500	44	16	the	the	DET
ajbspi-34500	44	17	nature	nature	NOUN
ajbspi-34500	44	18	of	of	ADP
ajbspi-34500	44	19	the	the	DET
ajbspi-34500	44	20	clinical	clinical	ADJ
ajbspi-34500	44	21	course	course	NOUN
ajbspi-34500	44	22	of	of	ADP
ajbspi-34500	44	23	the	the	DET
ajbspi-34500	44	24	disease	disease	NOUN
ajbspi-34500	44	25	acute	acute	NOUN
ajbspi-34500	44	26	or	or	CCONJ
ajbspi-34500	44	27	chronic	chronic	ADJ
ajbspi-34500	44	28	,	,	PUNCT
ajbspi-34500	44	29	both	both	CCONJ
ajbspi-34500	44	30	pro	pro	ADJ
ajbspi-34500	44	31	-	-	ADJ
ajbspi-34500	44	32	inflammatory	inflammatory	ADJ
ajbspi-34500	44	33	cytokines	cytokine	NOUN
ajbspi-34500	44	34	(	(	PUNCT
ajbspi-34500	44	35	il-1b	il-1b	PROPN
ajbspi-34500	44	36	,	,	PUNCT
ajbspi-34500	44	37	il-2	il-2	NUM
ajbspi-34500	44	38	)	)	PUNCT
ajbspi-34500	44	39	and	and	CCONJ
ajbspi-34500	44	40	anti	anti	ADJ
ajbspi-34500	44	41	-	-	ADJ
ajbspi-34500	44	42	inflammatory	inflammatory	ADJ
ajbspi-34500	44	43	cytokines	cytokine	NOUN
ajbspi-34500	44	44	are	be	AUX
ajbspi-34500	44	45	produced	produce	VERB
ajbspi-34500	44	46	.	.	PUNCT
ajbspi-34500	45	1	released	release	VERB
ajbspi-34500	45	2	il-10	il-10	PRON
ajbspi-34500	45	3	and	and	CCONJ
ajbspi-34500	45	4	ra	ra	PROPN
ajbspi-34500	45	5	-	-	PUNCT
ajbspi-34500	45	6	il-1b	il-1b	PROPN
ajbspi-34500	45	7	.	.	PUNCT
ajbspi-34500	46	1	an	an	DET
ajbspi-34500	46	2	exception	exception	NOUN
ajbspi-34500	46	3	is	be	AUX
ajbspi-34500	46	4	the	the	DET
ajbspi-34500	46	5	pro	pro	ADJ
ajbspi-34500	46	6	-	-	ADJ
ajbspi-34500	46	7	inflammatory	inflammatory	ADJ
ajbspi-34500	46	8	cytokine	cytokine	NOUN
ajbspi-34500	46	9	ifn	ifn	NOUN
ajbspi-34500	46	10	-	-	PUNCT
ajbspi-34500	46	11	γ	γ	NOUN
ajbspi-34500	46	12	,	,	PUNCT
ajbspi-34500	46	13	which	which	PRON
ajbspi-34500	46	14	has	have	VERB
ajbspi-34500	46	15	regulatory	regulatory	ADJ
ajbspi-34500	46	16	functions	function	NOUN
ajbspi-34500	46	17	,	,	PUNCT
ajbspi-34500	46	18	and	and	CCONJ
ajbspi-34500	46	19	their	their	PRON
ajbspi-34500	46	20	values	value	NOUN
ajbspi-34500	46	21	are	be	AUX
ajbspi-34500	46	22	at	at	ADP
ajbspi-34500	46	23	the	the	DET
ajbspi-34500	46	24	reference	reference	NOUN
ajbspi-34500	46	25	level	level	NOUN
ajbspi-34500	46	26	.	.	PUNCT
ajbspi-34500	47	1	during	during	ADP
ajbspi-34500	47	2	gn	gn	PROPN
ajbspi-34500	47	3	,	,	PUNCT
ajbspi-34500	47	4	the	the	DET
ajbspi-34500	47	5	increase	increase	NOUN
ajbspi-34500	47	6	in	in	ADP
ajbspi-34500	47	7	the	the	DET
ajbspi-34500	47	8	production	production	NOUN
ajbspi-34500	47	9	of	of	ADP
ajbspi-34500	47	10	proinflammatory	proinflammatory	ADJ
ajbspi-34500	47	11	cytokines	cytokine	NOUN
ajbspi-34500	47	12	is	be	AUX
ajbspi-34500	47	13	explained	explain	VERB
ajbspi-34500	47	14	by	by	ADP
ajbspi-34500	47	15	the	the	DET
ajbspi-34500	47	16	development	development	NOUN
ajbspi-34500	47	17	of	of	ADP
ajbspi-34500	47	18	inflammatory	inflammatory	ADJ
ajbspi-34500	47	19	changes	change	NOUN
ajbspi-34500	47	20	in	in	ADP
ajbspi-34500	47	21	the	the	DET
ajbspi-34500	47	22	glomeruli	glomeruli	NOUN
ajbspi-34500	47	23	as	as	ADP
ajbspi-34500	47	24	a	a	DET
ajbspi-34500	47	25	result	result	NOUN
ajbspi-34500	47	26	of	of	ADP
ajbspi-34500	47	27	infiltration	infiltration	NOUN
ajbspi-34500	47	28	by	by	ADP
ajbspi-34500	47	29	lymphocytes	lymphocyte	NOUN
ajbspi-34500	47	30	,	,	PUNCT
ajbspi-34500	47	31	monocytes	monocyte	NOUN
ajbspi-34500	47	32	and	and	CCONJ
ajbspi-34500	47	33	the	the	DET
ajbspi-34500	47	34	increase	increase	NOUN
ajbspi-34500	47	35	of	of	ADP
ajbspi-34500	47	36	resident	resident	ADJ
ajbspi-34500	47	37	glomerular	glomerular	ADJ
ajbspi-34500	47	38	cells	cell	NOUN
ajbspi-34500	47	39	[	[	X
ajbspi-34500	47	40	5	5	NUM
ajbspi-34500	47	41	]	]	PUNCT
ajbspi-34500	47	42	.	.	PUNCT
ajbspi-34500	48	1	an	an	DET
ajbspi-34500	48	2	increase	increase	NOUN
ajbspi-34500	48	3	in	in	ADP
ajbspi-34500	48	4	the	the	DET
ajbspi-34500	48	5	production	production	NOUN
ajbspi-34500	48	6	of	of	ADP
ajbspi-34500	48	7	anti	anti	ADJ
ajbspi-34500	48	8	-	-	ADJ
ajbspi-34500	48	9	inflammatory	inflammatory	ADJ
ajbspi-34500	48	10	cytokines	cytokine	NOUN
ajbspi-34500	48	11	il-10	il-10	PRON
ajbspi-34500	48	12	and	and	CCONJ
ajbspi-34500	48	13	ra	ra	PROPN
ajbspi-34500	48	14	-	-	PUNCT
ajbspi-34500	48	15	il-1b	il-1b	PROPN
ajbspi-34500	48	16	,	,	PUNCT
ajbspi-34500	48	17	which	which	PRON
ajbspi-34500	48	18	occurs	occur	VERB
ajbspi-34500	48	19	in	in	ADP
ajbspi-34500	48	20	parallel	parallel	NOUN
ajbspi-34500	48	21	with	with	ADP
ajbspi-34500	48	22	an	an	DET
ajbspi-34500	48	23	increase	increase	NOUN
ajbspi-34500	48	24	in	in	ADP
ajbspi-34500	48	25	the	the	DET
ajbspi-34500	48	26	level	level	NOUN
ajbspi-34500	48	27	of	of	ADP
ajbspi-34500	48	28	pro	pro	ADJ
ajbspi-34500	48	29	-	-	ADJ
ajbspi-34500	48	30	inflammatory	inflammatory	ADJ
ajbspi-34500	48	31	cytokines	cytokine	NOUN
ajbspi-34500	48	32	,	,	PUNCT
ajbspi-34500	48	33	can	can	AUX
ajbspi-34500	48	34	be	be	AUX
ajbspi-34500	48	35	considered	consider	VERB
ajbspi-34500	48	36	as	as	ADP
ajbspi-34500	48	37	an	an	DET
ajbspi-34500	48	38	autoregulatory	autoregulatory	ADJ
ajbspi-34500	48	39	reaction	reaction	NOUN
ajbspi-34500	48	40	aimed	aim	VERB
ajbspi-34500	48	41	at	at	ADP
ajbspi-34500	48	42	suppressing	suppress	VERB
ajbspi-34500	48	43	the	the	DET
ajbspi-34500	48	44	increase	increase	NOUN
ajbspi-34500	48	45	in	in	ADP
ajbspi-34500	48	46	production	production	NOUN
ajbspi-34500	48	47	,	,	PUNCT
ajbspi-34500	48	48	inflammation	inflammation	NOUN
ajbspi-34500	48	49	to	to	PART
ajbspi-34500	48	50	suppress	suppress	VERB
ajbspi-34500	48	51	the	the	DET
ajbspi-34500	48	52	production	production	NOUN
ajbspi-34500	48	53	of	of	ADP
ajbspi-34500	48	54	pro	pro	ADJ
ajbspi-34500	48	55	-	-	ADJ
ajbspi-34500	48	56	inflammatory	inflammatory	ADJ
ajbspi-34500	48	57	cytokines	cytokine	NOUN
ajbspi-34500	49	1	[	[	X
ajbspi-34500	49	2	6	6	NUM
ajbspi-34500	49	3	]	]	PUNCT
ajbspi-34500	49	4	.	.	PUNCT
ajbspi-34500	50	1	cytokine	cytokine	ADJ
ajbspi-34500	50	2	profile	profile	NOUN
ajbspi-34500	50	3	of	of	ADP
ajbspi-34500	50	4	patients	patient	NOUN
ajbspi-34500	50	5	with	with	ADP
ajbspi-34500	50	6	gn	gn	PROPN
ajbspi-34500	50	7	revealed	reveal	VERB
ajbspi-34500	50	8	some	some	DET
ajbspi-34500	50	9	features	feature	NOUN
ajbspi-34500	50	10	depending	depend	VERB
ajbspi-34500	50	11	on	on	ADP
ajbspi-34500	50	12	the	the	DET
ajbspi-34500	50	13	clinical	clinical	ADJ
ajbspi-34500	50	14	course	course	NOUN
ajbspi-34500	50	15	of	of	ADP
ajbspi-34500	50	16	the	the	DET
ajbspi-34500	50	17	disease	disease	NOUN
ajbspi-34500	50	18	.	.	PUNCT
ajbspi-34500	51	1	thus	thus	ADV
ajbspi-34500	51	2	,	,	PUNCT
ajbspi-34500	51	3	the	the	DET
ajbspi-34500	51	4	average	average	ADJ
ajbspi-34500	51	5	amount	amount	NOUN
ajbspi-34500	51	6	of	of	ADP
ajbspi-34500	51	7	ra	ra	PROPN
ajbspi-34500	51	8	-	-	NOUN
ajbspi-34500	51	9	il-1b	il-1b	PROPN
ajbspi-34500	51	10	in	in	ADP
ajbspi-34500	51	11	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	PROPN
ajbspi-34500	51	12	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	AUX
ajbspi-34500	51	13	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	ADJ
ajbspi-34500	51	14	volume	volume	NOUN
ajbspi-34500	51	15	04	04	NUM
ajbspi-34500	51	16	issue	issue	NOUN
ajbspi-34500	51	17	03	03	NUM
ajbspi-34500	51	18	-	-	SYM
ajbspi-34500	51	19	2024	2024	NUM
ajbspi-34500	51	20	39	39	NUM
ajbspi-34500	51	21	american	american	ADJ
ajbspi-34500	51	22	journal	journal	PROPN
ajbspi-34500	51	23	of	of	ADP
ajbspi-34500	51	24	biomedical	biomedical	PROPN
ajbspi-34500	51	25	science	science	PROPN
ajbspi-34500	51	26	&	&	CCONJ
ajbspi-34500	51	27	pharmaceutical	pharmaceutical	PROPN
ajbspi-34500	51	28	innovation	innovation	NOUN
ajbspi-34500	51	29	(	(	PUNCT
ajbspi-34500	51	30	issn	issn	PROPN
ajbspi-34500	51	31	–	–	PUNCT
ajbspi-34500	51	32	2771	2771	NUM
ajbspi-34500	51	33	-	-	SYM
ajbspi-34500	51	34	2753	2753	NUM
ajbspi-34500	51	35	)	)	PUNCT
ajbspi-34500	51	36	volume	volume	NOUN
ajbspi-34500	51	37	04	04	NUM
ajbspi-34500	51	38	issue	issue	NOUN
ajbspi-34500	51	39	03	03	NUM
ajbspi-34500	51	40	pages	page	NOUN
ajbspi-34500	51	41	:	:	PUNCT
ajbspi-34500	51	42	36	36	NUM
ajbspi-34500	51	43	-	-	SYM
ajbspi-34500	51	44	43	43	NUM
ajbspi-34500	51	45	sjif	sjif	NOUN
ajbspi-34500	51	46	impact	impact	NOUN
ajbspi-34500	51	47	factor	factor	NOUN
ajbspi-34500	51	48	(	(	PUNCT
ajbspi-34500	51	49	2022	2022	NUM
ajbspi-34500	51	50	:	:	PUNCT
ajbspi-34500	51	51	5	5	NUM
ajbspi-34500	51	52	.	.	NOUN
ajbspi-34500	51	53	705	705	NUM
ajbspi-34500	51	54	)	)	PUNCT
ajbspi-34500	51	55	(	(	PUNCT
ajbspi-34500	51	56	2023	2023	NUM
ajbspi-34500	51	57	:	:	PUNCT
ajbspi-34500	51	58	6.534	6.534	NUM
ajbspi-34500	51	59	)	)	PUNCT
ajbspi-34500	51	60	(	(	PUNCT
ajbspi-34500	51	61	2024	2024	NUM
ajbspi-34500	51	62	:	:	PUNCT
ajbspi-34500	51	63	7.7	7.7	NUM
ajbspi-34500	51	64	)	)	PUNCT
ajbspi-34500	51	65	oclc	oclc	PROPN
ajbspi-34500	51	66	–	–	PUNCT
ajbspi-34500	51	67	1121105677	1121105677	NUM
ajbspi-34500	51	68	publisher	publisher	NOUN
ajbspi-34500	51	69	:	:	PUNCT
ajbspi-34500	51	70	oscar	oscar	NOUN
ajbspi-34500	51	71	publishing	publishing	NOUN
ajbspi-34500	51	72	services	service	NOUN
ajbspi-34500	51	73	servi	servi	ADJ
ajbspi-34500	51	74	patients	patient	NOUN
ajbspi-34500	51	75	with	with	ADP
ajbspi-34500	51	76	exacerbation	exacerbation	NOUN
ajbspi-34500	51	77	of	of	ADP
ajbspi-34500	51	78	chronic	chronic	ADJ
ajbspi-34500	51	79	gn	gn	PROPN
ajbspi-34500	51	80	is	be	AUX
ajbspi-34500	51	81	2.6	2.6	NUM
ajbspi-34500	51	82	times	time	NOUN
ajbspi-34500	51	83	lower	low	ADJ
ajbspi-34500	51	84	than	than	ADP
ajbspi-34500	51	85	the	the	DET
ajbspi-34500	51	86	corresponding	corresponding	ADJ
ajbspi-34500	51	87	value	value	NOUN
ajbspi-34500	51	88	in	in	ADP
ajbspi-34500	51	89	patients	patient	NOUN
ajbspi-34500	51	90	with	with	ADP
ajbspi-34500	51	91	acute	acute	PROPN
ajbspi-34500	51	92	gn	gn	PROPN
ajbspi-34500	51	93	,	,	PUNCT
ajbspi-34500	51	94	and	and	CCONJ
ajbspi-34500	51	95	ifn	ifn	PROPN
ajbspi-34500	51	96	-	-	PUNCT
ajbspi-34500	51	97	γ	γ	NOUN
ajbspi-34500	51	98	in	in	ADP
ajbspi-34500	51	99	the	the	DET
ajbspi-34500	51	100	last	last	ADJ
ajbspi-34500	51	101	stage	stage	NOUN
ajbspi-34500	51	102	of	of	ADP
ajbspi-34500	51	103	inpatient	inpatient	NOUN
ajbspi-34500	51	104	treatment	treatment	NOUN
ajbspi-34500	51	105	with	with	ADP
ajbspi-34500	51	106	acute	acute	PROPN
ajbspi-34500	51	107	gn	gn	PROPN
ajbspi-34500	51	108	was	be	AUX
ajbspi-34500	51	109	1.6	1.6	NUM
ajbspi-34500	51	110	times	time	NOUN
ajbspi-34500	51	111	higher	high	ADJ
ajbspi-34500	51	112	than	than	ADP
ajbspi-34500	51	113	that	that	PRON
ajbspi-34500	51	114	of	of	ADP
ajbspi-34500	51	115	the	the	DET
ajbspi-34500	51	116	group	group	NOUN
ajbspi-34500	51	117	of	of	ADP
ajbspi-34500	51	118	sick	sick	ADJ
ajbspi-34500	51	119	patients	patient	NOUN
ajbspi-34500	51	120	.	.	PUNCT
ajbspi-34500	52	1	despite	despite	SCONJ
ajbspi-34500	52	2	the	the	DET
ajbspi-34500	52	3	fact	fact	NOUN
ajbspi-34500	52	4	that	that	SCONJ
ajbspi-34500	52	5	the	the	DET
ajbspi-34500	52	6	average	average	ADJ
ajbspi-34500	52	7	amount	amount	NOUN
ajbspi-34500	52	8	of	of	ADP
ajbspi-34500	52	9	il-1β	il-1β	PROPN
ajbspi-34500	52	10	in	in	ADP
ajbspi-34500	52	11	patients	patient	NOUN
ajbspi-34500	52	12	with	with	ADP
ajbspi-34500	52	13	chronic	chronic	ADJ
ajbspi-34500	52	14	gn	gn	PROPN
ajbspi-34500	52	15	was	be	AUX
ajbspi-34500	52	16	4.7	4.7	NUM
ajbspi-34500	52	17	times	time	NOUN
ajbspi-34500	52	18	lower	low	ADJ
ajbspi-34500	52	19	than	than	ADP
ajbspi-34500	52	20	the	the	DET
ajbspi-34500	52	21	corresponding	corresponding	ADJ
ajbspi-34500	52	22	value	value	NOUN
ajbspi-34500	52	23	in	in	ADP
ajbspi-34500	52	24	patients	patient	NOUN
ajbspi-34500	52	25	with	with	ADP
ajbspi-34500	52	26	acute	acute	PROPN
ajbspi-34500	52	27	gn	gn	PROPN
ajbspi-34500	52	28	,	,	PUNCT
ajbspi-34500	52	29	the	the	DET
ajbspi-34500	52	30	difference	difference	NOUN
ajbspi-34500	52	31	between	between	ADP
ajbspi-34500	52	32	the	the	DET
ajbspi-34500	52	33	level	level	NOUN
ajbspi-34500	52	34	of	of	ADP
ajbspi-34500	52	35	production	production	NOUN
ajbspi-34500	52	36	of	of	ADP
ajbspi-34500	52	37	this	this	DET
ajbspi-34500	52	38	cytokine	cytokine	NOUN
ajbspi-34500	52	39	in	in	ADP
ajbspi-34500	52	40	the	the	DET
ajbspi-34500	52	41	compared	compare	VERB
ajbspi-34500	52	42	groups	group	NOUN
ajbspi-34500	52	43	of	of	ADP
ajbspi-34500	52	44	patients	patient	NOUN
ajbspi-34500	52	45	was	be	AUX
ajbspi-34500	52	46	statistically	statistically	ADV
ajbspi-34500	52	47	not	not	PART
ajbspi-34500	52	48	important	important	ADJ
ajbspi-34500	52	49	.	.	PUNCT
ajbspi-34500	53	1	comparison	comparison	NOUN
ajbspi-34500	53	2	of	of	ADP
ajbspi-34500	53	3	cytokine	cytokine	ADJ
ajbspi-34500	53	4	levels	level	NOUN
ajbspi-34500	53	5	before	before	ADP
ajbspi-34500	53	6	and	and	CCONJ
ajbspi-34500	53	7	after	after	ADP
ajbspi-34500	53	8	treatment	treatment	NOUN
ajbspi-34500	53	9	using	use	VERB
ajbspi-34500	53	10	the	the	DET
ajbspi-34500	53	11	wilcoxon	wilcoxon	ADJ
ajbspi-34500	53	12	test	test	NOUN
ajbspi-34500	53	13	revealed	reveal	VERB
ajbspi-34500	53	14	certain	certain	ADJ
ajbspi-34500	53	15	dynamics	dynamic	NOUN
ajbspi-34500	53	16	of	of	ADP
ajbspi-34500	53	17	cytokine	cytokine	ADJ
ajbspi-34500	53	18	production	production	NOUN
ajbspi-34500	53	19	levels	level	NOUN
ajbspi-34500	53	20	during	during	ADP
ajbspi-34500	53	21	treatment	treatment	NOUN
ajbspi-34500	53	22	in	in	ADP
ajbspi-34500	53	23	patients	patient	NOUN
ajbspi-34500	53	24	with	with	ADP
ajbspi-34500	53	25	acute	acute	PROPN
ajbspi-34500	53	26	gn	gn	PROPN
ajbspi-34500	53	27	,	,	PUNCT
ajbspi-34500	53	28	with	with	ADP
ajbspi-34500	53	29	a	a	DET
ajbspi-34500	53	30	decrease	decrease	NOUN
ajbspi-34500	53	31	in	in	ADP
ajbspi-34500	53	32	the	the	DET
ajbspi-34500	53	33	initial	initial	ADJ
ajbspi-34500	53	34	high	high	ADJ
ajbspi-34500	53	35	levels	level	NOUN
ajbspi-34500	53	36	of	of	ADP
ajbspi-34500	53	37	il-1β	il-1β	PROPN
ajbspi-34500	53	38	,	,	PUNCT
ajbspi-34500	53	39	rα	rα	ADJ
ajbspi-34500	53	40	-	-	PUNCT
ajbspi-34500	53	41	il-1β	il-1β	PROPN
ajbspi-34500	53	42	and	and	CCONJ
ajbspi-34500	53	43	il-2	il-2	PROPN
ajbspi-34500	53	44	appeared	appear	VERB
ajbspi-34500	53	45	.	.	PUNCT
ajbspi-34500	54	1	the	the	DET
ajbspi-34500	54	2	level	level	NOUN
ajbspi-34500	54	3	of	of	ADP
ajbspi-34500	54	4	ifnγ	ifnγ	NOUN
ajbspi-34500	54	5	was	be	AUX
ajbspi-34500	54	6	also	also	ADV
ajbspi-34500	54	7	significantly	significantly	ADV
ajbspi-34500	54	8	decreased	decrease	VERB
ajbspi-34500	54	9	(	(	PUNCT
ajbspi-34500	54	10	pw<0.05	pw<0.05	PROPN
ajbspi-34500	54	11	)	)	PUNCT
ajbspi-34500	54	12	,	,	PUNCT
ajbspi-34500	54	13	its	its	PRON
ajbspi-34500	54	14	baseline	baseline	ADJ
ajbspi-34500	54	15	level	level	NOUN
ajbspi-34500	54	16	was	be	AUX
ajbspi-34500	54	17	not	not	PART
ajbspi-34500	54	18	different	different	ADJ
ajbspi-34500	54	19	from	from	ADP
ajbspi-34500	54	20	the	the	DET
ajbspi-34500	54	21	corresponding	corresponding	ADJ
ajbspi-34500	54	22	reference	reference	NOUN
ajbspi-34500	54	23	values	value	NOUN
ajbspi-34500	54	24	.	.	PUNCT
ajbspi-34500	55	1	no	no	DET
ajbspi-34500	55	2	significant	significant	ADJ
ajbspi-34500	55	3	dynamics	dynamic	NOUN
ajbspi-34500	55	4	in	in	ADP
ajbspi-34500	55	5	the	the	DET
ajbspi-34500	55	6	production	production	NOUN
ajbspi-34500	55	7	of	of	ADP
ajbspi-34500	55	8	cytokines	cytokine	NOUN
ajbspi-34500	55	9	were	be	AUX
ajbspi-34500	55	10	observed	observe	VERB
ajbspi-34500	55	11	during	during	ADP
ajbspi-34500	55	12	treatment	treatment	NOUN
ajbspi-34500	55	13	in	in	ADP
ajbspi-34500	55	14	patients	patient	NOUN
ajbspi-34500	55	15	with	with	ADP
ajbspi-34500	55	16	chronic	chronic	PROPN
ajbspi-34500	55	17	gn	gn	PROPN
ajbspi-34500	55	18	.	.	PROPN
ajbspi-34500	55	19	in	in	ADP
ajbspi-34500	55	20	connection	connection	NOUN
ajbspi-34500	55	21	with	with	ADP
ajbspi-34500	55	22	the	the	DET
ajbspi-34500	55	23	known	known	ADJ
ajbspi-34500	55	24	situation	situation	NOUN
ajbspi-34500	55	25	about	about	ADP
ajbspi-34500	55	26	the	the	DET
ajbspi-34500	55	27	mutual	mutual	ADJ
ajbspi-34500	55	28	dependence	dependence	NOUN
ajbspi-34500	55	29	of	of	ADP
ajbspi-34500	55	30	the	the	DET
ajbspi-34500	55	31	production	production	NOUN
ajbspi-34500	55	32	of	of	ADP
ajbspi-34500	55	33	individual	individual	ADJ
ajbspi-34500	55	34	cytokines	cytokine	NOUN
ajbspi-34500	55	35	,	,	PUNCT
ajbspi-34500	55	36	we	we	PRON
ajbspi-34500	55	37	investigated	investigate	VERB
ajbspi-34500	55	38	the	the	DET
ajbspi-34500	55	39	correlation	correlation	NOUN
ajbspi-34500	55	40	relationship	relationship	NOUN
ajbspi-34500	55	41	between	between	ADP
ajbspi-34500	55	42	the	the	DET
ajbspi-34500	55	43	levels	level	NOUN
ajbspi-34500	55	44	of	of	ADP
ajbspi-34500	55	45	the	the	DET
ajbspi-34500	55	46	studied	study	VERB
ajbspi-34500	55	47	cytokines	cytokine	NOUN
ajbspi-34500	55	48	.	.	PUNCT
ajbspi-34500	56	1	in	in	ADP
ajbspi-34500	56	2	healthy	healthy	ADJ
ajbspi-34500	56	3	people	people	NOUN
ajbspi-34500	56	4	,	,	PUNCT
ajbspi-34500	56	5	only	only	ADV
ajbspi-34500	56	6	one	one	NUM
ajbspi-34500	56	7	correlation	correlation	NOUN
ajbspi-34500	56	8	was	be	AUX
ajbspi-34500	56	9	established	establish	VERB
ajbspi-34500	56	10	between	between	ADP
ajbspi-34500	56	11	the	the	DET
ajbspi-34500	56	12	indicators	indicator	NOUN
ajbspi-34500	56	13	of	of	ADP
ajbspi-34500	56	14	cytokine	cytokine	ADJ
ajbspi-34500	56	15	status	status	NOUN
ajbspi-34500	56	16	a	a	DET
ajbspi-34500	56	17	negative	negative	ADJ
ajbspi-34500	56	18	correlation	correlation	NOUN
ajbspi-34500	56	19	of	of	ADP
ajbspi-34500	56	20	the	the	DET
ajbspi-34500	56	21	levels	level	NOUN
ajbspi-34500	56	22	of	of	ADP
ajbspi-34500	56	23	anti	anti	ADJ
ajbspi-34500	56	24	-	-	ADJ
ajbspi-34500	56	25	inflammatory	inflammatory	ADJ
ajbspi-34500	56	26	cytokines	cytokine	NOUN
ajbspi-34500	56	27	il-10	il-10	PRON
ajbspi-34500	56	28	and	and	CCONJ
ajbspi-34500	56	29	ra	ra	PROPN
ajbspi-34500	56	30	-	-	PROPN
ajbspi-34500	56	31	il-1b	il-1b	PROPN
ajbspi-34500	56	32	(	(	PUNCT
ajbspi-34500	56	33	rs	rs	PROPN
ajbspi-34500	56	34	=	=	SYM
ajbspi-34500	56	35	-0.76	-0.76	PROPN
ajbspi-34500	56	36	;	;	PUNCT
ajbspi-34500	56	37	prs	prs	NOUN
ajbspi-34500	56	38	=	=	NOUN
ajbspi-34500	56	39	0.030	0.030	NUM
ajbspi-34500	56	40	)	)	PUNCT
ajbspi-34500	56	41	.	.	PUNCT
ajbspi-34500	57	1	being	be	AUX
ajbspi-34500	57	2	with	with	ADP
ajbspi-34500	57	3	the	the	DET
ajbspi-34500	57	4	development	development	NOUN
ajbspi-34500	57	5	of	of	ADP
ajbspi-34500	57	6	glomerular	glomerular	ADJ
ajbspi-34500	57	7	kidney	kidney	NOUN
ajbspi-34500	57	8	damage	damage	NOUN
ajbspi-34500	57	9	,	,	PUNCT
ajbspi-34500	57	10	the	the	DET
ajbspi-34500	57	11	total	total	ADJ
ajbspi-34500	57	12	number	number	NOUN
ajbspi-34500	57	13	of	of	ADP
ajbspi-34500	57	14	connections	connection	NOUN
ajbspi-34500	57	15	increased	increase	VERB
ajbspi-34500	57	16	significantly	significantly	ADV
ajbspi-34500	57	17	.	.	PUNCT
ajbspi-34500	58	1	cytokine	cytokine	VERB
ajbspi-34500	58	2	profile	profile	NOUN
ajbspi-34500	58	3	of	of	ADP
ajbspi-34500	58	4	patients	patient	NOUN
ajbspi-34500	58	5	with	with	ADP
ajbspi-34500	58	6	chronic	chronic	ADJ
ajbspi-34500	58	7	gn	gn	PROPN
ajbspi-34500	58	8	including	include	VERB
ajbspi-34500	58	9	pro	pro	ADJ
ajbspi-34500	58	10	-	-	ADJ
ajbspi-34500	58	11	inflammatory	inflammatory	ADJ
ajbspi-34500	58	12	cytokine	cytokine	NOUN
ajbspi-34500	58	13	il-1β	il-1β	PROPN
ajbspi-34500	58	14	and	and	CCONJ
ajbspi-34500	58	15	its	its	PRON
ajbspi-34500	58	16	receptor	receptor	NOUN
ajbspi-34500	58	17	antagonist	antagonist	NOUN
ajbspi-34500	58	18	,	,	PUNCT
ajbspi-34500	58	19	pro	pro	ADJ
ajbspi-34500	58	20	-	-	ADJ
ajbspi-34500	58	21	inflammatory	inflammatory	ADJ
ajbspi-34500	58	22	cytokines	cytokine	NOUN
ajbspi-34500	58	23	il-2	il-2	NUM
ajbspi-34500	58	24	and	and	CCONJ
ajbspi-34500	58	25	ifnγ	ifnγ	NOUN
ajbspi-34500	58	26	,	,	PUNCT
ajbspi-34500	58	27	pro	pro	ADJ
ajbspi-34500	58	28	-	-	ADJ
ajbspi-34500	58	29	inflammatory	inflammatory	ADJ
ajbspi-34500	58	30	cytokine	cytokine	ADJ
ajbspi-34500	58	31	ifnγ	ifnγ	NOUN
ajbspi-34500	58	32	and	and	CCONJ
ajbspi-34500	58	33	pro	pro	ADJ
ajbspi-34500	58	34	-	-	ADJ
ajbspi-34500	58	35	inflammatory	inflammatory	ADJ
ajbspi-34500	58	36	cytokine	cytokine	NOUN
ajbspi-34500	58	37	il-10	il-10	PRON
ajbspi-34500	58	38	baseline	baseline	NOUN
ajbspi-34500	58	39	characterized	characterize	VERB
ajbspi-34500	58	40	by	by	ADP
ajbspi-34500	58	41	the	the	DET
ajbspi-34500	58	42	existence	existence	NOUN
ajbspi-34500	58	43	of	of	ADP
ajbspi-34500	58	44	a	a	DET
ajbspi-34500	58	45	direct	direct	ADJ
ajbspi-34500	58	46	relationship	relationship	NOUN
ajbspi-34500	58	47	between	between	ADP
ajbspi-34500	58	48	internal	internal	ADJ
ajbspi-34500	58	49	levels	level	NOUN
ajbspi-34500	58	50	.	.	PUNCT
ajbspi-34500	59	1	relationships	relationship	NOUN
ajbspi-34500	59	2	established	establish	VERB
ajbspi-34500	59	3	at	at	ADP
ajbspi-34500	59	4	the	the	DET
ajbspi-34500	59	5	end	end	NOUN
ajbspi-34500	59	6	of	of	ADP
ajbspi-34500	59	7	treatment	treatment	NOUN
ajbspi-34500	59	8	were	be	AUX
ajbspi-34500	59	9	also	also	ADV
ajbspi-34500	59	10	observed	observe	VERB
ajbspi-34500	59	11	.	.	PUNCT
ajbspi-34500	60	1	in	in	ADP
ajbspi-34500	60	2	addition	addition	NOUN
ajbspi-34500	60	3	,	,	PUNCT
ajbspi-34500	60	4	by	by	ADP
ajbspi-34500	60	5	the	the	DET
ajbspi-34500	60	6	end	end	NOUN
ajbspi-34500	60	7	of	of	ADP
ajbspi-34500	60	8	treatment	treatment	NOUN
ajbspi-34500	60	9	,	,	PUNCT
ajbspi-34500	60	10	a	a	DET
ajbspi-34500	60	11	new	new	ADJ
ajbspi-34500	60	12	correlation	correlation	NOUN
ajbspi-34500	60	13	was	be	AUX
ajbspi-34500	60	14	found	find	VERB
ajbspi-34500	60	15	between	between	ADP
ajbspi-34500	60	16	il-2	il-2	PROPN
ajbspi-34500	60	17	and	and	CCONJ
ajbspi-34500	60	18	il-10	il-10	NOUN
ajbspi-34500	60	19	levels	level	NOUN
ajbspi-34500	60	20	.	.	PUNCT
ajbspi-34500	61	1	the	the	DET
ajbspi-34500	61	2	correlations	correlation	NOUN
ajbspi-34500	61	3	found	find	VERB
ajbspi-34500	61	4	in	in	ADP
ajbspi-34500	61	5	patients	patient	NOUN
ajbspi-34500	61	6	with	with	ADP
ajbspi-34500	61	7	chronic	chronic	ADJ
ajbspi-34500	61	8	gn	gn	PROPN
ajbspi-34500	61	9	suggest	suggest	VERB
ajbspi-34500	61	10	the	the	DET
ajbspi-34500	61	11	interaction	interaction	NOUN
ajbspi-34500	61	12	of	of	ADP
ajbspi-34500	61	13	pro	pro	ADJ
ajbspi-34500	61	14	-	-	ADJ
ajbspi-34500	61	15	inflammatory	inflammatory	ADJ
ajbspi-34500	61	16	and	and	CCONJ
ajbspi-34500	61	17	anti	anti	ADJ
ajbspi-34500	61	18	-	-	ADJ
ajbspi-34500	61	19	inflammatory	inflammatory	ADJ
ajbspi-34500	61	20	cytokine	cytokine	NOUN
ajbspi-34500	61	21	production	production	NOUN
ajbspi-34500	61	22	.	.	PUNCT
ajbspi-34500	62	1	this	this	PRON
ajbspi-34500	62	2	,	,	PUNCT
ajbspi-34500	62	3	the	the	DET
ajbspi-34500	62	4	results	result	NOUN
ajbspi-34500	62	5	of	of	ADP
ajbspi-34500	62	6	the	the	DET
ajbspi-34500	62	7	correlation	correlation	NOUN
ajbspi-34500	62	8	analysis	analysis	NOUN
ajbspi-34500	62	9	show	show	VERB
ajbspi-34500	62	10	that	that	SCONJ
ajbspi-34500	62	11	there	there	PRON
ajbspi-34500	62	12	is	be	VERB
ajbspi-34500	62	13	a	a	DET
ajbspi-34500	62	14	correlation	correlation	NOUN
ajbspi-34500	62	15	between	between	ADP
ajbspi-34500	62	16	only	only	ADV
ajbspi-34500	62	17	pro	pro	ADJ
ajbspi-34500	62	18	-	-	ADJ
ajbspi-34500	62	19	inflammatory	inflammatory	ADJ
ajbspi-34500	62	20	cytokines	cytokine	NOUN
ajbspi-34500	62	21	in	in	ADP
ajbspi-34500	62	22	healthy	healthy	ADJ
ajbspi-34500	62	23	individuals	individual	NOUN
ajbspi-34500	62	24	.	.	PUNCT
ajbspi-34500	63	1	the	the	DET
ajbspi-34500	63	2	relationships	relationship	NOUN
ajbspi-34500	63	3	identified	identify	VERB
ajbspi-34500	63	4	in	in	ADP
ajbspi-34500	63	5	the	the	DET
ajbspi-34500	63	6	acute	acute	ADJ
ajbspi-34500	63	7	form	form	NOUN
ajbspi-34500	63	8	of	of	ADP
ajbspi-34500	63	9	gn	gn	PROPN
ajbspi-34500	63	10	reflect	reflect	VERB
ajbspi-34500	63	11	the	the	DET
ajbspi-34500	63	12	interdependence	interdependence	NOUN
ajbspi-34500	63	13	of	of	ADP
ajbspi-34500	63	14	the	the	DET
ajbspi-34500	63	15	production	production	NOUN
ajbspi-34500	63	16	of	of	ADP
ajbspi-34500	63	17	proinflammatory	proinflammatory	ADJ
ajbspi-34500	63	18	cytokines	cytokine	NOUN
ajbspi-34500	63	19	.	.	PUNCT
ajbspi-34500	64	1	a	a	DET
ajbspi-34500	64	2	close	close	ADJ
ajbspi-34500	64	3	relationship	relationship	NOUN
ajbspi-34500	64	4	between	between	ADP
ajbspi-34500	64	5	the	the	DET
ajbspi-34500	64	6	levels	level	NOUN
ajbspi-34500	64	7	of	of	ADP
ajbspi-34500	64	8	pro	pro	ADJ
ajbspi-34500	64	9	-	-	ADJ
ajbspi-34500	64	10	inflammatory	inflammatory	ADJ
ajbspi-34500	64	11	and	and	CCONJ
ajbspi-34500	64	12	anti	anti	ADJ
ajbspi-34500	64	13	-	-	ADJ
ajbspi-34500	64	14	inflammatory	inflammatory	ADJ
ajbspi-34500	64	15	cytokine	cytokine	NOUN
ajbspi-34500	64	16	production	production	NOUN
ajbspi-34500	64	17	during	during	ADP
ajbspi-34500	64	18	the	the	DET
ajbspi-34500	64	19	period	period	NOUN
ajbspi-34500	64	20	of	of	ADP
ajbspi-34500	64	21	exacerbation	exacerbation	NOUN
ajbspi-34500	64	22	of	of	ADP
ajbspi-34500	64	23	chronic	chronic	ADJ
ajbspi-34500	64	24	gn	gn	PROPN
ajbspi-34500	64	25	is	be	AUX
ajbspi-34500	64	26	revealed	reveal	VERB
ajbspi-34500	64	27	.	.	PUNCT
ajbspi-34500	65	1	in	in	ADP
ajbspi-34500	65	2	addition	addition	NOUN
ajbspi-34500	65	3	,	,	PUNCT
ajbspi-34500	65	4	by	by	ADP
ajbspi-34500	65	5	the	the	DET
ajbspi-34500	65	6	end	end	NOUN
ajbspi-34500	65	7	of	of	ADP
ajbspi-34500	65	8	chronic	chronic	ADJ
ajbspi-34500	65	9	gn	gn	PROPN
ajbspi-34500	65	10	exacerbation	exacerbation	NOUN
ajbspi-34500	65	11	relief	relief	NOUN
ajbspi-34500	65	12	,	,	PUNCT
ajbspi-34500	65	13	the	the	DET
ajbspi-34500	65	14	number	number	NOUN
ajbspi-34500	65	15	of	of	ADP
ajbspi-34500	65	16	such	such	ADJ
ajbspi-34500	65	17	connections	connection	NOUN
ajbspi-34500	65	18	increases	increase	NOUN
ajbspi-34500	65	19	,	,	PUNCT
ajbspi-34500	65	20	in	in	ADP
ajbspi-34500	65	21	patients	patient	NOUN
ajbspi-34500	65	22	with	with	ADP
ajbspi-34500	65	23	acute	acute	PROPN
ajbspi-34500	65	24	gn	gn	PROPN
ajbspi-34500	65	25	,	,	PUNCT
ajbspi-34500	65	26	by	by	ADP
ajbspi-34500	65	27	the	the	DET
ajbspi-34500	65	28	end	end	NOUN
ajbspi-34500	65	29	of	of	ADP
ajbspi-34500	65	30	inpatient	inpatient	NOUN
ajbspi-34500	65	31	treatment	treatment	NOUN
ajbspi-34500	65	32	,	,	PUNCT
ajbspi-34500	65	33	no	no	DET
ajbspi-34500	65	34	correlation	correlation	NOUN
ajbspi-34500	65	35	is	be	AUX
ajbspi-34500	65	36	found	find	VERB
ajbspi-34500	65	37	in	in	ADP
ajbspi-34500	65	38	the	the	DET
ajbspi-34500	65	39	level	level	NOUN
ajbspi-34500	65	40	of	of	ADP
ajbspi-34500	65	41	studied	study	VERB
ajbspi-34500	65	42	cytokines	cytokine	NOUN
ajbspi-34500	65	43	.	.	PUNCT
ajbspi-34500	66	1	in	in	ADP
ajbspi-34500	66	2	connection	connection	NOUN
ajbspi-34500	66	3	with	with	ADP
ajbspi-34500	66	4	the	the	DET
ajbspi-34500	66	5	differences	difference	NOUN
ajbspi-34500	66	6	in	in	ADP
ajbspi-34500	66	7	the	the	DET
ajbspi-34500	66	8	levels	level	NOUN
ajbspi-34500	66	9	of	of	ADP
ajbspi-34500	66	10	rαil-1β	rαil-1β	NOUN
ajbspi-34500	66	11	and	and	CCONJ
ajbspi-34500	66	12	ifnγ	ifnγ	NOUN
ajbspi-34500	66	13	detected	detect	VERB
ajbspi-34500	66	14	in	in	ADP
ajbspi-34500	66	15	patients	patient	NOUN
ajbspi-34500	66	16	with	with	ADP
ajbspi-34500	66	17	acute	acute	ADJ
ajbspi-34500	66	18	and	and	CCONJ
ajbspi-34500	66	19	chronic	chronic	ADJ
ajbspi-34500	66	20	gn	gn	PROPN
ajbspi-34500	66	21	,	,	PUNCT
ajbspi-34500	66	22	it	it	PRON
ajbspi-34500	66	23	is	be	AUX
ajbspi-34500	66	24	noteworthy	noteworthy	ADJ
ajbspi-34500	66	25	that	that	SCONJ
ajbspi-34500	66	26	these	these	DET
ajbspi-34500	66	27	cytokines	cytokine	NOUN
ajbspi-34500	66	28	correlate	correlate	VERB
ajbspi-34500	66	29	with	with	ADP
ajbspi-34500	66	30	the	the	DET
ajbspi-34500	66	31	indicators	indicator	NOUN
ajbspi-34500	66	32	of	of	ADP
ajbspi-34500	66	33	a	a	DET
ajbspi-34500	66	34	set	set	NOUN
ajbspi-34500	66	35	of	of	ADP
ajbspi-34500	66	36	standard	standard	ADJ
ajbspi-34500	66	37	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	PROPN
ajbspi-34500	66	38	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	AUX
ajbspi-34500	66	39	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	ADJ
ajbspi-34500	66	40	volume	volume	NOUN
ajbspi-34500	66	41	04	04	NUM
ajbspi-34500	67	1	issue	issue	NOUN
ajbspi-34500	67	2	03	03	NUM
ajbspi-34500	67	3	-	-	SYM
ajbspi-34500	67	4	2024	2024	NUM
ajbspi-34500	67	5	40	40	NUM
ajbspi-34500	67	6	american	american	ADJ
ajbspi-34500	67	7	journal	journal	PROPN
ajbspi-34500	67	8	of	of	ADP
ajbspi-34500	67	9	biomedical	biomedical	PROPN
ajbspi-34500	67	10	science	science	PROPN
ajbspi-34500	67	11	&	&	CCONJ
ajbspi-34500	67	12	pharmaceutical	pharmaceutical	PROPN
ajbspi-34500	67	13	innovation	innovation	NOUN
ajbspi-34500	67	14	(	(	PUNCT
ajbspi-34500	67	15	issn	issn	PROPN
ajbspi-34500	67	16	–	–	PUNCT
ajbspi-34500	67	17	2771	2771	NUM
ajbspi-34500	67	18	-	-	SYM
ajbspi-34500	67	19	2753	2753	NUM
ajbspi-34500	67	20	)	)	PUNCT
ajbspi-34500	67	21	volume	volume	NOUN
ajbspi-34500	67	22	04	04	NUM
ajbspi-34500	67	23	issue	issue	NOUN
ajbspi-34500	67	24	03	03	NUM
ajbspi-34500	67	25	pages	page	NOUN
ajbspi-34500	67	26	:	:	PUNCT
ajbspi-34500	67	27	36	36	NUM
ajbspi-34500	67	28	-	-	SYM
ajbspi-34500	67	29	43	43	NUM
ajbspi-34500	67	30	sjif	sjif	NOUN
ajbspi-34500	67	31	impact	impact	NOUN
ajbspi-34500	67	32	factor	factor	NOUN
ajbspi-34500	67	33	(	(	PUNCT
ajbspi-34500	67	34	2022	2022	NUM
ajbspi-34500	67	35	:	:	PUNCT
ajbspi-34500	67	36	5	5	NUM
ajbspi-34500	67	37	.	.	NOUN
ajbspi-34500	67	38	705	705	NUM
ajbspi-34500	67	39	)	)	PUNCT
ajbspi-34500	67	40	(	(	PUNCT
ajbspi-34500	67	41	2023	2023	NUM
ajbspi-34500	67	42	:	:	PUNCT
ajbspi-34500	67	43	6.534	6.534	NUM
ajbspi-34500	67	44	)	)	PUNCT
ajbspi-34500	67	45	(	(	PUNCT
ajbspi-34500	67	46	2024	2024	NUM
ajbspi-34500	67	47	:	:	PUNCT
ajbspi-34500	67	48	7.7	7.7	NUM
ajbspi-34500	67	49	)	)	PUNCT
ajbspi-34500	67	50	oclc	oclc	PROPN
ajbspi-34500	67	51	–	–	PUNCT
ajbspi-34500	67	52	1121105677	1121105677	NUM
ajbspi-34500	67	53	publisher	publisher	NOUN
ajbspi-34500	67	54	:	:	PUNCT
ajbspi-34500	67	55	oscar	oscar	NOUN
ajbspi-34500	67	56	publishing	publishing	NOUN
ajbspi-34500	67	57	services	service	NOUN
ajbspi-34500	67	58	servi	servi	PROPN
ajbspi-34500	67	59	laboratory	laboratory	NOUN
ajbspi-34500	67	60	tests	test	NOUN
ajbspi-34500	67	61	for	for	ADP
ajbspi-34500	67	62	gn	gn	PROPN
ajbspi-34500	67	63	(	(	PUNCT
ajbspi-34500	67	64	4	4	NUM
ajbspi-34500	67	65	-table	-table	ADJ
ajbspi-34500	67	66	)	)	PUNCT
ajbspi-34500	67	67	.	.	PUNCT
ajbspi-34500	68	1	baseline	baseline	ADJ
ajbspi-34500	68	2	values	value	NOUN
ajbspi-34500	68	3	of	of	ADP
ajbspi-34500	68	4	rαil-1β	rαil-1β	NOUN
ajbspi-34500	68	5	were	be	AUX
ajbspi-34500	68	6	positively	positively	ADV
ajbspi-34500	68	7	correlated	correlate	VERB
ajbspi-34500	68	8	with	with	ADP
ajbspi-34500	68	9	peripheral	peripheral	ADJ
ajbspi-34500	68	10	blood	blood	NOUN
ajbspi-34500	68	11	neutrophil	neutrophil	ADJ
ajbspi-34500	68	12	leukocyte	leukocyte	NOUN
ajbspi-34500	68	13	levels	level	NOUN
ajbspi-34500	68	14	and	and	CCONJ
ajbspi-34500	68	15	negatively	negatively	ADV
ajbspi-34500	68	16	correlated	correlate	VERB
ajbspi-34500	68	17	with	with	ADP
ajbspi-34500	68	18	urine	urine	NOUN
ajbspi-34500	68	19	specific	specific	ADJ
ajbspi-34500	68	20	gravity	gravity	NOUN
ajbspi-34500	68	21	.	.	PUNCT
ajbspi-34500	69	1	at	at	ADP
ajbspi-34500	69	2	the	the	DET
ajbspi-34500	69	3	end	end	NOUN
ajbspi-34500	69	4	of	of	ADP
ajbspi-34500	69	5	hospital	hospital	NOUN
ajbspi-34500	69	6	treatment	treatment	NOUN
ajbspi-34500	69	7	,	,	PUNCT
ajbspi-34500	69	8	ifnγ	ifnγ	NOUN
ajbspi-34500	69	9	levels	level	NOUN
ajbspi-34500	69	10	were	be	AUX
ajbspi-34500	69	11	positively	positively	ADV
ajbspi-34500	69	12	related	relate	VERB
ajbspi-34500	69	13	to	to	ADP
ajbspi-34500	69	14	serum	serum	VERB
ajbspi-34500	69	15	creatinine	creatinine	NOUN
ajbspi-34500	69	16	levels	level	NOUN
ajbspi-34500	69	17	.	.	PUNCT
ajbspi-34500	70	1	cytokines	cytokine	VERB
ajbspi-34500	70	2	laboratory	laboratory	NOUN
ajbspi-34500	70	3	indicators	indicator	NOUN
ajbspi-34500	70	4	rs	rs	INTJ
ajbspi-34500	70	5	prs	prs	VERB
ajbspi-34500	70	6	il-1b	il-1b	PROPN
ajbspi-34500	70	7	(	(	PUNCT
ajbspi-34500	70	8	1	1	NUM
ajbspi-34500	70	9	)	)	PUNCT
ajbspi-34500	70	10	serum	serum	NOUN
ajbspi-34500	70	11	urea	urea	NOUN
ajbspi-34500	70	12	(	(	PUNCT
ajbspi-34500	70	13	2	2	NUM
ajbspi-34500	70	14	)	)	PUNCT
ajbspi-34500	70	15	0,35	0,35	NOUN
ajbspi-34500	70	16	0,016	0,016	NUM
ajbspi-34500	70	17	specific	specific	ADJ
ajbspi-34500	70	18	gravity	gravity	NOUN
ajbspi-34500	70	19	of	of	ADP
ajbspi-34500	70	20	urine	urine	NOUN
ajbspi-34500	70	21	(	(	PUNCT
ajbspi-34500	70	22	1	1	NUM
ajbspi-34500	70	23	)	)	PUNCT
ajbspi-34500	70	24	-0,33	-0,33	PUNCT
ajbspi-34500	70	25	0,027	0,027	NUM
ajbspi-34500	71	1	ra	ra	PROPN
ajbspi-34500	71	2	-	-	PUNCT
ajbspi-34500	71	3	il-1b	il-1b	PROPN
ajbspi-34500	71	4	(	(	PUNCT
ajbspi-34500	71	5	1	1	NUM
ajbspi-34500	71	6	)	)	PUNCT
ajbspi-34500	71	7	neutrophils%	neutrophils%	NUM
ajbspi-34500	71	8	(	(	PUNCT
ajbspi-34500	71	9	1	1	NUM
ajbspi-34500	71	10	)	)	PUNCT
ajbspi-34500	71	11	0,45	0,45	NOUN
ajbspi-34500	71	12	0,009	0,009	NUM
ajbspi-34500	71	13	neutrophils	neutrophil	NOUN
ajbspi-34500	71	14	abs	ab	NOUN
ajbspi-34500	71	15	(	(	PUNCT
ajbspi-34500	71	16	1	1	NUM
ajbspi-34500	71	17	)	)	PUNCT
ajbspi-34500	71	18	0,37	0,37	PRON
ajbspi-34500	71	19	0,037	0,037	NUM
ajbspi-34500	71	20	neutrophils	neutrophil	NOUN
ajbspi-34500	71	21	abs	ab	NOUN
ajbspi-34500	71	22	(	(	PUNCT
ajbspi-34500	71	23	2	2	NUM
ajbspi-34500	71	24	)	)	PUNCT
ajbspi-34500	71	25	0,43	0,43	NOUN
ajbspi-34500	71	26	0,015	0,015	NUM
ajbspi-34500	71	27	ifny	ifny	NOUN
ajbspi-34500	71	28	serum	serum	NOUN
ajbspi-34500	71	29	creatinine(2	creatinine(2	PROPN
ajbspi-34500	71	30	)	)	PUNCT
ajbspi-34500	71	31	0,35	0,35	NOUN
ajbspi-34500	72	1	0,047	0,047	NUM
ajbspi-34500	72	2	table	table	NOUN
ajbspi-34500	72	3	1	1	NUM
ajbspi-34500	72	4	.	.	PUNCT
ajbspi-34500	72	5	statistically	statistically	ADV
ajbspi-34500	72	6	significant	significant	ADJ
ajbspi-34500	72	7	correlation	correlation	NOUN
ajbspi-34500	72	8	between	between	ADP
ajbspi-34500	72	9	indicators	indicator	NOUN
ajbspi-34500	72	10	of	of	ADP
ajbspi-34500	72	11	cytokine	cytokine	ADJ
ajbspi-34500	72	12	status	status	NOUN
ajbspi-34500	72	13	and	and	CCONJ
ajbspi-34500	72	14	standard	standard	ADJ
ajbspi-34500	72	15	laboratory	laboratory	NOUN
ajbspi-34500	72	16	tests	test	NOUN
ajbspi-34500	72	17	in	in	ADP
ajbspi-34500	72	18	patients	patient	NOUN
ajbspi-34500	72	19	with	with	ADP
ajbspi-34500	72	20	gnnote	gnnote	NOUN
ajbspi-34500	72	21	:	:	PUNCT
ajbspi-34500	72	22	(	(	PUNCT
ajbspi-34500	72	23	1	1	X
ajbspi-34500	72	24	)	)	PUNCT
ajbspi-34500	72	25	indicator	indicator	NOUN
ajbspi-34500	72	26	values	value	NOUN
ajbspi-34500	72	27	on	on	ADP
ajbspi-34500	72	28	days	day	NOUN
ajbspi-34500	72	29	2	2	NUM
ajbspi-34500	72	30	-	-	SYM
ajbspi-34500	72	31	3	3	NUM
ajbspi-34500	72	32	and	and	CCONJ
ajbspi-34500	72	33	(	(	PUNCT
ajbspi-34500	72	34	2	2	NUM
ajbspi-34500	72	35	)	)	PUNCT
ajbspi-34500	72	36	on	on	ADP
ajbspi-34500	72	37	days	day	NOUN
ajbspi-34500	72	38	12	12	NUM
ajbspi-34500	72	39	-	-	SYM
ajbspi-34500	72	40	14	14	NUM
ajbspi-34500	72	41	of	of	ADP
ajbspi-34500	72	42	hospital	hospital	NOUN
ajbspi-34500	72	43	treatment	treatment	NOUN
ajbspi-34500	72	44	;	;	PUNCT
ajbspi-34500	72	45	abs	ab	NOUN
ajbspi-34500	72	46	.	.	PUNCT
ajbspi-34500	72	47	–	–	PUNCT
ajbspi-34500	72	48	absolute	absolute	ADJ
ajbspi-34500	72	49	value	value	NOUN
ajbspi-34500	72	50	(	(	PUNCT
ajbspi-34500	72	51	in	in	ADP
ajbspi-34500	72	52	1	1	NUM
ajbspi-34500	72	53	l	l	NOUN
ajbspi-34500	72	54	)	)	PUNCT
ajbspi-34500	72	55	.	.	PUNCT
ajbspi-34500	73	1	in	in	ADP
ajbspi-34500	73	2	view	view	NOUN
ajbspi-34500	73	3	of	of	ADP
ajbspi-34500	73	4	the	the	DET
ajbspi-34500	73	5	established	establish	VERB
ajbspi-34500	73	6	correlation	correlation	NOUN
ajbspi-34500	73	7	of	of	ADP
ajbspi-34500	73	8	the	the	DET
ajbspi-34500	73	9	cytokine	cytokine	NOUN
ajbspi-34500	73	10	system	system	NOUN
ajbspi-34500	73	11	,	,	PUNCT
ajbspi-34500	73	12	some	some	DET
ajbspi-34500	73	13	features	feature	NOUN
ajbspi-34500	73	14	of	of	ADP
ajbspi-34500	73	15	laboratory	laboratory	NOUN
ajbspi-34500	73	16	results	result	NOUN
ajbspi-34500	73	17	of	of	ADP
ajbspi-34500	73	18	gn	gn	PROPN
ajbspi-34500	73	19	can	can	AUX
ajbspi-34500	73	20	be	be	AUX
ajbspi-34500	73	21	explained	explain	VERB
ajbspi-34500	73	22	by	by	ADP
ajbspi-34500	73	23	different	different	ADJ
ajbspi-34500	73	24	types	type	NOUN
ajbspi-34500	73	25	of	of	ADP
ajbspi-34500	73	26	clinical	clinical	ADJ
ajbspi-34500	73	27	course	course	NOUN
ajbspi-34500	73	28	.	.	PUNCT
ajbspi-34500	74	1	in	in	ADP
ajbspi-34500	74	2	patients	patient	NOUN
ajbspi-34500	74	3	with	with	ADP
ajbspi-34500	74	4	chronic	chronic	PROPN
ajbspi-34500	74	5	gn	gn	PROPN
ajbspi-34500	74	6	,	,	PUNCT
ajbspi-34500	74	7	the	the	DET
ajbspi-34500	74	8	content	content	NOUN
ajbspi-34500	74	9	of	of	ADP
ajbspi-34500	74	10	neutrophil	neutrophil	ADJ
ajbspi-34500	74	11	cells	cell	NOUN
ajbspi-34500	74	12	is	be	AUX
ajbspi-34500	74	13	lower	low	ADJ
ajbspi-34500	74	14	than	than	ADP
ajbspi-34500	74	15	in	in	ADP
ajbspi-34500	74	16	patients	patient	NOUN
ajbspi-34500	74	17	with	with	ADP
ajbspi-34500	74	18	acute	acute	PROPN
ajbspi-34500	74	19	gn	gn	PROPN
ajbspi-34500	74	20	.	.	PUNCT
ajbspi-34500	75	1	this	this	DET
ajbspi-34500	75	2	fact	fact	NOUN
ajbspi-34500	75	3	may	may	AUX
ajbspi-34500	75	4	be	be	AUX
ajbspi-34500	75	5	related	relate	VERB
ajbspi-34500	75	6	to	to	ADP
ajbspi-34500	75	7	the	the	DET
ajbspi-34500	75	8	low	low	ADJ
ajbspi-34500	75	9	initial	initial	ADJ
ajbspi-34500	75	10	level	level	NOUN
ajbspi-34500	75	11	of	of	ADP
ajbspi-34500	75	12	rα	rα	NOUN
ajbspi-34500	75	13	-	-	PUNCT
ajbspi-34500	75	14	il-1β	il-1β	ADJ
ajbspi-34500	75	15	in	in	ADP
ajbspi-34500	75	16	the	the	DET
ajbspi-34500	75	17	chronic	chronic	ADJ
ajbspi-34500	75	18	course	course	NOUN
ajbspi-34500	75	19	of	of	ADP
ajbspi-34500	75	20	gn	gn	PROPN
ajbspi-34500	75	21	,	,	PUNCT
ajbspi-34500	75	22	which	which	PRON
ajbspi-34500	75	23	is	be	AUX
ajbspi-34500	75	24	positively	positively	ADV
ajbspi-34500	75	25	related	relate	VERB
ajbspi-34500	75	26	to	to	ADP
ajbspi-34500	75	27	the	the	DET
ajbspi-34500	75	28	amount	amount	NOUN
ajbspi-34500	75	29	of	of	ADP
ajbspi-34500	75	30	neutrophils	neutrophil	NOUN
ajbspi-34500	75	31	in	in	ADP
ajbspi-34500	75	32	the	the	DET
ajbspi-34500	75	33	blood	blood	NOUN
ajbspi-34500	75	34	.	.	PUNCT
ajbspi-34500	76	1	table	table	NOUN
ajbspi-34500	76	2	2	2	NUM
ajbspi-34500	76	3	.	.	X
ajbspi-34500	76	4	statistically	statistically	ADV
ajbspi-34500	76	5	significant	significant	ADJ
ajbspi-34500	76	6	differences	difference	NOUN
ajbspi-34500	76	7	in	in	ADP
ajbspi-34500	76	8	laboratory	laboratory	NOUN
ajbspi-34500	76	9	parameters	parameter	NOUN
ajbspi-34500	76	10	in	in	ADP
ajbspi-34500	76	11	patients	patient	NOUN
ajbspi-34500	76	12	with	with	ADP
ajbspi-34500	76	13	different	different	ADJ
ajbspi-34500	76	14	clinical	clinical	ADJ
ajbspi-34500	76	15	course	course	NOUN
ajbspi-34500	76	16	of	of	ADP
ajbspi-34500	76	17	gn	gn	PROPN
ajbspi-34500	76	18	note	note	NOUN
ajbspi-34500	76	19	:	:	PUNCT
ajbspi-34500	76	20	(	(	PUNCT
ajbspi-34500	76	21	1	1	X
ajbspi-34500	76	22	)	)	PUNCT
ajbspi-34500	76	23	indicator	indicator	NOUN
ajbspi-34500	76	24	values	value	NOUN
ajbspi-34500	76	25	on	on	ADP
ajbspi-34500	76	26	days	day	NOUN
ajbspi-34500	76	27	2	2	NUM
ajbspi-34500	76	28	-	-	SYM
ajbspi-34500	76	29	3	3	NUM
ajbspi-34500	76	30	and	and	CCONJ
ajbspi-34500	76	31	(	(	PUNCT
ajbspi-34500	76	32	2	2	NUM
ajbspi-34500	76	33	)	)	PUNCT
ajbspi-34500	76	34	on	on	ADP
ajbspi-34500	76	35	days	day	NOUN
ajbspi-34500	76	36	12	12	NUM
ajbspi-34500	76	37	-	-	SYM
ajbspi-34500	76	38	14	14	NUM
ajbspi-34500	76	39	of	of	ADP
ajbspi-34500	76	40	hospital	hospital	NOUN
ajbspi-34500	76	41	treatment	treatment	NOUN
ajbspi-34500	76	42	;	;	PUNCT
ajbspi-34500	76	43	abs	ab	NOUN
ajbspi-34500	76	44	.	.	PUNCT
ajbspi-34500	77	1	–	–	PUNCT
ajbspi-34500	77	2	absolute	absolute	ADJ
ajbspi-34500	77	3	value	value	NOUN
ajbspi-34500	77	4	(	(	PUNCT
ajbspi-34500	77	5	in	in	ADP
ajbspi-34500	77	6	1	1	NUM
ajbspi-34500	77	7	l	l	NOUN
ajbspi-34500	77	8	)	)	PUNCT
ajbspi-34500	77	9	.	.	PUNCT
ajbspi-34500	78	1	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	PROPN
ajbspi-34500	78	2	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	AUX
ajbspi-34500	78	3	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	ADJ
ajbspi-34500	78	4	volume	volume	NOUN
ajbspi-34500	78	5	04	04	NUM
ajbspi-34500	78	6	issue	issue	NOUN
ajbspi-34500	78	7	03	03	NUM
ajbspi-34500	78	8	-	-	SYM
ajbspi-34500	78	9	2024	2024	NUM
ajbspi-34500	78	10	41	41	NUM
ajbspi-34500	78	11	american	american	ADJ
ajbspi-34500	78	12	journal	journal	PROPN
ajbspi-34500	78	13	of	of	ADP
ajbspi-34500	78	14	biomedical	biomedical	PROPN
ajbspi-34500	78	15	science	science	PROPN
ajbspi-34500	78	16	&	&	CCONJ
ajbspi-34500	78	17	pharmaceutical	pharmaceutical	PROPN
ajbspi-34500	78	18	innovation	innovation	NOUN
ajbspi-34500	78	19	(	(	PUNCT
ajbspi-34500	78	20	issn	issn	PROPN
ajbspi-34500	78	21	–	–	PUNCT
ajbspi-34500	78	22	2771	2771	NUM
ajbspi-34500	78	23	-	-	SYM
ajbspi-34500	78	24	2753	2753	NUM
ajbspi-34500	78	25	)	)	PUNCT
ajbspi-34500	78	26	volume	volume	NOUN
ajbspi-34500	78	27	04	04	NUM
ajbspi-34500	78	28	issue	issue	NOUN
ajbspi-34500	78	29	03	03	NUM
ajbspi-34500	78	30	pages	page	NOUN
ajbspi-34500	78	31	:	:	PUNCT
ajbspi-34500	78	32	36	36	NUM
ajbspi-34500	78	33	-	-	SYM
ajbspi-34500	78	34	43	43	NUM
ajbspi-34500	78	35	sjif	sjif	NOUN
ajbspi-34500	78	36	impact	impact	NOUN
ajbspi-34500	78	37	factor	factor	NOUN
ajbspi-34500	78	38	(	(	PUNCT
ajbspi-34500	78	39	2022	2022	NUM
ajbspi-34500	78	40	:	:	PUNCT
ajbspi-34500	78	41	5	5	NUM
ajbspi-34500	78	42	.	.	NOUN
ajbspi-34500	78	43	705	705	NUM
ajbspi-34500	78	44	)	)	PUNCT
ajbspi-34500	78	45	(	(	PUNCT
ajbspi-34500	78	46	2023	2023	NUM
ajbspi-34500	78	47	:	:	PUNCT
ajbspi-34500	78	48	6.534	6.534	NUM
ajbspi-34500	78	49	)	)	PUNCT
ajbspi-34500	78	50	(	(	PUNCT
ajbspi-34500	78	51	2024	2024	NUM
ajbspi-34500	78	52	:	:	PUNCT
ajbspi-34500	78	53	7.7	7.7	NUM
ajbspi-34500	78	54	)	)	PUNCT
ajbspi-34500	78	55	oclc	oclc	PROPN
ajbspi-34500	78	56	–	–	PUNCT
ajbspi-34500	78	57	1121105677	1121105677	NUM
ajbspi-34500	78	58	publisher	publisher	NOUN
ajbspi-34500	78	59	:	:	PUNCT
ajbspi-34500	78	60	oscar	oscar	NOUN
ajbspi-34500	78	61	publishing	publishing	NOUN
ajbspi-34500	78	62	services	service	NOUN
ajbspi-34500	78	63	servi	servi	VERB
ajbspi-34500	78	64	previously	previously	ADV
ajbspi-34500	78	65	,	,	PUNCT
ajbspi-34500	78	66	we	we	PRON
ajbspi-34500	78	67	tried	try	VERB
ajbspi-34500	78	68	to	to	PART
ajbspi-34500	78	69	find	find	VERB
ajbspi-34500	78	70	immuno	immuno	ADJ
ajbspi-34500	78	71	-	-	PUNCT
ajbspi-34500	78	72	hematological	hematological	ADJ
ajbspi-34500	78	73	markers	marker	NOUN
ajbspi-34500	78	74	that	that	PRON
ajbspi-34500	78	75	distinguish	distinguish	VERB
ajbspi-34500	78	76	the	the	DET
ajbspi-34500	78	77	exacerbation	exacerbation	NOUN
ajbspi-34500	78	78	of	of	ADP
ajbspi-34500	78	79	chronic	chronic	ADJ
ajbspi-34500	78	80	gn	gn	PROPN
ajbspi-34500	78	81	from	from	ADP
ajbspi-34500	78	82	the	the	DET
ajbspi-34500	78	83	onset	onset	NOUN
ajbspi-34500	78	84	of	of	ADP
ajbspi-34500	78	85	the	the	DET
ajbspi-34500	78	86	disease	disease	NOUN
ajbspi-34500	78	87	[	[	X
ajbspi-34500	78	88	1	1	NUM
ajbspi-34500	78	89	]	]	PUNCT
ajbspi-34500	78	90	.	.	PUNCT
ajbspi-34500	79	1	we	we	PRON
ajbspi-34500	79	2	found	find	VERB
ajbspi-34500	79	3	that	that	SCONJ
ajbspi-34500	79	4	the	the	DET
ajbspi-34500	79	5	absolute	absolute	ADJ
ajbspi-34500	79	6	number	number	NOUN
ajbspi-34500	79	7	of	of	ADP
ajbspi-34500	79	8	neutrophils	neutrophil	NOUN
ajbspi-34500	79	9	and	and	CCONJ
ajbspi-34500	79	10	the	the	DET
ajbspi-34500	79	11	relative	relative	ADJ
ajbspi-34500	79	12	number	number	NOUN
ajbspi-34500	79	13	of	of	ADP
ajbspi-34500	79	14	eosinophils	eosinophil	NOUN
ajbspi-34500	79	15	determined	determine	VERB
ajbspi-34500	79	16	before	before	ADP
ajbspi-34500	79	17	treatment	treatment	NOUN
ajbspi-34500	79	18	of	of	ADP
ajbspi-34500	79	19	a	a	DET
ajbspi-34500	79	20	patient	patient	NOUN
ajbspi-34500	79	21	with	with	ADP
ajbspi-34500	79	22	gn	gn	PROPN
ajbspi-34500	79	23	can	can	AUX
ajbspi-34500	79	24	be	be	AUX
ajbspi-34500	79	25	used	use	VERB
ajbspi-34500	79	26	to	to	PART
ajbspi-34500	79	27	distinguish	distinguish	VERB
ajbspi-34500	79	28	the	the	DET
ajbspi-34500	79	29	nature	nature	NOUN
ajbspi-34500	79	30	of	of	ADP
ajbspi-34500	79	31	the	the	DET
ajbspi-34500	79	32	clinical	clinical	ADJ
ajbspi-34500	79	33	course	course	NOUN
ajbspi-34500	79	34	of	of	ADP
ajbspi-34500	79	35	gn	gn	PROPN
ajbspi-34500	79	36	.	.	PROPN
ajbspi-34500	79	37	contrary	contrary	PROPN
ajbspi-34500	79	38	to	to	ADP
ajbspi-34500	79	39	expectations	expectation	NOUN
ajbspi-34500	79	40	,	,	PUNCT
ajbspi-34500	79	41	immunological	immunological	ADJ
ajbspi-34500	79	42	indicators	indicator	NOUN
ajbspi-34500	79	43	were	be	AUX
ajbspi-34500	79	44	not	not	PART
ajbspi-34500	79	45	suitable	suitable	ADJ
ajbspi-34500	79	46	for	for	ADP
ajbspi-34500	79	47	use	use	NOUN
ajbspi-34500	79	48	as	as	SCONJ
ajbspi-34500	79	49	diagnostic	diagnostic	ADJ
ajbspi-34500	79	50	criteria	criterion	NOUN
ajbspi-34500	79	51	to	to	PART
ajbspi-34500	79	52	determine	determine	VERB
ajbspi-34500	79	53	the	the	DET
ajbspi-34500	79	54	nature	nature	NOUN
ajbspi-34500	79	55	of	of	ADP
ajbspi-34500	79	56	the	the	DET
ajbspi-34500	79	57	clinical	clinical	ADJ
ajbspi-34500	79	58	course	course	NOUN
ajbspi-34500	79	59	of	of	ADP
ajbspi-34500	79	60	gn	gn	PROPN
ajbspi-34500	79	61	:	:	PUNCT
ajbspi-34500	79	62	we	we	PRON
ajbspi-34500	79	63	could	could	AUX
ajbspi-34500	79	64	not	not	PART
ajbspi-34500	79	65	find	find	VERB
ajbspi-34500	79	66	differences	difference	NOUN
ajbspi-34500	79	67	in	in	ADP
ajbspi-34500	79	68	innate	innate	ADJ
ajbspi-34500	79	69	and	and	CCONJ
ajbspi-34500	79	70	adaptive	adaptive	ADJ
ajbspi-34500	79	71	immune	immune	ADJ
ajbspi-34500	79	72	response	response	NOUN
ajbspi-34500	79	73	indicators	indicator	NOUN
ajbspi-34500	79	74	in	in	ADP
ajbspi-34500	79	75	groups	group	NOUN
ajbspi-34500	79	76	of	of	ADP
ajbspi-34500	79	77	patients	patient	NOUN
ajbspi-34500	79	78	with	with	ADP
ajbspi-34500	79	79	acute	acute	ADJ
ajbspi-34500	79	80	and	and	CCONJ
ajbspi-34500	79	81	chronic	chronic	ADJ
ajbspi-34500	79	82	diseases	disease	NOUN
ajbspi-34500	79	83	in	in	ADP
ajbspi-34500	79	84	patients	patient	NOUN
ajbspi-34500	79	85	with	with	ADP
ajbspi-34500	79	86	gn	gn	PROPN
ajbspi-34500	79	87	,	,	PUNCT
ajbspi-34500	79	88	a	a	DET
ajbspi-34500	79	89	different	different	ADJ
ajbspi-34500	79	90	situation	situation	NOUN
ajbspi-34500	79	91	occurs	occur	VERB
ajbspi-34500	79	92	according	accord	VERB
ajbspi-34500	79	93	to	to	ADP
ajbspi-34500	79	94	the	the	DET
ajbspi-34500	79	95	results	result	NOUN
ajbspi-34500	79	96	of	of	ADP
ajbspi-34500	79	97	the	the	DET
ajbspi-34500	79	98	study	study	NOUN
ajbspi-34500	79	99	of	of	ADP
ajbspi-34500	79	100	the	the	DET
ajbspi-34500	79	101	cytokine	cytokine	NOUN
ajbspi-34500	79	102	profile	profile	NOUN
ajbspi-34500	79	103	:	:	PUNCT
ajbspi-34500	79	104	the	the	DET
ajbspi-34500	79	105	exacerbation	exacerbation	NOUN
ajbspi-34500	79	106	of	of	ADP
ajbspi-34500	79	107	chronic	chronic	ADJ
ajbspi-34500	79	108	gn	gn	PROPN
ajbspi-34500	79	109	is	be	AUX
ajbspi-34500	79	110	distinguished	distinguish	VERB
ajbspi-34500	79	111	from	from	ADP
ajbspi-34500	79	112	the	the	DET
ajbspi-34500	79	113	onset	onset	NOUN
ajbspi-34500	79	114	of	of	ADP
ajbspi-34500	79	115	gn	gn	PROPN
ajbspi-34500	79	116	by	by	ADP
ajbspi-34500	79	117	a	a	DET
ajbspi-34500	79	118	smaller	small	ADJ
ajbspi-34500	79	119	increase	increase	NOUN
ajbspi-34500	79	120	in	in	ADP
ajbspi-34500	79	121	the	the	DET
ajbspi-34500	79	122	level	level	NOUN
ajbspi-34500	79	123	of	of	ADP
ajbspi-34500	79	124	anti	anti	ADJ
ajbspi-34500	79	125	-	-	ADJ
ajbspi-34500	79	126	inflammatory	inflammatory	ADJ
ajbspi-34500	79	127	cytokine	cytokine	NOUN
ajbspi-34500	79	128	ра	ра	PRON
ajbspi-34500	79	129	-	-	ADJ
ajbspi-34500	79	130	il-1b	il-1b	PROPN
ajbspi-34500	79	131	,	,	PUNCT
ajbspi-34500	79	132	the	the	DET
ajbspi-34500	79	133	characteristics	characteristic	NOUN
ajbspi-34500	79	134	of	of	ADP
ajbspi-34500	79	135	which	which	PRON
ajbspi-34500	79	136	are	be	AUX
ajbspi-34500	79	137	595	595	NUM
ajbspi-34500	79	138	percentile	percentile	ADJ
ajbspi-34500	79	139	interval	interval	NOUN
ajbspi-34500	79	140	from	from	ADP
ajbspi-34500	79	141	111	111	NUM
ajbspi-34500	79	142	to	to	ADP
ajbspi-34500	79	143	3915	3915	NUM
ajbspi-34500	79	144	pg	pg	NOUN
ajbspi-34500	79	145	/	/	SYM
ajbspi-34500	79	146	ml	ml	PROPN
ajbspi-34500	79	147	(	(	PUNCT
ajbspi-34500	79	148	in	in	ADP
ajbspi-34500	79	149	patients	patient	NOUN
ajbspi-34500	79	150	with	with	ADP
ajbspi-34500	79	151	acute	acute	PROPN
ajbspi-34500	79	152	gn	gn	PROPN
ajbspi-34500	79	153	from	from	ADP
ajbspi-34500	79	154	395	395	NUM
ajbspi-34500	79	155	to	to	ADP
ajbspi-34500	79	156	2942	2942	NUM
ajbspi-34500	79	157	pg	pg	NOUN
ajbspi-34500	79	158	/	/	SYM
ajbspi-34500	79	159	ml	ml	NOUN
ajbspi-34500	79	160	)	)	PUNCT
ajbspi-34500	79	161	and	and	CCONJ
ajbspi-34500	79	162	high	high	ADJ
ajbspi-34500	79	163	levels	level	NOUN
ajbspi-34500	79	164	of	of	ADP
ajbspi-34500	79	165	pro	pro	ADJ
ajbspi-34500	79	166	-	-	ADJ
ajbspi-34500	79	167	inflammatory	inflammatory	ADJ
ajbspi-34500	79	168	cytokine	cytokine	NOUN
ajbspi-34500	79	169	ifnγ	ifnγ	NOUN
ajbspi-34500	79	170	are	be	AUX
ajbspi-34500	79	171	distributed	distribute	VERB
ajbspi-34500	79	172	,	,	PUNCT
ajbspi-34500	79	173	at	at	ADP
ajbspi-34500	79	174	the	the	DET
ajbspi-34500	79	175	end	end	NOUN
ajbspi-34500	79	176	of	of	ADP
ajbspi-34500	79	177	treatment	treatment	NOUN
ajbspi-34500	79	178	from	from	ADP
ajbspi-34500	79	179	26.7	26.7	NUM
ajbspi-34500	79	180	with	with	ADP
ajbspi-34500	79	181	changes	change	NOUN
ajbspi-34500	79	182	up	up	ADP
ajbspi-34500	79	183	to	to	ADP
ajbspi-34500	79	184	412.4	412.4	NUM
ajbspi-34500	79	185	pg	pg	NOUN
ajbspi-34500	79	186	/	/	PUNCT
ajbspi-34500	79	187	ml	ml	INTJ
ajbspi-34500	79	188	(	(	PUNCT
ajbspi-34500	79	189	in	in	ADP
ajbspi-34500	79	190	patients	patient	NOUN
ajbspi-34500	79	191	with	with	ADP
ajbspi-34500	79	192	acute	acute	PROPN
ajbspi-34500	79	193	gn	gn	PROPN
ajbspi-34500	79	194	from	from	ADP
ajbspi-34500	79	195	24.1	24.1	NUM
ajbspi-34500	79	196	to	to	PART
ajbspi-34500	79	197	45	45	NUM
ajbspi-34500	79	198	pg	pg	NOUN
ajbspi-34500	79	199	/	/	SYM
ajbspi-34500	79	200	ml	ml	NOUN
ajbspi-34500	79	201	)	)	PUNCT
ajbspi-34500	79	202	.	.	PUNCT
ajbspi-34500	80	1	therefore	therefore	ADV
ajbspi-34500	80	2	,	,	PUNCT
ajbspi-34500	80	3	determination	determination	NOUN
ajbspi-34500	80	4	of	of	ADP
ajbspi-34500	80	5	the	the	DET
ajbspi-34500	80	6	levels	level	NOUN
ajbspi-34500	80	7	of	of	ADP
ajbspi-34500	80	8	rα	rα	NOUN
ajbspi-34500	80	9	-	-	PUNCT
ajbspi-34500	80	10	il-1β	il-1β	ADJ
ajbspi-34500	80	11	and	and	CCONJ
ajbspi-34500	80	12	ifn	ifn	PROPN
ajbspi-34500	80	13	-	-	PUNCT
ajbspi-34500	80	14	γ	γ	NOUN
ajbspi-34500	80	15	can	can	AUX
ajbspi-34500	80	16	be	be	AUX
ajbspi-34500	80	17	used	use	VERB
ajbspi-34500	80	18	to	to	PART
ajbspi-34500	80	19	distinguish	distinguish	VERB
ajbspi-34500	80	20	between	between	ADP
ajbspi-34500	80	21	acute	acute	ADJ
ajbspi-34500	80	22	and	and	CCONJ
ajbspi-34500	80	23	chronic	chronic	ADJ
ajbspi-34500	80	24	gn	gn	PROPN
ajbspi-34500	80	25	:	:	PUNCT
ajbspi-34500	80	26	a	a	DET
ajbspi-34500	80	27	baseline	baseline	ADJ
ajbspi-34500	80	28	rα	rα	ADJ
ajbspi-34500	80	29	-	-	PUNCT
ajbspi-34500	80	30	il-1β	il-1β	ADJ
ajbspi-34500	80	31	level	level	NOUN
ajbspi-34500	80	32	below	below	ADP
ajbspi-34500	80	33	395	395	NUM
ajbspi-34500	80	34	pg	pg	NOUN
ajbspi-34500	80	35	/	/	SYM
ajbspi-34500	80	36	ml	ml	X
ajbspi-34500	80	37	in	in	ADP
ajbspi-34500	80	38	a	a	DET
ajbspi-34500	80	39	patient	patient	NOUN
ajbspi-34500	80	40	with	with	ADP
ajbspi-34500	80	41	gn	gn	PROPN
ajbspi-34500	80	42	is	be	AUX
ajbspi-34500	80	43	concentration	concentration	NOUN
ajbspi-34500	80	44	increases	increase	VERB
ajbspi-34500	80	45	the	the	DET
ajbspi-34500	80	46	probability	probability	NOUN
ajbspi-34500	80	47	of	of	ADP
ajbspi-34500	80	48	diagnosis	diagnosis	NOUN
ajbspi-34500	80	49	in	in	ADP
ajbspi-34500	80	50	favor	favor	NOUN
ajbspi-34500	80	51	of	of	ADP
ajbspi-34500	80	52	chronic	chronic	ADJ
ajbspi-34500	80	53	gn	gn	PROPN
ajbspi-34500	80	54	with	with	ADP
ajbspi-34500	80	55	the	the	DET
ajbspi-34500	80	56	presence	presence	NOUN
ajbspi-34500	80	57	of	of	ADP
ajbspi-34500	80	58	other	other	ADJ
ajbspi-34500	80	59	symptoms	symptom	NOUN
ajbspi-34500	80	60	of	of	ADP
ajbspi-34500	80	61	chronic	chronic	ADJ
ajbspi-34500	80	62	gn	gn	PROPN
ajbspi-34500	80	63	.	.	PROPN
ajbspi-34500	81	1	in	in	ADP
ajbspi-34500	81	2	this	this	DET
ajbspi-34500	81	3	case	case	NOUN
ajbspi-34500	81	4	,	,	PUNCT
ajbspi-34500	81	5	if	if	SCONJ
ajbspi-34500	81	6	the	the	DET
ajbspi-34500	81	7	level	level	NOUN
ajbspi-34500	81	8	of	of	ADP
ajbspi-34500	81	9	ifn	ifn	PROPN
ajbspi-34500	81	10	-	-	PUNCT
ajbspi-34500	81	11	γ	γ	NOUN
ajbspi-34500	81	12	is	be	AUX
ajbspi-34500	81	13	higher	high	ADJ
ajbspi-34500	81	14	than	than	ADP
ajbspi-34500	81	15	45	45	NUM
ajbspi-34500	81	16	pg	pg	NOUN
ajbspi-34500	81	17	/	/	SYM
ajbspi-34500	81	18	ml	ml	ADP
ajbspi-34500	81	19	,	,	PUNCT
ajbspi-34500	81	20	the	the	DET
ajbspi-34500	81	21	diagnosis	diagnosis	NOUN
ajbspi-34500	81	22	of	of	ADP
ajbspi-34500	81	23	chronic	chronic	ADJ
ajbspi-34500	81	24	gn	gn	PROPN
ajbspi-34500	81	25	can	can	AUX
ajbspi-34500	81	26	be	be	AUX
ajbspi-34500	81	27	confirmed	confirm	VERB
ajbspi-34500	81	28	by	by	ADP
ajbspi-34500	81	29	the	the	DET
ajbspi-34500	81	30	14th	14th	ADJ
ajbspi-34500	81	31	day	day	NOUN
ajbspi-34500	81	32	of	of	ADP
ajbspi-34500	81	33	hospital	hospital	NOUN
ajbspi-34500	81	34	treatment	treatment	NOUN
ajbspi-34500	81	35	.	.	PUNCT
ajbspi-34500	82	1	conclusion	conclusion	NOUN
ajbspi-34500	82	2	1	1	NUM
ajbspi-34500	82	3	.	.	PUNCT
ajbspi-34500	82	4	differences	difference	NOUN
ajbspi-34500	82	5	in	in	ADP
ajbspi-34500	82	6	the	the	DET
ajbspi-34500	82	7	cytokine	cytokine	NOUN
ajbspi-34500	82	8	profile	profile	NOUN
ajbspi-34500	82	9	in	in	ADP
ajbspi-34500	82	10	patients	patient	NOUN
ajbspi-34500	82	11	with	with	ADP
ajbspi-34500	82	12	gn	gn	PROPN
ajbspi-34500	82	13	were	be	AUX
ajbspi-34500	82	14	determined	determine	VERB
ajbspi-34500	82	15	depending	depend	VERB
ajbspi-34500	82	16	on	on	ADP
ajbspi-34500	82	17	the	the	DET
ajbspi-34500	82	18	clinical	clinical	ADJ
ajbspi-34500	82	19	course	course	NOUN
ajbspi-34500	82	20	of	of	ADP
ajbspi-34500	82	21	the	the	DET
ajbspi-34500	82	22	disease	disease	NOUN
ajbspi-34500	82	23	.	.	PUNCT
ajbspi-34500	83	1	2	2	X
ajbspi-34500	83	2	.	.	X
ajbspi-34500	83	3	in	in	ADP
ajbspi-34500	83	4	the	the	DET
ajbspi-34500	83	5	acute	acute	ADJ
ajbspi-34500	83	6	period	period	NOUN
ajbspi-34500	83	7	of	of	ADP
ajbspi-34500	83	8	gn	gn	PROPN
ajbspi-34500	83	9	,	,	PUNCT
ajbspi-34500	83	10	a	a	DET
ajbspi-34500	83	11	direct	direct	ADJ
ajbspi-34500	83	12	correlation	correlation	NOUN
ajbspi-34500	83	13	was	be	AUX
ajbspi-34500	83	14	found	find	VERB
ajbspi-34500	83	15	in	in	ADP
ajbspi-34500	83	16	the	the	DET
ajbspi-34500	83	17	levels	level	NOUN
ajbspi-34500	83	18	of	of	ADP
ajbspi-34500	83	19	production	production	NOUN
ajbspi-34500	83	20	of	of	ADP
ajbspi-34500	83	21	pro	pro	ADJ
ajbspi-34500	83	22	-	-	ADJ
ajbspi-34500	83	23	inflammatory	inflammatory	ADJ
ajbspi-34500	83	24	cytokines	cytokine	NOUN
ajbspi-34500	83	25	,	,	PUNCT
ajbspi-34500	83	26	which	which	PRON
ajbspi-34500	83	27	disappear	disappear	VERB
ajbspi-34500	83	28	until	until	ADP
ajbspi-34500	83	29	the	the	DET
ajbspi-34500	83	30	end	end	NOUN
ajbspi-34500	83	31	of	of	ADP
ajbspi-34500	83	32	hospital	hospital	NOUN
ajbspi-34500	83	33	treatment	treatment	NOUN
ajbspi-34500	83	34	.	.	PUNCT
ajbspi-34500	84	1	the	the	DET
ajbspi-34500	84	2	chronic	chronic	ADJ
ajbspi-34500	84	3	course	course	NOUN
ajbspi-34500	84	4	of	of	ADP
ajbspi-34500	84	5	gn	gn	PROPN
ajbspi-34500	84	6	is	be	AUX
ajbspi-34500	84	7	characterized	characterize	VERB
ajbspi-34500	84	8	by	by	ADP
ajbspi-34500	84	9	the	the	DET
ajbspi-34500	84	10	presence	presence	NOUN
ajbspi-34500	84	11	of	of	ADP
ajbspi-34500	84	12	interdependence	interdependence	NOUN
ajbspi-34500	84	13	in	in	ADP
ajbspi-34500	84	14	the	the	DET
ajbspi-34500	84	15	production	production	NOUN
ajbspi-34500	84	16	of	of	ADP
ajbspi-34500	84	17	pro	pro	ADJ
ajbspi-34500	84	18	-	-	ADJ
ajbspi-34500	84	19	inflammatory	inflammatory	ADJ
ajbspi-34500	84	20	and	and	CCONJ
ajbspi-34500	84	21	anti	anti	ADJ
ajbspi-34500	84	22	-	-	ADJ
ajbspi-34500	84	23	inflammatory	inflammatory	ADJ
ajbspi-34500	84	24	cytokines	cytokine	NOUN
ajbspi-34500	84	25	.	.	PUNCT
ajbspi-34500	85	1	3	3	X
ajbspi-34500	85	2	.	.	X
ajbspi-34500	85	3	cytokine	cytokine	ADJ
ajbspi-34500	85	4	profile	profile	NOUN
ajbspi-34500	85	5	of	of	ADP
ajbspi-34500	85	6	patients	patient	NOUN
ajbspi-34500	85	7	with	with	ADP
ajbspi-34500	85	8	exacerbation	exacerbation	NOUN
ajbspi-34500	85	9	of	of	ADP
ajbspi-34500	85	10	chronic	chronic	ADJ
ajbspi-34500	85	11	gn	gn	PROPN
ajbspi-34500	85	12	is	be	AUX
ajbspi-34500	85	13	characterized	characterize	VERB
ajbspi-34500	85	14	by	by	ADP
ajbspi-34500	85	15	low	low	ADJ
ajbspi-34500	85	16	initial	initial	ADJ
ajbspi-34500	85	17	level	level	NOUN
ajbspi-34500	85	18	of	of	ADP
ajbspi-34500	85	19	circulating	circulate	VERB
ajbspi-34500	85	20	ра	ра	ADP
ajbspi-34500	85	21	-	-	ADJ
ajbspi-34500	85	22	il-1b	il-1b	PROPN
ajbspi-34500	85	23	and	and	CCONJ
ajbspi-34500	85	24	high	high	ADJ
ajbspi-34500	85	25	level	level	NOUN
ajbspi-34500	85	26	of	of	ADP
ajbspi-34500	85	27	ifn	ifn	PROPN
ajbspi-34500	85	28	-	-	PUNCT
ajbspi-34500	85	29	γ	γ	NOUN
ajbspi-34500	85	30	by	by	ADP
ajbspi-34500	85	31	the	the	DET
ajbspi-34500	85	32	end	end	NOUN
ajbspi-34500	85	33	of	of	ADP
ajbspi-34500	85	34	the	the	DET
ajbspi-34500	85	35	inpatient	inpatient	NOUN
ajbspi-34500	85	36	treatment	treatment	NOUN
ajbspi-34500	85	37	course	course	NOUN
ajbspi-34500	85	38	.	.	PUNCT
ajbspi-34500	86	1	4	4	X
ajbspi-34500	86	2	.	.	X
ajbspi-34500	86	3	the	the	DET
ajbspi-34500	86	4	initial	initial	ADJ
ajbspi-34500	86	5	concentration	concentration	NOUN
ajbspi-34500	86	6	of	of	ADP
ajbspi-34500	86	7	ra	ra	PROPN
ajbspi-34500	86	8	-	-	NOUN
ajbspi-34500	86	9	il-1b	il-1b	PROPN
ajbspi-34500	86	10	at	at	ADP
ajbspi-34500	86	11	hospitalization	hospitalization	NOUN
ajbspi-34500	86	12	of	of	ADP
ajbspi-34500	86	13	a	a	DET
ajbspi-34500	86	14	patient	patient	NOUN
ajbspi-34500	86	15	with	with	ADP
ajbspi-34500	86	16	gn	gn	PROPN
ajbspi-34500	86	17	below	below	ADP
ajbspi-34500	86	18	395	395	NUM
ajbspi-34500	86	19	pg	pg	NOUN
ajbspi-34500	86	20	/	/	SYM
ajbspi-34500	86	21	ml	ml	X
ajbspi-34500	86	22	increases	increase	VERB
ajbspi-34500	86	23	the	the	DET
ajbspi-34500	86	24	probability	probability	NOUN
ajbspi-34500	86	25	of	of	ADP
ajbspi-34500	86	26	diagnosis	diagnosis	NOUN
ajbspi-34500	86	27	in	in	ADP
ajbspi-34500	86	28	favor	favor	NOUN
ajbspi-34500	86	29	of	of	ADP
ajbspi-34500	86	30	chronic	chronic	ADJ
ajbspi-34500	86	31	gn	gn	PROPN
ajbspi-34500	86	32	.	.	PROPN
ajbspi-34500	86	33	references	reference	NOUN
ajbspi-34500	86	34	1	1	NUM
ajbspi-34500	86	35	.	.	PUNCT
ajbspi-34500	86	36	alchinbaev	alchinbaev	PROPN
ajbspi-34500	86	37	m.	m.	PROPN
ajbspi-34500	86	38	k.	k.	PROPN
ajbspi-34500	86	39	,	,	PUNCT
ajbspi-34500	86	40	sultonova	sultonova	PROPN
ajbspi-34500	86	41	b.	b.	PROPN
ajbspi-34500	86	42	g.	g.	PROPN
ajbspi-34500	86	43	,	,	PUNCT
ajbspi-34500	86	44	karabaeva	karabaeva	PROPN
ajbspi-34500	86	45	a.	a.	PROPN
ajbspi-34500	86	46	j.	j.	PROPN
ajbspi-34500	86	47	surunkali	surunkali	PROPN
ajbspi-34500	86	48	pielonefrit	pielonefrit	PROPN
ajbspi-34500	86	49	bilan	bilan	PROPN
ajbspi-34500	86	50	og'rigan	og'rigan	PROPN
ajbspi-34500	86	51	bemorlarda	bemorlarda	PROPN
ajbspi-34500	86	52	funktsional	funktsional	ADJ
ajbspi-34500	86	53	buyrak	buyrak	PROPN
ajbspi-34500	86	54	zaxirasi	zaxirasi	PROPN
ajbspi-34500	86	55	.	.	PUNCT
ajbspi-34500	87	1	//	//	PUNCT
ajbspi-34500	87	2	nefrologiya	nefrologiya	NOUN
ajbspi-34500	87	3	.	.	PUNCT
ajbspi-34500	88	1	2001	2001	NUM
ajbspi-34500	88	2	.	.	PUNCT
ajbspi-34500	89	1	5jild	5jild	NUM
ajbspi-34500	89	2	,	,	PUNCT
ajbspi-34500	89	3	2	2	NUM
ajbspi-34500	89	4	-	-	PUNCT
ajbspi-34500	89	5	son	son	NOUN
ajbspi-34500	89	6	.	.	PUNCT
ajbspi-34500	90	1	71	71	NUM
ajbspi-34500	90	2	-	-	SYM
ajbspi-34500	90	3	74	74	NUM
ajbspi-34500	90	4	betlar	betlar	ADJ
ajbspi-34500	90	5	.	.	PUNCT
ajbspi-34500	91	1	2	2	X
ajbspi-34500	91	2	.	.	NUM
ajbspi-34500	91	3	yesayan	yesayan	PROPN
ajbspi-34500	91	4	a.m.	a.m.	ADV
ajbspi-34500	91	5	,	,	PUNCT
ajbspi-34500	91	6	buyrakning	buyrakne	VERB
ajbspi-34500	91	7	to'qima	to'qima	PROPN
ajbspi-34500	91	8	reninangiotensin	reninangiotensin	NOUN
ajbspi-34500	91	9	tizimi	tizimi	PROPN
ajbspi-34500	91	10	.	.	PUNCT
ajbspi-34500	92	1	nefroproteksiyaning	nefroproteksiyane	VERB
ajbspi-34500	92	2	yangi	yangi	PROPN
ajbspi-34500	92	3	strategiyasi	strategiyasi	PROPN
ajbspi-34500	92	4	/	/	SYM
ajbspi-34500	92	5	/	/	SYM
ajbspi-34500	92	6	nefrologiya.2002	nefrologiya.2002	ADJ
ajbspi-34500	92	7	.	.	NOUN
ajbspi-34500	92	8	6	6	NUM
ajbspi-34500	92	9	-	-	PUNCT
ajbspi-34500	92	10	jild	jild	NOUN
ajbspi-34500	92	11	,	,	PUNCT
ajbspi-34500	92	12	3	3	NUM
ajbspi-34500	92	13	-	-	PUNCT
ajbspi-34500	92	14	son.10	son.10	NOUN
ajbspi-34500	92	15	-	-	PUNCT
ajbspi-34500	92	16	14	14	NUM
ajbspi-34500	92	17	betlar	betlar	ADJ
ajbspi-34500	92	18	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	NOUN
ajbspi-34500	92	19	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	AUX
ajbspi-34500	92	20	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	ADJ
ajbspi-34500	92	21	volume	volume	NOUN
ajbspi-34500	92	22	04	04	NUM
ajbspi-34500	92	23	issue	issue	NOUN
ajbspi-34500	92	24	03	03	NUM
ajbspi-34500	92	25	-	-	SYM
ajbspi-34500	92	26	2024	2024	NUM
ajbspi-34500	92	27	42	42	NUM
ajbspi-34500	92	28	american	american	ADJ
ajbspi-34500	92	29	journal	journal	PROPN
ajbspi-34500	92	30	of	of	ADP
ajbspi-34500	92	31	biomedical	biomedical	PROPN
ajbspi-34500	92	32	science	science	PROPN
ajbspi-34500	92	33	&	&	CCONJ
ajbspi-34500	92	34	pharmaceutical	pharmaceutical	PROPN
ajbspi-34500	92	35	innovation	innovation	NOUN
ajbspi-34500	92	36	(	(	PUNCT
ajbspi-34500	92	37	issn	issn	PROPN
ajbspi-34500	92	38	–	–	PUNCT
ajbspi-34500	92	39	2771	2771	NUM
ajbspi-34500	92	40	-	-	SYM
ajbspi-34500	92	41	2753	2753	NUM
ajbspi-34500	92	42	)	)	PUNCT
ajbspi-34500	92	43	volume	volume	NOUN
ajbspi-34500	92	44	04	04	NUM
ajbspi-34500	92	45	issue	issue	NOUN
ajbspi-34500	92	46	03	03	NUM
ajbspi-34500	92	47	pages	page	NOUN
ajbspi-34500	92	48	:	:	PUNCT
ajbspi-34500	92	49	36	36	NUM
ajbspi-34500	92	50	-	-	SYM
ajbspi-34500	92	51	43	43	NUM
ajbspi-34500	92	52	sjif	sjif	NOUN
ajbspi-34500	92	53	impact	impact	NOUN
ajbspi-34500	92	54	factor	factor	NOUN
ajbspi-34500	92	55	(	(	PUNCT
ajbspi-34500	92	56	2022	2022	NUM
ajbspi-34500	92	57	:	:	PUNCT
ajbspi-34500	92	58	5	5	NUM
ajbspi-34500	92	59	.	.	NOUN
ajbspi-34500	92	60	705	705	NUM
ajbspi-34500	92	61	)	)	PUNCT
ajbspi-34500	92	62	(	(	PUNCT
ajbspi-34500	92	63	2023	2023	NUM
ajbspi-34500	92	64	:	:	PUNCT
ajbspi-34500	92	65	6.534	6.534	NUM
ajbspi-34500	92	66	)	)	PUNCT
ajbspi-34500	92	67	(	(	PUNCT
ajbspi-34500	92	68	2024	2024	NUM
ajbspi-34500	92	69	:	:	PUNCT
ajbspi-34500	92	70	7.7	7.7	NUM
ajbspi-34500	92	71	)	)	PUNCT
ajbspi-34500	92	72	oclc	oclc	PROPN
ajbspi-34500	92	73	–	–	PUNCT
ajbspi-34500	92	74	1121105677	1121105677	NUM
ajbspi-34500	92	75	publisher	publisher	NOUN
ajbspi-34500	92	76	:	:	PUNCT
ajbspi-34500	92	77	oscar	oscar	NOUN
ajbspi-34500	92	78	publishing	publishing	NOUN
ajbspi-34500	92	79	services	service	NOUN
ajbspi-34500	92	80	servi	servi	PROPN
ajbspi-34500	92	81	3	3	X
ajbspi-34500	92	82	.	.	PUNCT
ajbspi-34500	92	83	kartamisheva	kartamisheva	PROPN
ajbspi-34500	92	84	n.	n.	PROPN
ajbspi-34500	92	85	n.	n.	PROPN
ajbspi-34500	92	86	,	,	PUNCT
ajbspi-34500	92	87	chumakova	chumakova	VERB
ajbspi-34500	93	1	o.	o.	PROPN
ajbspi-34500	93	2	v.	v.	PROPN
ajbspi-34500	93	3	,	,	PUNCT
ajbspi-34500	93	4	kucherenko	kucherenko	PROPN
ajbspi-34500	93	5	a.	a.	PROPN
ajbspi-34500	93	6	g.	g.	PROPN
ajbspi-34500	93	7	surunkali	surunkali	PROPN
ajbspi-34500	93	8	pielonefrit	pielonefrit	PROPN
ajbspi-34500	93	9	va	va	PROPN
ajbspi-34500	93	10	surunkali	surunkali	PROPN
ajbspi-34500	93	11	interstitsial	interstitsial	ADJ
ajbspi-34500	93	12	nefritning	nefritning	PROPN
ajbspi-34500	93	13	rivojlanish	rivojlanish	ADJ
ajbspi-34500	93	14	omillari	omillari	NOUN
ajbspi-34500	93	15	/	/	SYM
ajbspi-34500	93	16	/	/	SYM
ajbspi-34500	93	17	pediatriya	pediatriya	NOUN
ajbspi-34500	93	18	.	.	PUNCT
ajbspi-34500	94	1	g.	g.	PROPN
ajbspi-34500	94	2	n.	n.	PROPN
ajbspi-34500	94	3	speranskiy	speranskiy	PROPN
ajbspi-34500	94	4	tomonidan	tomonidan	PROPN
ajbspi-34500	94	5	2004	2004	NUM
ajbspi-34500	94	6	yil	yil	PROPN
ajbspi-34500	94	7	.	.	PROPN
ajbspi-34500	94	8	№	№	NUM
ajbspi-34500	94	9	5.50	5.50	NUM
ajbspi-34500	94	10	-	-	SYM
ajbspi-34500	94	11	53	53	NUM
ajbspi-34500	94	12	betlar	betlar	ADJ
ajbspi-34500	94	13	.	.	PUNCT
ajbspi-34500	95	1	4	4	X
ajbspi-34500	95	2	.	.	X
ajbspi-34500	95	3	muhin	muhin	PROPN
ajbspi-34500	95	4	n.	n.	PROPN
ajbspi-34500	95	5	a.	a.	PROPN
ajbspi-34500	95	6	,	,	PUNCT
ajbspi-34500	95	7	balkarov	balkarov	PROPN
ajbspi-34500	95	8	i.	i.	PROPN
ajbspi-34500	95	9	m.	m.	PROPN
ajbspi-34500	95	10	,	,	PUNCT
ajbspi-34500	95	11	moiseev	moiseev	PROPN
ajbspi-34500	95	12	s.	s.	PROPN
ajbspi-34500	95	13	v.	v.	PROPN
ajbspi-34500	95	14	va	va	PROPN
ajbspi-34500	95	15	boshqalar	boshqalar	PROPN
ajbspi-34500	95	16	.	.	PUNCT
ajbspi-34500	96	1	surunkali	surunkali	PROPN
ajbspi-34500	96	2	progressiv	progressiv	PROPN
ajbspi-34500	96	3	nefropatiyalar	nefropatiyalar	PROPN
ajbspi-34500	96	4	va	va	PROPN
ajbspi-34500	96	5	zamonaviy	zamonaviy	PROPN
ajbspi-34500	96	6	insonning	insonne	VERB
ajbspi-34500	96	7	turmush	turmush	ADJ
ajbspi-34500	96	8	tarzi	tarzi	NOUN
ajbspi-34500	96	9	/	/	SYM
ajbspi-34500	96	10	/	/	SYM
ajbspi-34500	96	11	ter	ter	NOUN
ajbspi-34500	96	12	.	.	PUNCT
ajbspi-34500	96	13	arx	arx	PROPN
ajbspi-34500	96	14	.	.	PUNCT
ajbspi-34500	97	1	-2004.-	-2004.-	NUM
ajbspi-34500	97	2	№	№	SYM
ajbspi-34500	97	3	9.5	9.5	NUM
ajbspi-34500	97	4	10	10	NUM
ajbspi-34500	97	5	sahifa	sahifa	NOUN
ajbspi-34500	97	6	.	.	PUNCT
ajbspi-34500	98	1	5	5	X
ajbspi-34500	98	2	.	.	X
ajbspi-34500	98	3	ni	ni	PROPN
ajbspi-34500	98	4	a.	a.	PROPN
ajbspi-34500	98	5	n.	n.	PROPN
ajbspi-34500	98	6	,	,	PUNCT
ajbspi-34500	98	7	luchaninova	luchaninova	PROPN
ajbspi-34500	98	8	v.	v.	ADP
ajbspi-34500	98	9	n.	n.	PROPN
ajbspi-34500	98	10	,	,	PUNCT
ajbspi-34500	98	11	popova	popova	NOUN
ajbspi-34500	98	12	v.	v.	CCONJ
ajbspi-34500	98	13	v.	v.	ADV
ajbspi-34500	98	14	,	,	PUNCT
ajbspi-34500	98	15	simeshina	simeshina	PROPN
ajbspi-34500	98	16	o.	o.	PROPN
ajbspi-34500	98	17	v.	v.	ADP
ajbspi-34500	98	18	bolalardagi	bolalardagi	PROPN
ajbspi-34500	98	19	dismetabolik	dismetabolik	PROPN
ajbspi-34500	98	20	bilan	bilan	PROPN
ajbspi-34500	98	21	nefropatiyalarning	nefropatiyalarning	PROPN
ajbspi-34500	98	22	gomeostatik	gomeostatik	NOUN
ajbspi-34500	98	23	buyrak	buyrak	NOUN
ajbspi-34500	98	24	funktsiyalarining	funktsiyalarine	VERB
ajbspi-34500	98	25	tuzilishi	tuzilishi	PROPN
ajbspi-34500	98	26	/	/	SYM
ajbspi-34500	98	27	/	/	SYM
ajbspi-34500	98	28	nefrologiya.-2004.8jild	nefrologiya.-2004.8jild	NUM
ajbspi-34500	98	29	,	,	PUNCT
ajbspi-34500	98	30	2	2	NUM
ajbspi-34500	98	31	-	-	SYM
ajbspi-34500	98	32	son.-c	son.-c	NUM
ajbspi-34500	98	33	.	.	PUNCT
ajbspi-34500	99	1	68	68	NUM
ajbspi-34500	99	2	-	-	SYM
ajbspi-34500	99	3	72	72	NUM
ajbspi-34500	99	4	.	.	NOUN
ajbspi-34500	100	1	6	6	NUM
ajbspi-34500	100	2	.	.	X
ajbspi-34500	100	3	rogov	rogov	NOUN
ajbspi-34500	100	4	v.	v.	PROPN
ajbspi-34500	100	5	a.	a.	PROPN
ajbspi-34500	100	6	,	,	PUNCT
ajbspi-34500	100	7	kutirina	kutirina	PROPN
ajbspi-34500	100	8	i.	i.	PROPN
ajbspi-34500	100	9	m.	m.	PROPN
ajbspi-34500	100	10	,	,	PUNCT
ajbspi-34500	100	11	tareyeva	tareyeva	PROPN
ajbspi-34500	100	12	i.	i.	PROPN
ajbspi-34500	100	13	e.	e.	PROPN
ajbspi-34500	100	14	va	va	PROPN
ajbspi-34500	100	15	boshqalar	boshqalar	PROPN
ajbspi-34500	100	16	.	.	PUNCT
ajbspi-34500	101	1	nefrotik	nefrotik	PROPN
ajbspi-34500	101	2	sindromda	sindromda	PROPN
ajbspi-34500	101	3	buyraklarning	buyraklarne	VERB
ajbspi-34500	101	4	funktsional	funktsional	ADJ
ajbspi-34500	101	5	zaxirasi	zaxirasi	NOUN
ajbspi-34500	101	6	/	/	SYM
ajbspi-34500	101	7	/	/	SYM
ajbspi-34500	101	8	ter	ter	NOUN
ajbspi-34500	101	9	.	.	PUNCT
ajbspi-34500	102	1	arx	arx	PROPN
ajbspi-34500	102	2	.	.	PUNCT
ajbspi-34500	102	3	qaniydi	qaniydi	PROPN
ajbspi-34500	102	4	?	?	PUNCT
ajbspi-34500	103	1	1996.-no6.c	1996.-no6.c	NUM
ajbspi-34500	103	2	.	.	PUNCT
ajbspi-34500	104	1	55	55	NUM
ajbspi-34500	104	2	-	-	SYM
ajbspi-34500	104	3	58	58	NUM
ajbspi-34500	104	4	.	.	PUNCT
ajbspi-34500	105	1	7	7	X
ajbspi-34500	105	2	.	.	X
ajbspi-34500	105	3	smirnov	smirnov	PROPN
ajbspi-34500	105	4	a.	a.	PROPN
ajbspi-34500	105	5	v.	v.	PROPN
ajbspi-34500	105	6	,	,	PUNCT
ajbspi-34500	105	7	yesayan	yesayan	ADJ
ajbspi-34500	105	8	a.	a.	NOUN
ajbspi-34500	105	9	m.	m.	NOUN
ajbspi-34500	105	10	,	,	PUNCT
ajbspi-34500	105	11	kayukov	kayukov	PROPN
ajbspi-34500	105	12	i.	i.	PROPN
ajbspi-34500	105	13	g.	g.	PROPN
ajbspi-34500	105	14	surunkali	surunkali	PROPN
ajbspi-34500	106	1	buyrak	buyrak	PROPN
ajbspi-34500	106	2	kasalligi	kasalligi	PROPN
ajbspi-34500	106	3	:	:	PUNCT
ajbspi-34500	106	4	yakdillik	yakdillik	NOUN
ajbspi-34500	106	5	birligi	birligi	NOUN
ajbspi-34500	106	6	yo'lida	yo'lida	PROPN
ajbspi-34500	106	7	//nefrologiya.-2002.6	//nefrologiya.-2002.6	PROPN
ajbspi-34500	106	8	-	-	PUNCT
ajbspi-34500	106	9	jild	jild	NOUN
ajbspi-34500	106	10	,	,	PUNCT
ajbspi-34500	106	11	4	4	NUM
ajbspi-34500	106	12	-	-	PUNCT
ajbspi-34500	106	13	son.11	son.11	ADJ
ajbspi-34500	106	14	-	-	PUNCT
ajbspi-34500	106	15	17	17	NUM
ajbspi-34500	106	16	betlar	betlar	ADJ
ajbspi-34500	106	17	.	.	PUNCT
ajbspi-34500	107	1	8	8	X
ajbspi-34500	107	2	.	.	X
ajbspi-34500	107	3	ишкабулова	ишкабулова	PROPN
ajbspi-34500	108	1	г.д	г.д	PROPN
ajbspi-34500	108	2	.	.	PROPN
ajbspi-34500	108	3	,	,	PUNCT
ajbspi-34500	108	4	холмурадова	холмурадова	AUX
ajbspi-34500	108	5	з.э	з.э	PROPN
ajbspi-34500	108	6	.	.	PROPN
ajbspi-34500	108	7	фосфолипидная	фосфолипидная	PROPN
ajbspi-34500	108	8	структура	структура	PROPN
ajbspi-34500	108	9	и	и	PROPN
ajbspi-34500	108	10	состояние	состояние	NOUN
ajbspi-34500	108	11	перекисного	перекисного	ADJ
ajbspi-34500	108	12	окисления	окисления	NOUN
ajbspi-34500	108	13	липидов	липидов	VERB
ajbspi-34500	108	14	эритроцитарных	эритроцитарных	NOUN
ajbspi-34500	108	15	мембран	мембран	PROPN
ajbspi-34500	108	16	у	у	PROPN
ajbspi-34500	108	17	новорожденных	новорожденных	NOUN
ajbspi-34500	108	18	от	от	ADP
ajbspi-34500	108	19	матерей	матерей	PROPN
ajbspi-34500	108	20	с	с	PROPN
ajbspi-34500	108	21	гестозом	гестозом	PROPN
ajbspi-34500	108	22	,	,	PUNCT
ajbspi-34500	108	23	сочетанным	сочетанным	PROPN
ajbspi-34500	108	24	хроническим	хроническим	NOUN
ajbspi-34500	108	25	пиелонефритом	пиелонефритом	NOUN
ajbspi-34500	108	26	.	.	PUNCT
ajbspi-34500	108	27	//журнал	//журнал	PUNCT
ajbspi-34500	109	1	биомедицины	биомедицины	NOUN
ajbspi-34500	109	2	и	и	X
ajbspi-34500	109	3	практики	практики	ADJ
ajbspi-34500	109	4	.2022.-	.2022.-	PROPN
ajbspi-34500	109	5	№	№	ADJ
ajbspi-34500	109	6	3	3	NUM
ajbspi-34500	109	7	–	–	PUNCT
ajbspi-34500	109	8	с71	с71	NOUN
ajbspi-34500	109	9	-	-	PUNCT
ajbspi-34500	109	10	77	77	NUM
ajbspi-34500	109	11	.	.	PUNCT
ajbspi-34500	110	1	9	9	NUM
ajbspi-34500	110	2	.	.	X
ajbspi-34500	110	3	epstein	epstein	PROPN
ajbspi-34500	110	4	m.	m.	NOUN
ajbspi-34500	110	5	aldosterone	aldosterone	NOUN
ajbspi-34500	110	6	as	as	ADP
ajbspi-34500	110	7	a	a	DET
ajbspi-34500	110	8	mediator	mediator	NOUN
ajbspi-34500	110	9	of	of	ADP
ajbspi-34500	110	10	progressive	progressive	ADJ
ajbspi-34500	110	11	renal	renal	ADJ
ajbspi-34500	110	12	disease	disease	NOUN
ajbspi-34500	110	13	:	:	PUNCT
ajbspi-34500	110	14	pathogenetic	pathogenetic	ADJ
ajbspi-34500	110	15	and	and	CCONJ
ajbspi-34500	110	16	clinical	clinical	ADJ
ajbspi-34500	110	17	implications	implication	NOUN
ajbspi-34500	110	18	||am	||am	NOUN
ajbspi-34500	110	19	,	,	PUNCT
ajbspi-34500	110	20	j.	j.	PROPN
ajbspi-34500	110	21	kidney	kidney	PROPN
ajbspi-34500	110	22	dis.-2001	dis.-2001	PROPN
ajbspi-34500	110	23	;	;	PUNCT
ajbspi-34500	110	24	237:677	237:677	NUM
ajbspi-34500	110	25	-	-	PUNCT
ajbspi-34500	110	26	688	688	NUM
ajbspi-34500	110	27	.	.	PUNCT
ajbspi-34500	111	1	10	10	NUM
ajbspi-34500	111	2	.	.	PUNCT
ajbspi-34500	111	3	mazzali	mazzali	PROPN
ajbspi-34500	111	4	m.	m.	PROPN
ajbspi-34500	111	5	,	,	PUNCT
ajbspi-34500	111	6	hyghes	hyghe	VERB
ajbspi-34500	111	7	j.	j.	PROPN
ajbspi-34500	111	8	;	;	PUNCT
ajbspi-34500	111	9	kin	kin	PROPN
ajbspi-34500	111	10	y.	y.	PROPN
ajbspi-34500	111	11	et	et	PROPN
ajbspi-34500	111	12	.	.	PUNCT
ajbspi-34500	112	1	al	al	PROPN
ajbspi-34500	112	2	.	.	PROPN
ajbspi-34500	112	3	elevated	elevated	ADJ
ajbspi-34500	112	4	uricacid	uricacid	ADJ
ajbspi-34500	112	5	increases	increase	VERB
ajbspi-34500	112	6	blood	blood	NOUN
ajbspi-34500	112	7	pressure	pressure	NOUN
ajbspi-34500	112	8	in	in	ADP
ajbspi-34500	112	9	the	the	DET
ajbspi-34500	112	10	rat	rat	NOUN
ajbspi-34500	112	11	by	by	ADP
ajbspi-34500	112	12	a	a	DET
ajbspi-34500	112	13	novel	novel	ADJ
ajbspi-34500	112	14	crystalindependent	crystalindependent	NOUN
ajbspi-34500	112	15	mechanism	mechanism	NOUN
ajbspi-34500	112	16	hypertension	hypertension	NOUN
ajbspi-34500	112	17	.	.	PUNCT
ajbspi-34500	113	1	2001	2001	NUM
ajbspi-34500	113	2	;	;	PUNCT
ajbspi-34500	113	3	38	38	NUM
ajbspi-34500	113	4	:	:	PUNCT
ajbspi-34500	113	5	1101	1101	NUM
ajbspi-34500	113	6	-	-	SYM
ajbspi-34500	113	7	1106	1106	NUM
ajbspi-34500	113	8	.	.	PUNCT
ajbspi-34500	114	1	11	11	NUM
ajbspi-34500	114	2	.	.	X
ajbspi-34500	115	1	ishkabulova	ishkabulova	PROPN
ajbspi-34500	116	1	g.	g.	PROPN
ajbspi-34500	116	2	d.	d.	PROPN
ajbspi-34500	116	3	et	et	PROPN
ajbspi-34500	117	1	al	al	PROPN
ajbspi-34500	117	2	.	.	PUNCT
ajbspi-34500	118	1	modern	modern	ADJ
ajbspi-34500	118	2	methods	method	NOUN
ajbspi-34500	118	3	for	for	ADP
ajbspi-34500	118	4	assessing	assess	VERB
ajbspi-34500	118	5	the	the	DET
ajbspi-34500	118	6	course	course	NOUN
ajbspi-34500	118	7	,	,	PUNCT
ajbspi-34500	118	8	treatment	treatment	NOUN
ajbspi-34500	118	9	,	,	PUNCT
ajbspi-34500	118	10	and	and	CCONJ
ajbspi-34500	118	11	prognosis	prognosis	NOUN
ajbspi-34500	118	12	of	of	ADP
ajbspi-34500	118	13	chronic	chronic	ADJ
ajbspi-34500	118	14	renal	renal	ADJ
ajbspi-34500	118	15	failure	failure	NOUN
ajbspi-34500	118	16	in	in	ADP
ajbspi-34500	118	17	children	child	NOUN
ajbspi-34500	118	18	//british	//british	PUNCT
ajbspi-34500	118	19	medical	medical	ADJ
ajbspi-34500	118	20	journal	journal	NOUN
ajbspi-34500	118	21	.	.	PUNCT
ajbspi-34500	119	1	–	–	PUNCT
ajbspi-34500	119	2	2023	2023	NUM
ajbspi-34500	119	3	.	.	PUNCT
ajbspi-34500	120	1	–	–	PUNCT
ajbspi-34500	120	2	т	т	X
ajbspi-34500	120	3	.	.	NOUN
ajbspi-34500	120	4	3	3	NUM
ajbspi-34500	120	5	.	.	X
ajbspi-34500	120	6	–	–	PUNCT
ajbspi-34500	120	7	№	№	NOUN
ajbspi-34500	120	8	.	.	NOUN
ajbspi-34500	121	1	1	1	NUM
ajbspi-34500	121	2	.	.	NUM
ajbspi-34500	121	3	12	12	NUM
ajbspi-34500	121	4	.	.	PUNCT
ajbspi-34500	122	1	yuryeva	yuryeva	PROPN
ajbspi-34500	122	2	e.	e.	PROPN
ajbspi-34500	122	3	a.	a.	PROPN
ajbspi-34500	122	4	,	,	PUNCT
ajbspi-34500	122	5	dlin	dlin	PROPN
ajbspi-34500	122	6	v.	v.	PROPN
ajbspi-34500	122	7	v.	v.	CCONJ
ajbspi-34500	122	8	“	"	PUNCT
ajbspi-34500	122	9	nefrologiya	nefrologiya	NOUN
ajbspi-34500	122	10	diagnostik	diagnostik	NOUN
ajbspi-34500	122	11	qo'llanmasi,".-2002.-95c	qo'llanmasi,".-2002.-95c	NOUN
ajbspi-34500	122	12	.	.	PROPN
ajbspi-34500	122	13	13	13	NUM
ajbspi-34500	122	14	.	.	PUNCT
ajbspi-34500	122	15	ишкабулова	ишкабулова	PROPN
ajbspi-34500	122	16	г	г	PROPN
ajbspi-34500	122	17	.	.	PUNCT
ajbspi-34500	123	1	д	д	PROPN
ajbspi-34500	123	2	.	.	PROPN
ajbspi-34500	123	3	,	,	PUNCT
ajbspi-34500	123	4	холмурадова	холмурадова	VERB
ajbspi-34500	123	5	з	з	X
ajbspi-34500	123	6	.	.	PROPN
ajbspi-34500	124	1	э	э	X
ajbspi-34500	124	2	.	.	PUNCT
ajbspi-34500	125	1	homiladorlik	homiladorlik	PROPN
ajbspi-34500	125	2	surunkali	surunkali	PROPN
ajbspi-34500	125	3	pielonefrit	pielonefrit	PROPN
ajbspi-34500	125	4	va	va	PROPN
ajbspi-34500	125	5	gestoz	gestoz	PROPN
ajbspi-34500	125	6	bilan	bilan	PROPN
ajbspi-34500	125	7	kechgan	kechgan	PROPN
ajbspi-34500	125	8	onalardan	onalardan	PROPN
ajbspi-34500	125	9	tug'ilgan	tug'ilgan	PROPN
ajbspi-34500	125	10	chaqaloqlarda	chaqaloqlarda	PROPN
ajbspi-34500	125	11	fosfolipid	fosfolipid	PROPN
ajbspi-34500	125	12	tuzilishi	tuzilishi	PROPN
ajbspi-34500	125	13	va	va	PROPN
ajbspi-34500	125	14	eritrotsit	eritrotsit	PROPN
ajbspi-34500	125	15	membranalarining	membranalarining	NOUN
ajbspi-34500	125	16	lipid	lipid	NOUN
ajbspi-34500	125	17	peroksidlanish	peroksidlanish	PROPN
ajbspi-34500	125	18	holati	holati	PROPN
ajbspi-34500	125	19	//журнал	//журнал	PUNCT
ajbspi-34500	125	20	биомедицины	биомедицины	NOUN
ajbspi-34500	125	21	и	и	X
ajbspi-34500	125	22	практики	практики	ADJ
ajbspi-34500	125	23	.	.	PUNCT
ajbspi-34500	126	1	–	–	PUNCT
ajbspi-34500	126	2	2022	2022	NUM
ajbspi-34500	126	3	.	.	PUNCT
ajbspi-34500	127	1	–	–	PUNCT
ajbspi-34500	127	2	т	т	X
ajbspi-34500	127	3	.	.	NOUN
ajbspi-34500	127	4	7	7	NUM
ajbspi-34500	127	5	.	.	X
ajbspi-34500	127	6	–	–	PUNCT
ajbspi-34500	127	7	№	№	NOUN
ajbspi-34500	127	8	.	.	PUNCT
ajbspi-34500	128	1	3	3	NUM
ajbspi-34500	128	2	.	.	NOUN
ajbspi-34500	128	3	14	14	NUM
ajbspi-34500	128	4	.	.	PUNCT
ajbspi-34500	128	5	ishkabulova	ishkabulova	PROPN
ajbspi-34500	128	6	g.d	g.d	PROPN
ajbspi-34500	128	7	.	.	PROPN
ajbspi-34500	128	8	,kholmuradova	,kholmuradova	PUNCT
ajbspi-34500	128	9	z.e	z.e	PROPN
ajbspi-34500	128	10	.	.	PROPN
ajbspi-34500	128	11	functional	functional	ADJ
ajbspi-34500	128	12	state	state	NOUN
ajbspi-34500	128	13	of	of	ADP
ajbspi-34500	128	14	the	the	DET
ajbspi-34500	128	15	kidneys	kidney	NOUN
ajbspi-34500	128	16	in	in	ADP
ajbspi-34500	128	17	newborn	newborn	ADJ
ajbspi-34500	128	18	born	bear	VERB
ajbspi-34500	128	19	from	from	ADP
ajbspi-34500	128	20	mothers	mother	NOUN
ajbspi-34500	128	21	with	with	ADP
ajbspi-34500	128	22	pre	pre	ADJ
ajbspi-34500	128	23	-	-	ADJ
ajbspi-34500	128	24	eklampsia	eklampsia	ADJ
ajbspi-34500	128	25	//	//	NUM
ajbspi-34500	128	26	world	world	NOUN
ajbspi-34500	128	27	bulletin	bulletin	NOUN
ajbspi-34500	128	28	of	of	ADP
ajbspi-34500	128	29	public	public	ADJ
ajbspi-34500	128	30	health	health	NOUN
ajbspi-34500	128	31	(	(	PUNCT
ajbspi-34500	128	32	wbph).-2022	wbph).-2022	NOUN
ajbspi-34500	128	33	semtember	semtember	NOUN
ajbspi-34500	128	34	,	,	PUNCT
ajbspi-34500	128	35	-c75	-c75	NOUN
ajbspi-34500	128	36	-	-	SYM
ajbspi-34500	128	37	78	78	NUM
ajbspi-34500	128	38	15	15	NUM
ajbspi-34500	128	39	.	.	PUNCT
ajbspi-34500	128	40	сomparative	сomparative	ADJ
ajbspi-34500	128	41	assessment	assessment	NOUN
ajbspi-34500	128	42	on	on	ADP
ajbspi-34500	128	43	the	the	DET
ajbspi-34500	128	44	effect	effect	NOUN
ajbspi-34500	128	45	of	of	ADP
ajbspi-34500	128	46	different	different	ADJ
ajbspi-34500	128	47	methods	method	NOUN
ajbspi-34500	128	48	of	of	ADP
ajbspi-34500	128	49	corrective	corrective	ADJ
ajbspi-34500	128	50	therapy	therapy	NOUN
ajbspi-34500	128	51	on	on	ADP
ajbspi-34500	128	52	lipid	lipid	PROPN
ajbspi-34500	128	53	metabolismand	metabolismand	CCONJ
ajbspi-34500	128	54	homeostatic	homeostatic	ADJ
ajbspi-34500	128	55	renal	renal	ADJ
ajbspi-34500	128	56	function	function	NOUN
ajbspi-34500	128	57	.	.	PUNCT
ajbspi-34500	129	1	ishkabulova	ishkabulova	PROPN
ajbspi-34500	129	2	g.j.1	g.j.1	PROPN
ajbspi-34500	129	3	,	,	PUNCT
ajbspi-34500	129	4	khaidarova	khaidarova	PROPN
ajbspi-34500	129	5	k.r.1	k.r.1	PROPN
ajbspi-34500	129	6	,	,	PUNCT
ajbspi-34500	129	7	kudratova	kudratova	PROPN
ajbspi-34500	129	8	g.n.1	g.n.1	NOUN
ajbspi-34500	129	9	,	,	PUNCT
ajbspi-34500	129	10	kholmuradova	kholmuradova	X
ajbspi-34500	129	11	z.e.1	z.e.1	PROPN
ajbspi-34500	129	12	department	department	NOUN
ajbspi-34500	129	13	of	of	ADP
ajbspi-34500	129	14	pediatrics	pediatric	NOUN
ajbspi-34500	129	15	,	,	PUNCT
ajbspi-34500	129	16	faculty	faculty	NOUN
ajbspi-34500	129	17	of	of	ADP
ajbspi-34500	129	18	therapeutics	therapeutic	NOUN
ajbspi-34500	129	19	,	,	PUNCT
ajbspi-34500	129	20	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	PROPN
ajbspi-34500	129	21	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	NOUN
ajbspi-34500	129	22	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	ADJ
ajbspi-34500	129	23	volume	volume	NOUN
ajbspi-34500	129	24	04	04	NUM
ajbspi-34500	129	25	issue	issue	NOUN
ajbspi-34500	129	26	03	03	NUM
ajbspi-34500	129	27	-	-	SYM
ajbspi-34500	129	28	2024	2024	NUM
ajbspi-34500	129	29	43	43	NUM
ajbspi-34500	129	30	american	american	ADJ
ajbspi-34500	129	31	journal	journal	PROPN
ajbspi-34500	129	32	of	of	ADP
ajbspi-34500	129	33	biomedical	biomedical	PROPN
ajbspi-34500	129	34	science	science	PROPN
ajbspi-34500	129	35	&	&	CCONJ
ajbspi-34500	129	36	pharmaceutical	pharmaceutical	PROPN
ajbspi-34500	129	37	innovation	innovation	NOUN
ajbspi-34500	129	38	(	(	PUNCT
ajbspi-34500	129	39	issn	issn	PROPN
ajbspi-34500	129	40	–	–	PUNCT
ajbspi-34500	129	41	2771	2771	NUM
ajbspi-34500	129	42	-	-	SYM
ajbspi-34500	129	43	2753	2753	NUM
ajbspi-34500	129	44	)	)	PUNCT
ajbspi-34500	129	45	volume	volume	NOUN
ajbspi-34500	129	46	04	04	NUM
ajbspi-34500	129	47	issue	issue	NOUN
ajbspi-34500	129	48	03	03	NUM
ajbspi-34500	129	49	pages	page	NOUN
ajbspi-34500	129	50	:	:	PUNCT
ajbspi-34500	129	51	36	36	NUM
ajbspi-34500	129	52	-	-	SYM
ajbspi-34500	129	53	43	43	NUM
ajbspi-34500	129	54	sjif	sjif	NOUN
ajbspi-34500	129	55	impact	impact	NOUN
ajbspi-34500	129	56	factor	factor	NOUN
ajbspi-34500	129	57	(	(	PUNCT
ajbspi-34500	129	58	2022	2022	NUM
ajbspi-34500	129	59	:	:	PUNCT
ajbspi-34500	129	60	5	5	NUM
ajbspi-34500	129	61	.	.	NOUN
ajbspi-34500	129	62	705	705	NUM
ajbspi-34500	129	63	)	)	PUNCT
ajbspi-34500	129	64	(	(	PUNCT
ajbspi-34500	129	65	2023	2023	NUM
ajbspi-34500	129	66	:	:	PUNCT
ajbspi-34500	129	67	6.534	6.534	NUM
ajbspi-34500	129	68	)	)	PUNCT
ajbspi-34500	129	69	(	(	PUNCT
ajbspi-34500	129	70	2024	2024	NUM
ajbspi-34500	129	71	:	:	PUNCT
ajbspi-34500	129	72	7.7	7.7	NUM
ajbspi-34500	129	73	)	)	PUNCT
ajbspi-34500	129	74	oclc	oclc	PROPN
ajbspi-34500	129	75	–	–	PUNCT
ajbspi-34500	129	76	1121105677	1121105677	NUM
ajbspi-34500	129	77	publisher	publisher	NOUN
ajbspi-34500	129	78	:	:	PUNCT
ajbspi-34500	129	79	oscar	oscar	NOUN
ajbspi-34500	129	80	publishing	publishing	NOUN
ajbspi-34500	129	81	services	service	NOUN
ajbspi-34500	129	82	servi	servi	PROPN
ajbspi-34500	129	83	samarkand	samarkand	PROPN
ajbspi-34500	129	84	state	state	PROPN
ajbspi-34500	129	85	medical	medical	PROPN
ajbspi-34500	129	86	institute	institute	PROPN
ajbspi-34500	129	87	том	том	PROPN
ajbspi-34500	129	88	:	:	PUNCT
ajbspi-34500	129	89	7	7	NUM
ajbspi-34500	129	90	номер	номер	ADJ
ajbspi-34500	129	91	:	:	PUNCT
ajbspi-34500	129	92	3	3	NUM
ajbspi-34500	129	93	год	год	NOUN
ajbspi-34500	129	94	:	:	PUNCT
ajbspi-34500	129	95	2020	2020	NUM
ajbspi-34500	129	96	страницы	страницы	NOUN
ajbspi-34500	129	97	:	:	PUNCT
ajbspi-34500	129	98	2794	2794	NUM
ajbspi-34500	129	99	-	-	SYM
ajbspi-34500	129	100	2800	2800	NUM
ajbspi-34500	129	101	16	16	NUM
ajbspi-34500	129	102	.	.	PUNCT
ajbspi-34500	130	1	ergashevna	ergashevna	VERB
ajbspi-34500	130	2	k.	k.	PROPN
ajbspi-34500	130	3	z.	z.	PROPN
ajbspi-34500	130	4	,	,	PUNCT
ajbspi-34500	130	5	ramizovna	ramizovna	VERB
ajbspi-34500	130	6	k.	k.	PROPN
ajbspi-34500	130	7	k.	k.	PROPN
ajbspi-34500	130	8	,	,	PUNCT
ajbspi-34500	130	9	botirbekovna	botirbekovna	VERB
ajbspi-34500	130	10	i.	i.	PROPN
ajbspi-34500	130	11	y.	y.	PROPN
ajbspi-34500	130	12	obesity	obesity	PROPN
ajbspi-34500	130	13	and	and	CCONJ
ajbspi-34500	130	14	the	the	DET
ajbspi-34500	130	15	functional	functional	ADJ
ajbspi-34500	130	16	state	state	NOUN
ajbspi-34500	130	17	of	of	ADP
ajbspi-34500	130	18	the	the	DET
ajbspi-34500	130	19	cardiovascular	cardiovascular	ADJ
ajbspi-34500	130	20	system	system	NOUN
ajbspi-34500	130	21	in	in	ADP
ajbspi-34500	130	22	children	child	NOUN
ajbspi-34500	130	23	//eurasian	//eurasian	PUNCT
ajbspi-34500	130	24	medical	medical	ADJ
ajbspi-34500	130	25	research	research	NOUN
ajbspi-34500	130	26	periodical	periodical	NOUN
ajbspi-34500	130	27	.	.	PUNCT
ajbspi-34500	131	1	–	–	PUNCT
ajbspi-34500	131	2	2022	2022	NUM
ajbspi-34500	131	3	.	.	PUNCT
ajbspi-34500	132	1	–	–	PUNCT
ajbspi-34500	132	2	т	т	X
ajbspi-34500	132	3	.	.	NOUN
ajbspi-34500	132	4	8	8	NUM
ajbspi-34500	132	5	.	.	X
ajbspi-34500	132	6	–	–	PUNCT
ajbspi-34500	132	7	с	с	PROPN
ajbspi-34500	132	8	.	.	PUNCT
ajbspi-34500	132	9	4851	4851	NUM
ajbspi-34500	132	10	.	.	PUNCT
ajbspi-34500	133	1	17	17	NUM
ajbspi-34500	133	2	.	.	PUNCT
ajbspi-34500	134	1	jonhurozovna	jonhurozovna	PROPN
ajbspi-34500	134	2	i.	i.	PROPN
ajbspi-34500	134	3	g.	g.	PROPN
ajbspi-34500	134	4	,	,	PUNCT
ajbspi-34500	134	5	ergashevna	ergashevna	VERB
ajbspi-34500	134	6	k.	k.	PROPN
ajbspi-34500	134	7	z.	z.	PROPN
ajbspi-34500	134	8	clinical	clinical	ADJ
ajbspi-34500	134	9	significance	significance	NOUN
ajbspi-34500	134	10	of	of	ADP
ajbspi-34500	134	11	functional	functional	ADJ
ajbspi-34500	134	12	reserving	reserving	NOUN
ajbspi-34500	134	13	of	of	ADP
ajbspi-34500	134	14	the	the	DET
ajbspi-34500	134	15	kidneys	kidney	NOUN
ajbspi-34500	134	16	in	in	ADP
ajbspi-34500	134	17	dismetabolic	dismetabolic	ADJ
ajbspi-34500	134	18	nephropathy	nephropathy	NOUN
ajbspi-34500	134	19	and	and	CCONJ
ajbspi-34500	134	20	children	child	NOUN
ajbspi-34500	134	21	//archive	//archive	PUNCT
ajbspi-34500	134	22	of	of	ADP
ajbspi-34500	134	23	conferences	conference	NOUN
ajbspi-34500	134	24	.	.	PUNCT
ajbspi-34500	135	1	–	–	PUNCT
ajbspi-34500	135	2	2021	2021	NUM
ajbspi-34500	135	3	.	.	PUNCT
ajbspi-34500	136	1	–	–	PUNCT
ajbspi-34500	136	2	т	т	X
ajbspi-34500	136	3	.	.	NOUN
ajbspi-34500	136	4	17	17	NUM
ajbspi-34500	136	5	.	.	PUNCT
ajbspi-34500	136	6	–	–	PUNCT
ajbspi-34500	136	7	№	№	NOUN
ajbspi-34500	136	8	.	.	NOUN
ajbspi-34500	137	1	1	1	NUM
ajbspi-34500	137	2	.	.	X
ajbspi-34500	137	3	–	–	PUNCT
ajbspi-34500	137	4	с	с	NOUN
ajbspi-34500	137	5	.	.	PROPN
ajbspi-34500	137	6	60	60	NUM
ajbspi-34500	137	7	-	-	SYM
ajbspi-34500	137	8	65	65	NUM
ajbspi-34500	137	9	.	.	PUNCT
ajbspi-34500	138	1	https://doi.org/10.37547/ajbspi/volume03issue03-01	https://doi.org/10.37547/ajbspi/volume03issue03-01	PROPN
ajbspi-34500	138	2	https://scholar.google.co.in/scholar?q=	https://scholar.google.co.in/scholar?q=	PROPN
ajbspi-34500	138	3	https://www.mendeley.com/search/?page=1&query=	https://www.mendeley.com/search/?page=1&query=	NOUN